0001144204-16-100556.txt : 20160510 0001144204-16-100556.hdr.sgml : 20160510 20160510172221 ACCESSION NUMBER: 0001144204-16-100556 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 74 CONFORMED PERIOD OF REPORT: 20160331 FILED AS OF DATE: 20160510 DATE AS OF CHANGE: 20160510 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EKSO BIONICS HOLDINGS, INC. CENTRAL INDEX KEY: 0001549084 STANDARD INDUSTRIAL CLASSIFICATION: GENERAL INDUSTRIAL MACHINERY & EQUIPMENT, NEC [3569] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-55442 FILM NUMBER: 161636944 BUSINESS ADDRESS: STREET 1: 1414 HARBOUR WAY SOUTH STREET 2: SUITE 1201 CITY: RICHMOND STATE: CA ZIP: 94804 BUSINESS PHONE: 510-984-1761 MAIL ADDRESS: STREET 1: 1414 HARBOUR WAY SOUTH STREET 2: SUITE 1201 CITY: RICHMOND STATE: CA ZIP: 94804 FORMER COMPANY: FORMER CONFORMED NAME: PN Med Group Inc DATE OF NAME CHANGE: 20120503 10-Q 1 v438707_10q.htm FORM 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2016

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______ to ______

Commission File Number: 000-55442

Ekso Bionics Holdings, Inc.

(Exact name of registrant as specified in its charter)

Nevada		99-0367049
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

1414 Harbour Way South, Suite 1201 Richmond, CA		94804
(Address of principal executive offices)		(Zip Code)

(510) 984-1761

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted to its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ¨		Accelerated filer x

Non-accelerated filer ¨		Smaller reporting company ¨
(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x

The number of shares of registrant’s common stock outstanding as of May 5, 2016 was: 16,182,889

Ekso Bionics Holdings, Inc.

Quarterly Report on Form 10-Q

Table of Contents

		Page No.
	PART I. FINANCIAL INFORMATION

Item 1.	Financial Statements	3

	Condensed Consolidated Balance Sheets as of March 31, 2016 (unaudited) and December 31, 2015	3

	Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2016 and 2015 (unaudited)	4

	Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2016 and 2015 (unaudited)	5

	Notes to Condensed Consolidated Financial Statements (unaudited)	6

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	20

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	28

Item 4.	Controls and Procedures	28

	PART II. OTHER INFORMATION

Item 1.	Legal Proceedings	29

Item 1A.	Risk Factors	29

Item 6.	Exhibits	30

	Signatures	31

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

Ekso Bionics Holdings, Inc.

Condensed Consolidated Balance Sheets

(In thousands, except par value)

	March 31,			December 31,
	2016			2015
	(unaudited)			(Note 2)
Assets
Current assets:
Cash	$	12,314		$	19,552
Accounts receivable		2,383			2,069
Inventories, net		2,531			1,056
Prepaid expenses and other current assets		738			436
Deferred cost of revenue, current		255			2,088
Total current assets		18,221			25,201
Property and equipment, net		2,617			2,625
Deferred cost of revenue		-			2,502
Intangible assets, net		1,431			1,584
Goodwill		189			189
Other assets		93			97
Total assets	$	22,551		$	32,198

Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable	$	3,618		$	2,694
Accrued liabilities		2,928			1,885
Deferred revenues, current		1,222			3,960
Capital lease obligation, current		81			80
Total current liabilities		7,849			8,619
Deferred revenues		766			4,613
Warrant liability		6,210			9,195
Contingent consideration liability		768			768
Other non-current liabilities		205			195
Total liabilities		15,798			23,390
Commitments and contingencies (Note 12)
Stockholders' equity:
Convertible preferred stock, $0.001 par value; 10,000 shares authorized at March 31, 2016 and December 31, 2015; 9 and 13 outstanding at March 31, 2016 and December 31, 2015, respectively		-			-
Common stock, $0.001 par value; 71,429 shares authorized at March 31, 2016 and December 31, 2015; 15,604 and 15,027 outstanding at March 31, 2016 and December 31, 2015, respectively		109			105
Additional paid-in capital		101,686			100,094
Accumulated deficit		(95,042	)		(91,391	)
Total stockholders' equity		6,753			8,808
Total liabilities and stockholders' equity	$	22,551		$	32,198

See Accompanying Notes to Unaudited Condensed Consolidated Financial Statements

Ekso Bionics Holdings, Inc.

Condensed Consolidated Statement of Operations

(In thousands, except per share amounts)

(Unaudited)

	Three months ended March 31,
	2016			2015
Revenue:
Medical devices (see Note 2)	$	8,057		$	985
Engineering services		429			704
Total revenue		8,486			1,689

Cost of revenue:
Medical devices		6,669			798
Engineering services		319			488
Total cost of revenue		6,988			1,286

Gross profit		1,498			403

Operating expenses:
Sales and marketing		2,503			1,851
Research and development		2,149			983
General and administrative		3,488			1,662
Total operating expenses		8,140			4,496

Loss from operations		(6,642	)		(4,093	)

Other income (expense) net:
Gain on warrant liability		2,985			-
Interest and other, net		6			(22	)
Total other income (expense), net		2,991			(22	)

Net loss		(3,651	)		(4,115	)

Less: Preferred deemed dividend		(3,124	)		-
Net loss applicable to common shareholders	$	(6,775	)	$	(4,115	)

Basic and diluted net loss per share	$	(0.44	)	$	(0.28	)

Weighted average number of shares of common stock outstanding, basic and diluted		15,388			14,542

See Accompanying Notes to the Unaudited Condensed Consolidated Financial Statements

Ekso Bionics Holdings, Inc.

Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

	Three months ended
	March 31,
	2016			2015
Operating activities:
Net loss	$	(3,651	)	$	(4,115	)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization		440			200
Inventory allowance expense		-			45
Amortization of deferred rent		(9	)		(10	)
Stock-based compensation expense		1,574			349
(Gain) on change in fair value of warrant liability		(2,985	)		-
Changes in operating assets and liabilities:
Accounts receivable		(314	)		94
Inventories		(1,475	)		(261	)
Prepaid expense and other assets		(298	)		(59	)
Deferred costs of revenue		4,335			(354	)
Accounts payable		924			681
Accrued liabilities		1,255			(721	)
Deferred revenues		(6,585	)		323
Net cash used in operating activities		(6,789	)		(3,828	)

Investing activities:
Acquisition of property and equipment		(285	)		(281	)
Net cash used in investing activities		(285	)		(281	)

Financing activities:
Principal payments on note payable		(19	)		(11	)
Fees paid related to 2015 issuance of convertible preferred stock		(173	)		-
Proceeds from exercise of stock options		28			31
Proceeds from exercise of warrants		-			32
Net cash (used in) provided by financing activities		(164	)		52
Net decrease in cash		(7,238	)		(4,057	)
Cash at beginning of period		19,552			25,190
Cash at end of period	$	12,314		$	21,133

See Accompanying Notes to Unaudited Condensed Consolidated Financial Statements

Ekso Bionics Holdings, Inc.

Notes to Condensed Consolidated Financial Statements

(in thousands, except per share amounts)

(Unaudited)

1. Organization

Description of Business

On January 15, 2014, a wholly-owned subsidiary of Ekso Bionics Holdings, Inc. named Ekso Acquisition Corp. merged with and into Ekso Bionics, Inc. (the “Merger”). Ekso Bionics, Inc. was the surviving corporation and became a wholly-owned subsidiary of Ekso Bionics Holdings, Inc. As a result of this transaction, Ekso Bionics Holdings, Inc. discontinued its pre-merger operations, acquired the business of Ekso Bionics, Inc. and continues the operations of Ekso Bionics, Inc. as a publicly traded company. Ekso Bionics, Inc. was incorporated in January 2005 in the State of Delaware.

As used in these notes to the consolidated financial statements, the term “the Company” refers to Ekso Bionics Holdings, Inc. formerly known as PN Med Group, Inc., and its wholly-owned subsidiaries, including Ekso Bionics, Inc. after giving effect to the Merger; the term “Holdings” refers to the business of Ekso Bionics Holdings, Inc. prior to the Merger, and the term “Ekso Bionics” refers to Ekso Bionics, Inc. prior to the Merger. Unless otherwise indicated, all dollar and share amounts included in these notes to the financial statements are in thousands. All common stock share and per share amounts have been retroactively adjusted to reflect the one-for-seven reverse stock split completed on May 4, 2016. See Note 15, Subsequent Event.

The Company designs, develops, and sells exoskeletons that augment human strength, endurance and mobility. The Company’s exoskeletons have applications in health care, industrial, military, and consumer markets.

Liquidity

Largely as a result of significant research and development activities related to the development of the Company’s advanced technology and commercialization of this technology into its medical device business, the Company has incurred significant operating losses and negative cash flows from operations since inception. The Company has also recognized significant non-cash losses associated with the revaluation of certain securities, which have also contributed significantly to its accumulated deficit. As of March 31, 2016, the Company had an accumulated deficit of $95,042.

Cash on hand at March 31, 2016 was $12,314, compared to $19,552 at December 31, 2015. For the three months ended March 31, 2016, the Company used $6,789 of cash in operations which included non-routine investments of working capital, the majority of which the Company expects will be reversed during the year, compared to $3,828 for the three months ended March 31, 2015.

Based upon the Company’s current twelve-month average net use of cash of approximately $1,800 per month and assuming increases in current revenue, offset by an incremental increase in expenses related to increased sales and marketing and research and development, and a potential increase in rental activity from its medical device business, the Company believes it has sufficient resources to meet its financial obligations into the first quarter of 2017.

The Company’s actual capital requirements may vary significantly and will depend on many factors. For example, the Company plans to continue to increase its investments (i) in its clinical, sales and marketing initiatives to accelerate adoption of the Ekso robotic exoskeleton in the rehabilitation market, (ii) in its research, development and commercialization activities with respect to an Ekso robotic exoskeleton for home use, and/or (iii) in the development and commercialization of able-bodied exoskeletons for industrial use. Consequently, the Company will require significant additional financing in the future, which the Company intends to raise by the end of the year through corporate collaborations, public or private equity offerings, debt financings or warrant solicitations. Sales of additional equity securities by us could result in the dilution of the interests of existing stockholders. There can be no assurance that financing will be available when required in sufficient amounts, on acceptable terms or at all. In the event that the necessary additional financing is not obtained, the Company may be required to reduce its discretionary overhead costs substantially, including research and development, general and administrative, and sales and marketing expenses or otherwise curtail operations.

Ekso Bionics Holdings, Inc.

Notes to Condensed Consolidated Financial Statements

(in thousands, except per share amounts)

(Unaudited)

2. Basis of Presentation and Summary of Significant Accounting Policies and Estimates

Basis of Presentation

These unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”), for the presentation of interim financial information. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed, or omitted, pursuant to such rules and regulations. The condensed consolidated balance sheet at December 31, 2015, has been derived from the audited consolidated financial statements at that date but does not include all disclosures required for the annual financial statements and should be read in conjunction with our audited consolidated financial statements and notes thereto included as part of our Annual Report on Form 10-K for the year ended December 31, 2015. Unless otherwise indicated, all dollar and share amounts (excluding per share amounts) included in these notes to the financial statements are in thousands.

In management’s opinion, the condensed consolidated financial statements reflect all adjustments (including reclassifications and normal recurring adjustments) necessary to present fairly the financial position at March 31, 2016, and results of operations and cash flows for all periods presented. The interim results presented are not necessarily indicative of results that can be expected for a full year. The condensed consolidated financial statements include the accounts of the Company and our wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.

Use of Estimates

The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet, and the reported amounts of revenues and expenses during the reporting period. For the Company, these estimates include, but are not limited to: revenue recognition, deferred revenue and the deferral of the associated costs, future warranty costs, maintenance and planned improvement costs associated with medical device units sold prior to 2016, useful lives assigned to long-lived assets, realizability of deferred tax assets, the valuation of options and warrants, and contingencies. Actual results could differ from those estimates.

Concentration of Credit Risk and Other Risks and Uncertainties

Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash and accounts receivable. We maintain our cash accounts in excess of federally insured limits. However, we believe we are not exposed to significant credit risk due to the financial position of the depository institutions in which these deposits are held. We extend credit to customers in the normal course of business and perform ongoing credit evaluations of our customers. Concentrations of credit risk with respect to accounts receivable exist to the full extent of amounts presented in the consolidated financial statements. We do not require collateral from our customers to secure accounts receivable.

Accounts receivable are derived from the sale of products shipped and services performed for customers located in the U.S. and throughout the world. Invoices are aged based on contractual terms with the customer. We review accounts receivable for collectability and provide an allowance for credit losses, as needed. We have not experienced any material losses related to accounts receivable as of March 31, 2016 and December 31, 2015. Many of the sales contracts with customers outside of the U.S. are settled in a foreign currency other than the U.S. dollar.

Ekso Bionics Holdings, Inc.

Notes to Condensed Consolidated Financial Statements

(in thousands, except per share amounts)

(Unaudited)

We do not enter into any foreign currency hedging agreements and are susceptible to gains and losses from foreign currency fluctuations. To date, we have not experienced significant gains or losses upon settling foreign currency denominated accounts receivable.

As of March 31, 2016, we had one customer with accounts receivable balances totaling 10% or more of our total accounts receivable (16%), compared with one customer as of December 31, 2015 (10%).

In the three months ended March 31, 2016, we had four customers with billed revenue of 10% or more of total billed revenue (27%, 20%, 11% and 10%), compared with two customers in the three months ended March 31, 2015 (17% and 16%).

Medical Device Revenue and Cost of Revenue Recognition

The Company builds medical device robotic exoskeletons for sale and capitalizes into inventory materials, direct and indirect labor and overhead in connection with manufacture and assembly of these units.

When the Company brought its first version medical device to market in 2012, the Company could not be certain as to the costs it would incur to support, maintain, service and upgrade these early stage devices. Primarily for this reason, prior to January 1, 2016, the sale of a device, associated software, initial training, and extended support and maintenance were deemed as a single unit of accounting due to the uncertainty of the Company’s follow-up maintenance and upgrade expenses, which were forecast to extend over three years. Accordingly, the revenue from the sales of the device and associated cost of revenue were deferred at the time of shipment. Upon completion of training, such amounts were recognized as revenue and cost of revenue over a three year period on a straight line basis, while all service expenses, whether or not covered by the Company’s original warranty, extended warranty contracts, or neither, were recognized as incurred.

Effective January 1, 2016, the Company determined it had established (i) separate individual pricing for training, extended warranty coverage, and out-of-contract service or repairs, (ii) sufficient historical evidence of customer buying patterns for extended warranty and maintenance coverage, and (iii) a basis for estimating and recording warranty and service costs, to allow the Company to bifurcate its sales transactions into two separate units of accounting: (1) the device, associated software, original manufacturer warranty and training if required, and (2) extended support and maintenance. The Company has therefore now begun to recognize revenue related to its sales transactions on a multiple element approach in which revenue is recognized upon the delivery of the separate elements to the customer. Revenue relating to the undelivered elements is deferred using the relative selling price method, which allocates revenue to each element using the estimated selling prices for the deliverables when vendor-specific objective evidence or third-party evidence is not available. For sales beginning January 1, 2016, revenue and associated cost of revenue of medical devices will be recognized when delivered, or training has been completed, if required. Revenue for extended maintenance and support agreements will be recognized on a straight line basis over the contractual term of the agreement, which typically ranges from one to four years. Consistent with this change, the Company recognized medical device revenue previously deferred at December 31, 2015 of $6,517 (which represents the fair value of the already delivered devices) and associated cost of revenue of $4,159, resulting in additional gross profit, reduction in net loss from operations, and reduction of net loss applicable to common stockholders of $2,358. In addition, the Company recorded $212 for warranty expenses and a one-time charge of $911 for a planned preventative maintenance and upgrade program associated with the devices it had sold prior to 2016.

Recent Accounting Pronouncements

In March 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-09 Compensation – Stock Compensation (Topic 718) Improvements to Employee Share-Based Payment Accounting. ASU 2016-09 simplifies several aspects of the accounting for share-based payment award transactions for public companies, including: (1) income tax consequences, (2) classification of awards as either equity or liabilities, and (3) classification on the statement of cash flows. The amendments in this update are effective for annual periods beginning after December 15, 2016. Management is in the process of assessing the impact of ASU 2016-09 on the Company’s consolidated financial statements.

Ekso Bionics Holdings, Inc.

Notes to Condensed Consolidated Financial Statements

(in thousands, except per share amounts)

(Unaudited)

In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers. The updated standard will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective and permits the use of either the retrospective or cumulative effect transition method. In August 2015, the FASB issued an update, ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, to defer the effective date of this update by one year. In April 2016, the FASB issued a further update, ASU 2016-10 Revenue from Contracts with Customers (Topic 606) Identifying Performance Obligations and Licensing. ASU 2016-10 clarifies the contractual provisions that explicitly or implicitly, require an entity to transfer control of additional goods or services to a customer should be distinguished from contractual provisions that explicitly or implicitly, define the attributes of a single promised license. The updated standard becomes effective for the Company in the first quarter of fiscal year 2018, but allows the Company to adopt the standard one year earlier if it so chooses. The Company has not yet selected a transition method and is currently evaluating the effect that the updated standard will have on its Consolidated Financial Statements and related disclosures, and is therefore unable to determine the impact on the Company's financial statements.

3. Fair Value Measurements

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Three levels of inputs, of which the first two are considered observable and the last unobservable, may be used to measure fair value which are the following:

•

Level 1—Quoted prices in active markets for identical assets or liabilities. The Company considers a market to be active when transactions for the asset occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

•

Level 2—Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

•

Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The valuation of Level 3 investments requires the use of significant management judgments or estimation.

Ekso Bionics Holdings, Inc.

Notes to Condensed Consolidated Financial Statements

(in thousands, except per share amounts)

(Unaudited)

The Company’s fair value hierarchies for its financial assets and liabilities which require fair value measurement are as follows:

				Quoted Prices in Active Markets For Identical Items		Significant Other Observable Inputs		Significant Unobservable Inputs
	Total			(Level 1)		(Level 2)		(Level 3)
March 31, 2016
Liabilities
Warrant liability	$	(6,210	)	$	-	$	-	$	(6,210	)
Contingent consideration liability	$	(768	)	$	-	$	-	$	(768	)

December 31, 2015
Liabilities
Warrant liability	$	(9,195	)	$	-	$	-	$	(9,195	)
Contingent consideration liability	$	(768	)	$	-	$	-	$	(768	)

The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial liabilities for the three month period ended March 31, 2016, which were measured at fair value on a recurring basis:

	Warrant Liability			Contingent Consideration Liability
Balance at December 31, 2015	$	(9,195	)	$	(768	)
Gain on decrease in fair value of warrants issued with 2015 financing		2,985			-
Balance at March 31, 2016	$	(6,210	)		(768	)

Refer to Note 9. Capitalization and Equity Structure – Warrants for additional information regarding the valuation of warrants.

4. Deferred Revenues

In connection with our medical device sales and engineering services, we often receive cash payments before our earnings process is complete. In these instances, we record the payments as customer deposits until a device is shipped to the customer, or as customer advances in the case of engineering services until the earnings process is achieved. In both cases, the cash received is recorded as a component of deferred revenue.

As described in Note 2. Summary of Significant Accounting Policies and Estimates, Medical Device Revenue and Cost of Revenue Recognition prior to January 1, 2016, the sale of a device, associated software, initial training, and extended support and maintenance were deemed as a single unit of accounting due to the uncertainty of the Company’s follow-up maintenance and upgrade expenses, which were forecast to extend over three years. Accordingly, the revenue from the sales of the device and associated cost of revenue were deferred at the time of shipment. Upon completion of training, such amounts were recognized as revenue and cost of revenue over a three year period on a straight line basis, while all service expenses, whether or not covered by the Company’s original warranty, extended warranty contracts, or neither, were recognized as incurred. For sales beginning January 1, 2016, revenue and associated cost of revenue of medical devices are being recognized when delivered, or training has been completed, if required. Revenue for extended maintenance and support agreements will be recognized on a straight line basis over the contractual term of the agreement, which typically ranges from one to four years. Consistent with this change, the Company recognized medical device revenue previously deferred at December 31, 2015 of $6,517 (which represents the fair value of the already delivered devices) and associated cost of revenue of $4,159.

Ekso Bionics Holdings, Inc.

Notes to Condensed Consolidated Financial Statements

(in thousands, except per share amounts)

(Unaudited)

Deferred revenues and deferred cost of revenues consist of the following:

	March 31 2016			December 31, 2015
Customer deposits and advances	$	47		$	48
Deferred medical device revenues		551			7,388
Deferred rental income		64			71
Deferred extended maintenance and support		1,326			1,066
Total deferred revenues		1,988			8,573
Less current portion		(1,222	)		(3,960	)
Deferred revenues, non-current		766			4,613

Deferred medical device unit costs	$	255		$	4,590
Less current portion		(255	)		(2,088	)
Deferred cost of revenue, non-current	$	-		$	2,502

5. Intangible Assets

On December 1, 2015, the Company acquired substantially all of the assets of Equipois, LLC, a New Hampshire limited liability company, for an initial payment of $1,071, payable in shares of the Company’s common stock, and recorded $768 of estimated contingent consideration. The transaction resulted in the Company recording $1,610 of intangible assets with an estimated life of three years. The following table reflects the amortization of the purchased intangible assets as of March 31, 2016:

	Cost		Accumulated Amortization			Net
Developed technology	$	1,160	$	(129	)	$	1,031
Customer relationships		70		(8	)		62
Customer trade name		380		(42	)		338
	$	1,610	$	(179	)	$	1,431

Estimated future amortization for the remainder of 2016 is $404, and $537 and $490 for the years 2017 and 2018, respectively.

Ekso Bionics Holdings, Inc.

Notes to Condensed Consolidated Financial Statements

(in thousands, except per share amounts)

(Unaudited)

6. Accrued Liabilities

Accrued liabilities consist of the following:

	March 31,		December 31,
	2016		2015
Salaries, benefits and related expenses	$	1,563	$	1,464
Maintenance		911		-
Warranty expense		216		-
Professional fees		158		257
Other		80		164
Total	$	2,928	$	1,885

7. Maintenance and Warranty

Sales of devices generally include an initial warranty for parts and services for one year in the U.S. and two years in Europe, the Middle East and Africa. During the quarter ended March 31, 2016, the Company determined it had sufficient historical experience of warranty costs to estimate future costs for devices sold. As a result, and beginning during the quarter ended March 31, 2016, a liability for the estimated cost of product warranty is established at the time revenue is recognized based on the historical experience of known product failure rates and expected material and labor costs to provide warranty services. From time to time, specific additional warranty accruals may be made if unforeseen technical problems arise. Alternatively, if estimates are determined to be greater than the actual amounts necessary, a portion of the liability may be reversed in future periods. Warranty costs are reflected in the condensed consolidated statement of operations as a component of costs of revenue.

In addition, for the quarter ended March 31, 2016, the Company recorded a one-time charge of $911 for a preventative maintenance and improvement program for devices sold prior to 2016 to bring the devices to second generation GT-level of functionality.

Ekso Bionics Holdings, Inc.

Notes to Condensed Consolidated Financial Statements

(in thousands, except per share amounts)

(Unaudited)

A reconciliation of the changes in the maintenance and warranty liabilities for the periods ended March 31, 2016 and 2015 are as follows:

	2016
	Maintenance		Warranty			Total
Balance at December 31, 2015	$	-	$	-		$	-
Additions for estimated future expense		911		255			1,166
Incurred costs		-		-			-
Other		-		-			-
Balance at March 31, 2016	$	911	$	255		$	1,166

Current portion		911		216			1,127
Long-term portion		-		39			39
Total	$	911	$	255		$	1,166

	2015
	Maintenance		Warranty			Total
Balance at December 31, 2014	$	-	$	126		$	126
Additions for estimated future expense		-		-			-
Incurred costs		-		(17	)		(17	)
Other		-		-			-
Balance at March 31, 2015	$	-	$	109		$	109

Current portion		-		109			109
Long-term portion		-		-			-
Total	$	-	$	109		$	109

The long-term portion of warranty accrual is included as a component of Other long-term liabilities in the condensed consolidated balance sheets.

8. Lease and Note Obligations

On November 29, 2011, the Company entered into an operating lease agreement for its headquarters and manufacturing facility in Richmond, California. The lease term commenced in March 2012 and expires in May 2017. The lease provides the Company with one option to renew for five additional years. The Company also leases nominal office space in Germany.

In 2012, the Company entered into a note agreement in connection with the lease for its Richmond, California facility. The note, for an aggregate principal of $200, with an interest rate of 7%, minimum monthly payments of $4, and a May 31, 2017 maturity, was used to fund leasehold improvements. This note is classified as a component of capital lease obligation-current and other non-current liabilities in the condensed consolidated balance sheet.

Ekso Bionics Holdings, Inc.

Notes to Condensed Consolidated Financial Statements

(in thousands, except per share amounts)

(Unaudited)

Commencing in August 2015, the Company entered into a long-term capital lease obligation for equipment. The aggregate principal of the lease is $166, with an interest rate of 4.7%, minimum monthly payments of $3 and matures on July 1, 2020. This capital lease is classified as a component of capital lease obligation-current and other non-current liabilities in the condensed consolidated balance sheet.

The Company estimates future minimum payments as of March 31, 2016 to be the following:

Period	Operating Lease		Note Payable			Capital Lease			Total Minimum Payments
2016 - remainder	$	350	$	36		$	32		$	68
2017		248		20			40			60
2018		91		-			37			37
2019		91		-			37			37
2020		89		-			22			22
Total minimum payments	$	869		56			168			224
Less interest				(2	)		(16	)		(18	)
Present value minimum payments				54			152			206
less current portion				(45	)		(36	)		(81	)
Long-term portion			$	9		$	116		$	125

Rent expense under the Company’s operating leases was $96 and $86 for the three month periods ended March 31, 2016 and 2015, respectively.

9. Capitalization and Equity Structure

Refer to Note 15, Subsequent Event, for a discussion of the Company’s May 4, 2016 reverse stock split.

Summary:

The Company’s authorized capital stock at March 31, 2016 consisted of 71,429 shares of common stock and 10,000 shares of preferred stock. At March 31, 2016, 15,604 shares of common stock were issued and outstanding and 9 shares of preferred stock were issued and outstanding.

Convertible Preferred Stock:

In December 2015, the Company issued 15 shares of Series A Convertible Preferred Stock (the “Preferred Shares”) and warrants to purchase 2,122 shares of the Company’s common stock for which the Company received gross proceeds of $15,000. Each Preferred Share is convertible into Common Stock at any time at the election of the investor. At December 31, 2015, 13 Preferred Shares remained outstanding. During the three-months ended March 31, 2016, 4 Preferred Shares were converted to 566 shares of common stock at the Series A Conversion Price of $7.07 per share. The conversion resulted in the amortization of the discount related to the issuance of warrants in the December 2015 transaction of $3,124, which has been accounted for as a preferred deemed dividend in the condensed consolidated statement of operations. As of March 31, 2016, $7,221 of non-cash warrant discounts remain unamortized, and will be recognized as preferred deemed dividend on the conversion of outstanding shares of convertible preferred stock.

Ekso Bionics Holdings, Inc.

Notes to Condensed Consolidated Financial Statements

(in thousands, except per share amounts)

(Unaudited)

Warrants

Warrant share activity for the three-month period ended March 31, 2016 is as follows:

Source	Exercise Price		Term (Years)	At December 31, 2015		At March 31, 2016
2015 Series A Preferred warrants	$	8.75	5		2,122		2,122

2014 PPO and Merger
Placement agent warrants	$	7.00	5		426		426
Bridge warrants	$	7.00	3		371		371
PPO warrants	$	14.00	5		1,078		1,078

Pre 2014 warrants	$	9.66	various		88		88
					4,085		4,085

In connection with the December 2015 issuance of convertible preferred stock mentioned above, the Company issued warrants to purchase up to an aggregate of 2,122 shares of common stock. The warrants have a 5 year term and an exercise price of $8.75 per share. The Company estimates the fair value of the warrant liability by using a Binomial Lattice Option Pricing Model. The warrant liability is measured at fair value using certain estimated inputs, which are classified within Level 3 of the valuation hierarchy. The following assumptions were used in the Binomial Lattice Option Pricing Model to measure the fair value of the embedded anti-dilution feature in the warrants as of March 31, 2016:

Current share price	$	5.25
Conversion price	$	8.75
Risk-free interest rate		1.16	%
Periodic rate		0.55	%
Term (years)		4.73
Volatility of stock		75	%

The warrants were valued at $9,195 at December 31, 2015. Due to a decrease in the Company’s common stock price from December 31, 2015 to March 31, 2016, the fair value of the warrants decreased by $2,985, which was recorded as a gain in the Company’s consolidated statements of operations for the three month period ended March 31, 2016.

10. Stock-based Compensation

Refer to Note 15, Subsequent Event, for a discussion of the Company’s May 4, 2016 reverse stock split.

The Company’s Amended and Restated 2014 Equity Incentive Plan (the “2014 Plan”) allows for the issuance of an aggregate of 3,714 shares of common stock, of which 1,480 are available for future grant as of March 31, 2016.

Ekso Bionics Holdings, Inc.

Notes to Condensed Consolidated Financial Statements

(in thousands, except per share amounts)

(Unaudited)

The following table summarizes information about the Company’s stock options outstanding at March 31, 2016, and activity during the three-month period then ended:

						Weighted-
						Average
				Weighted-		Remaining
				Average		Contractual		Aggregate
	Stock Awards			Exercise Price		Life (Years)		Intrinsic Value
Balance as of December 31, 2015		1,963		$	7.09
Options granted		145		$	5.55
Options exercised		(10	)	$	2.73
Options forfeited		(110	)	$	8.41
Options cancelled		(9	)	$	10.11
Balance as of March 31, 2016		1,979			6.91		7.00		1,522
Vested and expected to vest at March 31, 2016		1,851					6.85		1,518
Exercisable as of March 31, 2016		1,062					5.23		1,464

As of March 31, 2016, total unrecognized compensation cost related to unvested stock options was $4,640. This amount is expected to be recognized as stock-based compensation expense in the Company’s Condensed Consolidated Statements of Operations over the remaining weighted average vesting period of 2.8 years.

The per-share fair value of each stock option was determined on the date of grant using the Black-Scholes option pricing model using the following assumptions:

	Three months ended March 31,
	2016			2015

Dividend yield		—			—
Risk-free interest rate		1.24% - 1.78	%		1.41% - 1.92	%
Expected term (in years)		5-10			6-10
Volatility		77	%		73	%

Total stock-based compensation expense related to options granted to employees and non-employees was included in the Condensed Consolidated Statements of Operations as follows:

	Three months ended March 31,
	2016		2015
Sales and marketing	$	232	$	132
Research and development		231		54
General and administrative		1,111		163
	$	1,574	$	349

Ekso Bionics Holdings, Inc.

Notes to Condensed Consolidated Financial Statements

(in thousands, except per share amounts)

(Unaudited)

In conjunction with the resignation of the Company’s then Chief Executive Officer in February 2016, the Company accelerated the vesting of options that would have vested in the subsequent twelve months and extended the exercise period of the resulting shares from three months to six years. In addition, the Company extended the exercise period for an employee that was terminated in March 2016 from three months to one year. These modifications resulted in incremental stock compensation expense of $59 and $774 included in research and development and general administration, respectively.

11. Income Taxes

There were no material changes to the unrecognized tax benefits in the three months ended March 31, 2016, and the Company does not expect significant changes to unrecognized tax benefits through the end of the fiscal year. Because of the Company’s history of tax losses, all years remain open to tax audit.

12. Commitments and Contingencies

Contingencies

In the normal course of business, the Company is subject to various legal matters. In the opinion of management, the resolution of such matters will not have a material adverse effect on the Company’s condensed consolidated financial statements.

Material Contracts

The Company enters into various license, research collaboration and development agreements which provide for payments to the Company for government grants, fees, cost reimbursements typically with a markup, technology transfer and license fees, and royalty payments on sales.

The Company has two license agreements to maintain exclusive rights to patents. The Company is also required to pay 1% of net sales of products sold to entities other than the U.S. government. In the event of a sublicense, the Company will owe 21% of license fees and must pass through 1% of the sub-licensee’s net sales of products sold to entities other than the U.S. government. The agreements also stipulate minimum annual royalties of $50.

In connection with acquisition of Equipois, the Company assumed the rights and obligations of Equipois under a license agreement with Garrett Brown, the developer of certain intellectual property related to mechanical balance and support arm technologies, which grants us an exclusive license with respect to the technology and patent rights for certain fields of use. Pursuant to the terms of the license agreement, the Company will be required to pay Mr. Brown a single-digit royalty on net receipts, subject to a $50 annual minimum royalty requirement.

The Company entered into a supply agreement with Equipois to purchase mechanical arm products on a quarterly basis commencing on December 1, 2015 through December 31, 2016, with a minimum annual price of $157.

U.S. Food and Drug Administration Clearance

On April 4, 2016, the Company received clearance from the U.S. Food and Drug Administration (“FDA”) to market its Ekso GT robotic exoskeleton for use in the treatment of individuals with hemiplegia due to stroke, individuals with spinal cord injuries at levels T4 to L5, and individuals with spinal cord injuries at levels of T3 to C7 (ASIA D), in accordance with the device’s labeling.

Ekso Bionics Holdings, Inc.

Notes to Condensed Consolidated Financial Statements

(in thousands, except per share amounts)

(Unaudited)

The Company believes that prior to April 4, 2016, the Company’s Ekso GT robotic exoskeleton had been appropriately marketed in the United States as a Class I 510(k) exempt Powered Exercise Equipment device since February 2012. On June 26, 2014, the FDA announced the creation of a new product classification for Powered Exoskeleton devices. On October 21, 2014, the FDA published the summary for the new Powered Exoskeleton classification and designated it as being Class II, which requires the clearance of a 510(k) notice. On October 21, 2014, concurrent with the FDA’s publication of the reclassification of Powered Exoskeleton devices, the FDA issued the Company an “Untitled Letter” which informed the Company in writing of the agency’s belief that this new product classification applied to the Ekso GT device. On December 24, 2014, the Company filed a 510(k) notice for the Ekso robotic exoskeleton which was accepted by the FDA for substantive review on July 29, 2015. As discussed above, the Company received FDA clearance to market the Ekso GT in accordance with the devise’s labeling on April 4, 2016.

From September 2, 2015 to September 11, 2015, the Division of Bioresearch Monitoring Center for Devices and Radiological Health of the FDA conducted an inspection of the Company’s facility in Richmond, California. At the conclusion of the inspection, the FDA issued a Form FDA 483 with four observations. These observations were inspectional and did not represent a final FDA determination of non-compliance. The observations pertained to informed consent requirements, reporting of adverse results and records maintenance. On October 2, 2015, the Company responded to the FDA describing the corrective and preventive actions that the Company had implemented and continued to implement to address the FDA’s concerns. On March 30, 2016, the FDA accepted the Company’s corrective actions for the Form 483 observations that were generated during the FDA’s inspection.

13. Net Loss Per Share

Refer to Note 15, Subsequent Event, for a discussion of the Company’s May 4, 2016 reverse stock split.

The following table sets forth the computation of basic and diluted net loss per share:

	Three months ended March 31,
	2016			2015
Numerator:
Net loss applicable to common stockholders, basic and diluted	$	(6,775	)	$	(4,115	)

Denominator
Weighted-average number of shares, basic and diluted		15,388			14,542

Net loss per share, basic and diluted	$	(0.44	)	$	(0.28	)

Recognition of previously deferred revenue and cost of goods in the quarter ended March 31, 2016 as described in Note 2. Summary of Significant Accounting Policies and Estimates, Medical Device Revenue and Cost of Revenue Recognition reduced net loss applicable to common stockholders by $2,358, or $0.15 per share.

The following table sets forth potential shares of common stock that are not included in the calculation of diluted net loss per share because to do so would be anti-dilutive as of the end of each period presented:

	March 31,
	2016		2015
Options to purchase common stock		1,979		1,496
Warrants for common stock		4,085		1,966
Common stock issuable upon conversion of preferred shares		1,309		-
Total common stock equivalents		7,373		3,462

Ekso Bionics Holdings, Inc.

Notes to Condensed Consolidated Financial Statements

(in thousands, except per share amounts)

(Unaudited)

14. Segment Disclosures

The Company has two reportable segments, Engineering Services and Medical Devices. Engineering Services generates revenue principally from collaborative research and development service arrangements, technology license agreements, and government grants where the Company uses its robotics domain knowledge in bionic exoskeletons to bid on and procure contracts and grants from entities such as such as the National Science Foundation and the Defense Advanced Research Projects Agency. The Medical Devices segment designs, engineers, and manufactures exoskeletons for applications in the medical and military markets.

The Company evaluates performance and allocates resources based on segment gross profit margin. The reportable segments are each managed separately because they serve distinct markets, and one segment provides a service and the other manufactures and distributes a unique product. The Company does not consider net assets as a segment measure and, accordingly, assets are not allocated.

Segment reporting information is as follows:

	Medical		Engineering
	Devices		Services		Total
Three months ended March 31, 2016
Revenue	$	8,057	$	429	$	8,486
Cost of revenue		6,669		319		6,988
Gross profit	$	1,388	$	110	$	1,498

Three months ended March 31, 2015
Revenue	$	985	$	704	$	1,689
Cost of revenue		798		488		1,286
Gross profit	$	187	$	216	$	403

Geographic information for revenue based on location of customer is as follows:

	Three Months Ended March 31,
	2016		2015
North America	$	4,521	$	1,271
All Other		3,965		418
	$	8,486	$	1,689

15. Subsequent Event – Reverse Stock Split

After the close of the stock market on May 4, 2016, the Company effected a 1-for-7 reverse split of its common stock in preparation for its planned application for listing of its common stock on the NASDAQ Capital Market. The reverse stock split was approved by the Company’s board of directors and is intended to allow the Company to meet the minimum share price requirement for listing on the NASDAQ Capital Market. However, there can be no assurance that the Company’s listing application will be approved by NASDAQ. As a result, all common stock share amounts included in this filing have been retroactively reduced by a factor of seven, and all common stock per share amounts have been increased by a factor of seven, with the exception of our common stock par value. Amounts affected include common stock outstanding, including those that have resulted from the conversion of preferred stock, stock options, and warrants that convert to common stock.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

You should read the following discussion of our financial condition and results of operation in conjunction with the condensed consolidated financial statements and the notes thereto included elsewhere in this Quarterly Report on Form 10-Q and on our Annual Report on Form 10-K for the year ended December 31, 2015.

This Quarterly Report on Form 10-Q contains forward-looking statements. These forward-looking statements include all statements other than statements of historical facts contained or incorporated by reference in this prospectus, including statements regarding (i) the plans and objectives of management for future operations, including plans or objectives relating to the design, development and commercialization of human exoskeletons, (ii) a projection of income (including income/loss), earnings (including earnings/loss) per share, capital expenditures, dividends, capital structure or other financial items, (iii) our future financial performance, including any such statement contained in a discussion and analysis of financial condition by management or in the results of operations included pursuant to the rules and regulations of the SEC, (iv) our beliefs regarding the potential for commercial opportunity for exoskeleton technology in general and our exoskeleton products in particular, (v) our beliefs regarding potential clinical and other health benefits of our medical devices, and (vi) the assumptions underlying or relating to any statement described in points (i), (ii), (iii), (iv) or (v) above. The words “may,” “might,” “would,” “should,” “could,” “project,” “estimate,” “pro-forma,” “predict,” “potential,” “strategy,” “anticipate,” “attempt,” “develop,” “plan,” “help,” “believe,” “continue,” “intend,” “expect,” “future,” and similar expressions (including the negative of any of the foregoing) are intended to identify forward-looking statements.

The following factors, among others, including those described in the section titled “Risk Factors” included in our Annual Report on Form 10-K for the year ended December 31, 2015, could cause our future results to differ materially from those expressed in the forward-looking information:

our ability to obtain or maintain regulatory approval to market the Company’s medical devices;

the anticipated timing, cost and progress of the development and commercialization of new products or services, and improvements to our existing products, and related impacts on our profitability and cash position;

our ability to effectively market and sell our products and expand our business, both in unit sales and product diversification;

our ability to achieve broad customer adoption of our products and services;

our ability to complete clinical trials on a timely basis and that completed clinical trials will be sufficient to support commercialization of our products;

existing or increased competition;

rapid changes in technological solutions available to our markets;

volatility with our business, including long and variable sales cycles, which could have a negative impact on our results of operations for any given quarter;

our ability to obtain or maintain patent protection for the Company’s intellectual property;

the scope, validity and enforceability of our and third party intellectual property rights;

significant government regulation of medical devices and the healthcare industry;

our customers’ ability to get third party reimbursement for our products and services associated with them;

our failure to implement our business plan or strategies;

our ability to retain or attract key employees;

our ability to obtain adequate financing to fund operations and to develop or enhance our technology;

stock volatility or illiquidity;

our ability to maintain adequate internal controls over financial reporting; and

overall economic and market conditions.

Although we believe that the assumptions underlying the forward-looking statements and forward-looking information contained herein are reasonable, any of the assumptions could be inaccurate, and therefore such statements and information included in this Quarterly Report on Form 10-Q may not prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements and forward-looking information included herein, the inclusion of such statements and information should not be regarded as a representation by us or any other person that the results or conditions described in such statements and information or that our objectives and plans will be achieved. Such forward-looking statements speak only as of the date of this report. Except as required by law, we undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statements.

Overview

Ekso Bionics designs, develops and sells exoskeletons that have applications in healthcare, industrial, military, and consumer markets. Our exoskeleton systems are worn over the user’s clothing to enhance human strength, endurance and mobility. These systems serve multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. We or our partners have sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (for example, spinal cord injury or stroke) to rehabilitate and to walk again; (b) allow industrial workers to perform heavy duty work for extended periods; and (c) permit soldiers to carry heavy loads for long distances while mitigating lower back, knee, and ankle injuries.

Our long-term goal is to have one million persons stand and walk in Ekso exoskeletons by February 2022. The first step to achieving that goal is for us to focus on selling our medical exoskeletons to rehabilitation centers and hospitals in the United States and Europe. Ekso Bionics began that effort with the February 2012 sale of Ekso, an exoskeleton for complete spinal cord injuries (“SCI”). We have expanded that effort with the launch of our Variable Assist software and the announcement of our newest hardware platform, Ekso GT. The Variable Assist software enables users with any amount of lower extremity strength to contribute their own power for either leg to achieve self-initiated walking. The Ekso GT builds on the experience of the Ekso and incorporates Variable Assist, allowing us to expand our sales and marketing efforts beyond SCI-focused centers to centers supporting stroke and related neurological patients. In the U.S. there are about 5.9 million stroke and SCI rehabilitation sessions conducted on about 680,000 stroke and SCI patients at 16,900 facilities. Globally, there are an estimated 50,000 rehabilitation facilities.

In parallel to the development and early commercialization of medical exoskeletons, we have begun to work on the commercialization of exoskeletons for able-bodied users, specifically for industrial and construction applications.

As we continue to develop, commercialize and market our various exoskeleton technologies, we may seek to establish new strategic relationships with third parties. Potential relationships may be in the form of technology or product development agreements, sales or distribution agreements, or license agreements.

Regulatory Update

The U.S. government regulates the medical device industry through various agencies, including but not limited to, the FDA, which administers the federal Food, Drug and Cosmetic Act. The FDA classifies medical devices into one of three classes (Class I, II or III) based on the degree of risk the FDA determines to be associated with a device and the extent of control deemed necessary to ensure the device’s safety and effectiveness. Devices requiring fewer controls because they are deemed to pose lower risk are placed in Class I or II. Class I devices are deemed to pose the least risk and are subject only to general controls applicable to all devices, such as requirements for device labeling, premarket notification, and adherence to the FDA’s current good manufacturing practice requirements, as reflected in its Quality System Regulation (“QSR”). Class II devices are intermediate risk devices that are subject to general controls and may also be subject to special controls such as performance standards, product-specific guidance documents, special labeling requirements, patient registries or post-market surveillance. Class III devices are those for which insufficient information exists to assure safety and effectiveness solely through general or special controls, and include life-sustaining, life-supporting, or implantable devices, and devices not “substantially equivalent” to a device that is already legally marketed. Most Class I devices, and some Class II devices are exempted by regulation from the 510(k) clearance requirement and can be marketed without prior authorization from FDA. Class I and Class II devices that have not been so exempted are eligible for marketing through the 510(k) clearance pathway. By contrast, devices placed in Class III generally require premarket approval, or PMA, prior to commercial marketing.

To obtain 510(k) clearance for a medical device, an applicant must submit a premarket notification application to the FDA demonstrating that the device is “substantially equivalent” to a predicate device, which is typically a legally marketed Class II device in the United States. A device is substantially equivalent to a predicate device if it has the same intended use and (i) the same technological characteristics, or (ii) has different technological characteristics and the information submitted demonstrates that the device is as safe and effective as a legally marketed device and does not raise different questions of safety or effectiveness.

The Company believes that prior to April 4, 2016, the Company’s Ekso GT robotic exoskeleton had been appropriately marketed as a Class I 510(k) exempt Powered Exercise Equipment device since February 2012. On June 26, 2014, the FDA announced the creation of a new product classification for Powered Exoskeleton devices. On October 21, 2014, the FDA published the summary for the new Powered Exoskeleton classification and designated it as being Class II, which requires the clearance of a 510(k) notice.

On October 21, 2014, concurrent with the FDA’s publication of the reclassification of Powered Exoskeleton devices, the FDA issued the Company an “Untitled Letter” which informed the Company in writing of the agency’s belief that this new product classification applied to our Ekso GT device. On December 24, 2014 the Company filed a 510(k) notice for the Ekso robotic exoskeleton, which was accepted by the FDA for substantive review on July 29, 2015. As discussed above, the Company received FDA clearance to market its Ekso GT in accordance with the device’s labeling on April 4, 2016.

From September 2, 2015 to September 11, 2015, the Division of Bioresearch Monitoring Center for Devices and Radiological Health of the FDA conducted an inspection of the Company’s facility in Richmond, California. At the conclusion of the inspection, the FDA issued a Form FDA 483 with observations pertained to informed consent requirements, reporting of events to FDA, and records maintenance. These observations were inspectional and did not represent a final FDA determination of non-compliance. On October 2, 2015, the Company responded to the FDA describing the corrective and preventive actions that the Company had implemented and continued to implement to address the FDA’s observations. Due to the nature of the findings, the Company does not expect that the Form FDA 483 will result in a warning letter or other action that could interfere with the Company’s operations. On March 30, 2016, the FDA accepted the Company’s corrective actions for the Form 483 observations that were generated during the FDA inspection.

Since July 1, 2015, we have been informed of seven events with respect to our Ekso GT devices that are reportable pursuant to the FDA’s medical device reporting, or MDR, regulations. There were no reported patient injuries related to any of these events, and in each case we have filed the required adverse event reports with the FDA. We have analyzed the root causes of these issues and have improved the design and strengthened our manufacturing processes as a result. In addition, we have proactively adjusted the device maintenance schedules based on field usage to address these issues.

Critical Accounting Policies and Estimates

Our discussion and analysis of our financial condition and results of operations is based upon our condensed consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these condensed consolidated financial statements requires us to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, and the related disclosure of contingent assets and liabilities. We base our estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances. Our estimates form the basis for our judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.

An accounting policy is considered to be critical if it requires an accounting estimate to be made based on assumptions about matters that are highly uncertain at the time the estimate is made, and if different estimates that reasonably could have been used, or changes in the accounting estimate that are reasonably likely to occur, could materially impact the condensed consolidated financial statements. We believe that our critical accounting policies reflect the more significant estimates and assumptions used in the preparation of the condensed consolidated financial statements.

Effective January 1, 2016, the Company determined it had established (i) separate individual pricing for training, extended warranty coverage, and out-of-contract service or repairs, (ii) sufficient historical evidence of customer buying patterns for extended warranty and maintenance coverage, and (iii) a basis for estimating and recording warranty and service costs, to allow the Company to bifurcate its sales transactions into two separate units of accounting: (1) the device, associated software, original manufacturers warranty and training if required, and (2) extended support and maintenance. The Company has therefore now begun to recognize revenue related to its sales transactions on a multiple element approach in which revenue is recognized upon the delivery of the separate elements to the customer. Revenue relating to the undelivered elements is deferred using the relative selling price method, which allocates revenue to each element using the estimated selling prices for the deliverables when vendor-specific objective evidence or third-party evidence is not available. For sales beginning January 1, 2016, revenue and associated cost of revenue of medical devices will be recognized when delivered, or training has been completed, if required. Revenue for extended maintenance and support agreements will be recognized on a straight line basis over the contractual term of the agreement, which typically ranges from one to four years. Consistent with this change, the Company recognized medical device revenue previously deferred at December 31, 2015 of $6.5 million (which represents the fair value of the already delivered devices) and associated cost of revenue of $4.2 million, resulting in additional gross profit, reduction in net loss from operations, and reduction of net loss applicable to common stockholders of $2.4 million. In addition, the Company recorded $0.2 million for warranty expenses and a one-time charge of $0.9 million for a planned preventative maintenance and upgrade program associated with the devices it had sold prior to 2016.

Results of Operations

The following table present our results of operations for the periods indicated (in thousands):

	Three months ended March 31,
	2016			2015			Change			% Change
Revenue:
Medical devices (see Note 2)	$	8,057		$	985		$	7,072			718	%
Engineering services		429			704			(275	)		-39	%
Total revenue		8,486			1,689			6,797			402	%

Cost of revenue:
Medical devices		6,669			798			5,871			736	%
Engineering services		319			488			(169	)		-35	%
Total cost of revenue		6,988			1,286			5,702			443	%

Gross profit		1,498			403			1,095			272	%

Operating expenses:
Sales and marketing		2,503			1,851			652			35	%
Research and development		2,149			983			1,166			119	%
General and administrative		3,488			1,662			1,826			110	%
Total operating expenses		8,140			4,496			3,644			81	%

Loss from operations		(6,642	)		(4,093	)		(2,549	)		62	%

Other income (expense) net:
Gain (loss) on warrant liability		2,985			-			2,985			-
Interest and other, net		6			(22	)		28			-127	%
Total other income (expense), net		2,991			(22	)		3,013			-

Net loss		(3,651	)		(4,115	)		464			-11	%

Less: Preferred deemed dividend		(3,124	)		-			(3,124	)		-
Net loss applicable to common shareholders	$	(6,775	)	$	(4,115	)	$	(2,660	)		65	%

Revenue

Medical device revenue was $8.1 million for the quarter ended March 31, 2016. Contributing to this revenue was $6.5 million of previously deferred revenue that was recognized as a result of a change of an accounting estimate related to revenue recognition. In addition, the current quarter amounts include $1.2 million of revenue derived from the sale of devices during the period and attributable to the Company’s revised accounting estimate, as well as $0.3 million of other device related revenues. See Note 2 in the notes to our condensed consolidated financial statements under the caption Basis of Presentation and Summary of Significant Accounting Policies and Estimates - Medical Device Revenue and Cost of Revenue Recognition.

Engineering services revenue decreased $0.3 million, or 39%, primarily due to a decrease in revenue generating projects.

Gross Profit

Gross profit for quarter ended March 31, 2016 consists of $1.4 million attributable to device sales and $0.1 million attributable to engineering services. Device sales gross profit primarily includes $2.4 million from our change in accounting estimate for shipments made prior to January 1, 2016 and, $0.5 million based on our revised accounting estimate for units shipped or trained in the current quarter, offset primarily by $0.9 million of maintenance and $0.2 million of warranty expenses, both of which relate to devices sold prior to 2016. See Note 2 in the notes to our condensed consolidated financial statements under the caption Basis of Presentation and Summary of Significant Accounting Policies and Estimates - Medical Device Revenue and Cost of Revenue Recognition.

Operating Expenses

Sales and marketing expenses increased $0.7 million, or 35%, in the first quarter of 2016 compared to the first quarter of 2015 primarily due to an increase of $0.3 million in compensation expense, which included a non-cash stock-based compensation increase of $0.1 million, as a result of an increase in employee headcount. We also experienced an increase of $0.3 million related to the increase of the use of market research consultants, trade show presence, and website and social media activities in connection with ramping up our marketing efforts.

Research and development expenses increased $1.2 million, or 119%, in the first quarter of 2016 compared to the first quarter of 2015 primarily due to a $0.4 million increase in employee compensation expense, which included a non-cash stock-based compensation increase of $0.2 million, as a result of an increase in employee headcount. In addition, we incurred costs of $0.5 million related to the industrial business in anticipation of the product launch in the first half of 2016.

General and administrative expenses increased $1.8 million, or 110%, during the first quarter of 2015 compared to the first quarter of 2015, primarily due to an increase of $1.5 million of employee compensation expense, which included a non-cash stock-based compensation increase of $1.0 million and a one-time severance expense of $0.3 million. Stock based compensation expense included a one-time $0.8 million non-cash charge related to the modification of stock options previously granted to our former Chief Executive Officer. The remaining increase in employee compensation expense is due to increased headcount. In addition, we incurred additional amortization expense of $0.2 million as a result of acquiring assets from Equipois in December of 2015.

Other Income (Expense), Net

Other income (expense), net reflects a change of $3.0 million in the first quarter of 2016 compared to the first quarter of 2015 primarily due to a non-cash gain on the revaluation of warrants issued in December 2015. See Note 7 on our condensed consolidated financial statements under the caption, Capitalization and Equity Structure – Warrants for a description of the warrants, including the method and inputs used to estimate their fair value.

Preferred Deemed Dividend

In the first quarter of 2016, 4,005 shares of convertible preferred stock were converted into approximately 566,400 shares of common stock resulting in a $3.1 million non-cash preferred deemed dividend that related to the amortization of the discount associated with the warrants issued in December 2015. See Note 7 on our condensed consolidated financial statements under the caption, Capitalization and Equity Structure – Convertible Preferred Stock for additional information.

Financial Condition, Liquidity and Capital Resources

Since the Company’s inception, we have devoted substantially all of our efforts toward the development of exoskeletons for the medical, military and industrial markets, toward the commercialization of our medical exoskeletons to rehabilitation centers and toward raising capital. Accordingly, we are considered to be in the early commercialization stage. We have financed our operations primarily through the issuance and sale of equity securities for cash consideration and convertible and promissory notes, as well as from government research grant awards and strategic collaboration payments.

Cash and Working Capital

Since the Company’s inception, we have incurred recurring net losses and negative cash flows from operations. The Company incurred net losses of $3.7 million for the three months ended March 31, 2016, and $19.6 million for the year ended December 31, 2015.

In addition, our operating activities used $6.8 million for the three months ended March 31, 2016, and $18.3 million for the year ended December 31, 2015.

Liquidity and Capital Resources

Cash on hand at March 31, 2016 was $12.3 million, compared to $19.6 million at December 31, 2015. For the three months ended March 31, 2016, the Company used $6.8 million of cash in operations which included non-routine investments of working capital, the majority of which the Company expects will be reversed during the year, compared to $3.8 million for the three months ended March 31, 2015.

Based upon the Company’s current twelve-month average net use of cash of approximately $1.8 million per month and assuming increases in current revenue, offset by an incremental increase in expenses related to increased sales and marketing and research and development, and a potential increase in rental activity from its medical device business, the Company believes it has sufficient resources to meet its financial obligations into the first quarter of 2017.

Cash and Cash Equivalents

The following table summarizes the sources and uses of cash for the periods stated (in thousands). The Company held no cash equivalents for any of the periods presented.

	Three months ended
	March 31,
	2016			2015
Net cash used in operating activities	$	(6,789	)	$	(3,828	)
Net cash used in investing activities		(285	)		(281	)
Net cash (used in) provided by financing activities		(164	)		52
Net decrease in cash		(7,238	)		(4,057	)
Cash at the beginning of the period		19,552			25,190
Cash at the end of the period	$	12,314		$	21,133

Net Cash Used in Operating Activities

Net cash used in operations for the three months ended March 31, 2016 was driven by our $3.7 million operating loss, offset by $2.0 million in non-cash charges related to depreciation and amortization, and stock compensation expense and a $3.0 million non-cash gain from the revaluation of warrants issued in December 2015. In addition, our change in accounting estimate related to our revenue recognition policy resulted in a non-cash gain of $6.5 million of previously deferred revenue, offset by non-cash charges of $4.2 million of previously deferred cost of revenues, $0.9 million of accrued maintenance and $0.2 million of accrued warranty costs.

Net cash used in operations for the three months ended March 31, 2015 was driven by our $4.1 million operating loss, offset by $0.5 million in non-cash charges related to depreciation and amortization, and stock compensation expense.

Net Cash Used in Investing Activities

Net cash used in investing activities of $0.3 million for the three months ended March 31, 2016 and 2015 was primarily to acquire property and equipment, including expansion of our company-owned fleet of Ekso units used for demonstrations, loaners to current customers, and as rental units.

Net Cash (used) provided by Financing Activities

The net cash used by financing activities for the three months ended March 31, 2016 consisted primarily of expenses related to the December 2015 issuance of convertible preferred stock.

The net cash provided by financing activities for the three months ended March 31, 2015 of $0.1 million was primarily from the exercise of common stock warrants and options.

Contractual Obligations and Commitments

The following table summarizes our outstanding contractual obligations as of March 31, 2016, and the effect those obligations are expected to have on our liquidity and cash flows in future periods (in thousands):

	Payments Due By Period:
			Less than						After
	Total		One Year		1-3 Years		4-5 Years		5 Years
Facility operating lease	$	869	$	350	$	430	$	89	$	-
Capital lease		168		32		114		22		-
Leasehold improvement loan		56		36		20		-		-
Equipois supply agreement		157		157		-		-		-
Total	$	1,250	$	575	$	564	$	111	$	-

The amount above under Equipois supply agreement reflects the minimum purchase amount under the agreement, with a maximum purchase amount that may be due of $0.5 million. The agreement is set to expire on December 31, 2016, unless mutually extended by the parties.

In addition to the table above, which reflects only fixed payment obligations, we have two license agreements to maintain exclusive rights to certain patents. Under these license agreements, we are required to pay 1% of net sales of products sold to entities other than the U.S. government. In the event of a sublicense, we will owe 21% of license fees and must pass through 1% of the sub-licensee’s net sales of products sold to entities other than the U.S. government. The license agreements also stipulate minimum annual royalties of $50,000 per year.

In connection with our acquisition of Equipois in December 2015, we assumed the rights and obligations of Equipois under a license agreement with Garrett Brown, the developer of certain intellectual property related to mechanical balance and support arm technologies, which grants us an exclusive license with respect to the technology and patent rights for certain fields of use. Pursuant to the terms of the license agreement, we will be required to pay Mr. Brown a single-digit royalty on net receipts, subject to a $50,000 annual minimum royalty requirement.

Item 3. Quantitative and Qualitative Disclosure About Market Risk

We are exposed to market risks in the ordinary course of our business, including inflation risks.

We do not believe that inflation has had a material effect on our business, financial condition or results of operations. If our costs were to become subject to significant inflationary pressures, we may not be able to fully offset such higher costs through price increases. Our inability or failure to do so could harm our business, financial condition and results of operations.

In addition, we conduct business in foreign countries and have United Kingdom and Germany based subsidiaries. Accordingly, we are exposed to exchange rate risk. See Item 7A. Quantitative and Qualitative Disclosures About Market Risk in our Annual Report on Form 10-K for the year ended December 31, 2015.

Item 4. Controls and Procedures

Disclosure Controls and Procedures.

Our management, with the participation of our principal executive officer and principal financial officer, conducted an evaluation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, (“Exchange Act”)) as of the end of the period covered by this report. Based upon that evaluation, our principal executive officer and principal financial officer concluded that, as of such date, our disclosure controls and procedures were effective to ensure that information required to be disclosed in reports filed by us under the Exchange Act is recorded, processed, summarized and reported within the required time periods and is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

It should be noted that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment and makes assumptions about the likelihood of future events. There can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote. Management believes that the financial statements included in this Report fairly present in all material respects our financial condition, results of operations and cash flows for the periods presented.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

During the three months ended March 31, 2016, we were not a party to any material legal proceedings.

Item 1A. Risk Factors

An investment in our securities involves a risk of loss. You should carefully consider the information set forth in this Quarterly Report on Form 10-Q and in the section titled “Risk Factors” included in our Annual Report on Form 10-K for the year ended December 31, 2015. Except as set forth in the Management’s Discussion and Analysis of Financial Condition and Results of Operations – Regulatory Update section of this Quarterly Report on Form 10-Q there have been no material changes to the Risk Factors described in our Annual Report on Form 10-K for the year ended December 31, 2015.

Item 6. Exhibits

Exhibit Number		Description
3.1		Articles of Incorporation of the Registrant (incorporated by reference from Exhibit 3.1 to the Registrant’s Annual Report on Form 10-K filed on March 19, 2015)
3.4		Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock, filed on December 23, 2015 (incorporated by reference from Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on December 24, 2015)
3.5		Certificate of Amendment to Certificate of Designation of Series A Convertible Preferred Stock, filed on April 4, 2016 (incorporated by reference from Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on April 7, 2016)
3.6		Certificate of Change, effective May 4, 2016 (incorporated by reference from Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on May 5, 2016)
10.37		Form of Amendment to Securities Purchase Agreement (incorporated by reference from Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on April 7, 2016)
31.1*		Certification of Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as amended.
31.2*		Certification of Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as amended.

32.1*		Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2*		Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101*

The following financial statements from the Ekso Bionics Holdings, Inc. Quarterly Report on Form 10Q for the quarter ended March 31, 2016, formatted in Extensible Business Reporting Language (“XBRL”):

unaudited condensed consolidated balance sheets;

unaudited condensed consolidated statement of operations;

unaudited condensed consolidated statement of cash flows;

notes to unaudited condensed consolidated financial statements;

* Filed herewith

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, Ekso Bionics Holdings, Inc. has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	EKSO BIONICS HOLDINGS, INC.

Date: May 10, 2016	By:	/s/ Thomas Looby
		Thomas Looby
		President and Chief Executive Officer

Date: May 10, 2016	By:	/s/ Maximilian Scheder-Bieschin
		Maximilian Scheder-Bieschin
		Chief Financial Officer

		(Duly Authorized Officer and Principal Financial and Accounting Officer)

EX-31.1 2 v438707_ex31-1.htm EXHIBIT 31.1

Exhibit 31.1

CERTIFICATION

I, Thomas Looby, certify that:

(1)

I have reviewed this Quarterly Report on Form 10-Q of Ekso Bionics Holdings, Inc.;

(2)

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

(3)

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;

(4)

The company’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting; and

(5)

The company’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the audit committee of the company’s board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting.

Date: May 10, 2016

	/s/Thomas Looby
	Thomas Looby
	Principal Executive Officer

EX-31.2 3 v438707_ex31-2.htm EXHIBIT 31.2

Exhibit 31.2

CERTIFICATION

I, Maximilian Scheder-Bieschin, certify that:

(1)

I have reviewed this Quarterly Report on Form 10-Q of Ekso Bionics Holdings, Inc.;

(2)

(3)

(4)

(a)

(b)

(c)

(d)

(5)

(a)

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting.

Date: May 10, 2016

	/s/ Maximilian Scheder-Bieschin
	Maximilian Scheder-Bieschin
	Principal Financial Officer

EX-32.1 4 v438707_ex32-1.htm EXHIBIT 32.1

Exhibit 32.1

CERTIFICATION BY THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO

18 U.S.C. SECTION 1350

In connection with the Quarterly Report on Form 10-Q of Ekso Bionics Holdings, Inc. (the “Company”), for the quarterly period ended March 31, 2016 as filed with the Securities and Exchange Commission (the “Report”), I, Thomas Looby, President and Chief Executive Officer and principal executive officer, hereby certify as of the date hereof, solely for purposes of 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

Dated: May 10, 2016

	/s/Thomas Looby
	Thomas Looby
	Principal Executive Officer

EX-32.2 5 v438707_ex32-2.htm EXHIBIT 32.2

Exhibit 32.2

CERTIFICATION BY THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO

18 U.S.C. SECTION 1350

In connection with the Quarterly Report on Form 10-Q of Ekso Bionics Holdings, Inc. (the “Company”), for the quarterly period ended March 31, 2016 as filed with the Securities and Exchange Commission (the “Report”), I, Maximilian Scheder-Bieschin, Chief Financial Officer and principal financial officer, hereby certify as of the date hereof, solely for purposes of 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

Dated: May 10, 2016

	/s/ Maximilian Scheder-Bieschin
	Maximilian Scheder-Bieschin
	Principal Financial Officer

EX-101.INS 6 pnmd-20160331.xml XBRL INSTANCE DOCUMENT 0001549084 2015-01-01 2015-03-31 0001549084 2016-01-01 2016-03-31 0001549084 2015-03-31 0001549084 2016-03-31 0001549084 2016-05-05 0001549084 2015-12-31 0001549084 2014-12-31 0001549084 pnmd:QuotedPricesInActiveMarketsForIdenticalItemsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0001549084 pnmd:SignificantOtherObservableInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0001549084 pnmd:SignificantUnobservableInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0001549084 us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0001549084 pnmd:QuotedPricesInActiveMarketsForIdenticalItemsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2016-03-31 0001549084 pnmd:SignificantOtherObservableInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2016-03-31 0001549084 pnmd:SignificantUnobservableInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2016-03-31 0001549084 us-gaap:FairValueMeasurementsRecurringMember 2016-03-31 0001549084 us-gaap:SoftwareLicenseArrangementMember 2016-03-31 0001549084 us-gaap:NonsoftwareServiceSupportAndMaintenanceArrangementMember 2016-03-31 0001549084 us-gaap:SoftwareServiceSupportAndMaintenanceArrangementMember 2016-03-31 0001549084 us-gaap:SoftwareLicenseArrangementMember 2015-12-31 0001549084 us-gaap:NonsoftwareServiceSupportAndMaintenanceArrangementMember 2015-12-31 0001549084 us-gaap:SoftwareServiceSupportAndMaintenanceArrangementMember 2015-12-31 0001549084 us-gaap:NotesPayableOtherPayablesMember 2016-03-31 0001549084 us-gaap:NotesPayableOtherPayablesMember 2016-01-01 2016-03-31 0001549084 us-gaap:CapitalLeaseObligationsMember 2016-03-31 0001549084 us-gaap:CapitalLeaseObligationsMember 2016-01-01 2016-03-31 0001549084 pnmd:LeaseHoldImprovementNoteMember 2016-03-31 0001549084 us-gaap:CapitalLeaseObligationsMember 2016-03-31 0001549084 pnmd:OperatingLeaseMember 2016-03-31 0001549084 pnmd:TwoThousandFifteenSeriesPreferredWarrantsMember 2016-03-31 0001549084 pnmd:TwoThousandFifteenSeriesPreferredWarrantsMember 2016-01-01 2016-03-31 0001549084 pnmd:TwoThousandFifteenSeriesPreferredWarrantsMember 2015-12-31 0001549084 pnmd:PpoAndMerger2014Member pnmd:PlacementAgentWarrantsMember 2016-03-31 0001549084 pnmd:PpoAndMerger2014Member pnmd:BridgeWarrantsMember 2016-03-31 0001549084 pnmd:PpoAndMerger2014Member pnmd:BridgeNoteWarrantsMember 2016-03-31 0001549084 pnmd:Pre2014WarrantsMember 2016-03-31 0001549084 pnmd:PpoAndMerger2014Member pnmd:PlacementAgentWarrantsMember 2016-01-01 2016-03-31 0001549084 pnmd:PpoAndMerger2014Member pnmd:BridgeWarrantsMember 2016-01-01 2016-03-31 0001549084 pnmd:PpoAndMerger2014Member pnmd:BridgeNoteWarrantsMember 2016-01-01 2016-03-31 0001549084 pnmd:PpoAndMerger2014Member pnmd:PlacementAgentWarrantsMember 2015-12-31 0001549084 pnmd:PpoAndMerger2014Member pnmd:BridgeWarrantsMember 2015-12-31 0001549084 pnmd:PpoAndMerger2014Member pnmd:BridgeNoteWarrantsMember 2015-12-31 0001549084 pnmd:Pre2014WarrantsMember 2015-12-31 0001549084 pnmd:BinomialLatticeOptionPricingModelMember us-gaap:WarrantMember 2016-01-01 2016-03-31 0001549084 pnmd:EquityIncentivePlan2014Member 2015-12-31 0001549084 pnmd:EquityIncentivePlan2014Member 2016-01-01 2016-03-31 0001549084 pnmd:EquityIncentivePlan2014Member 2016-03-31 0001549084 us-gaap:SellingAndMarketingExpenseMember 2016-01-01 2016-03-31 0001549084 us-gaap:ResearchAndDevelopmentExpenseMember 2016-01-01 2016-03-31 0001549084 us-gaap:GeneralAndAdministrativeExpenseMember 2016-01-01 2016-03-31 0001549084 us-gaap:SellingAndMarketingExpenseMember 2015-01-01 2015-03-31 0001549084 us-gaap:ResearchAndDevelopmentExpenseMember 2015-01-01 2015-03-31 0001549084 us-gaap:GeneralAndAdministrativeExpenseMember 2015-01-01 2015-03-31 0001549084 us-gaap:RoyaltyAgreementTermsMember pnmd:SalesRevenueGoodsNetExcludingGovernmentSalesMember 2016-01-01 2016-03-31 0001549084 us-gaap:RoyaltyAgreementTermsMember pnmd:LicenseRevenueMember 2016-01-01 2016-03-31 0001549084 us-gaap:RoyaltyAgreementTermsMember pnmd:SublicenseeSalesRevenueGoodsNetExcludingGovernmentSalesMember 2016-01-01 2016-03-31 0001549084 us-gaap:RoyaltyAgreementTermsMember 2016-03-31 0001549084 us-gaap:EmployeeStockOptionMember 2016-01-01 2016-03-31 0001549084 us-gaap:WarrantMember 2016-01-01 2016-03-31 0001549084 us-gaap:EmployeeStockOptionMember 2015-01-01 2015-03-31 0001549084 us-gaap:WarrantMember 2015-01-01 2015-03-31 0001549084 pnmd:CommonStockIssuableUponConversionOfPreferredSharesMember 2016-01-01 2016-03-31 0001549084 pnmd:CommonStockIssuableUponConversionOfPreferredSharesMember 2015-01-01 2015-03-31 0001549084 us-gaap:NorthAmericaMember 2016-01-01 2016-03-31 0001549084 us-gaap:NorthAmericaMember 2015-01-01 2015-03-31 0001549084 pnmd:MedicalDeviceMember 2015-01-01 2015-12-31 0001549084 us-gaap:AccountsReceivableMember pnmd:CustomerConcentrationRiskOneMember 2016-01-01 2016-03-31 0001549084 us-gaap:AccountsReceivableMember pnmd:CustomerConcentrationRiskOneMember 2015-01-01 2015-12-31 0001549084 pnmd:CustomerConcentrationRiskOneMember us-gaap:SalesRevenueNetMember 2016-01-01 2016-03-31 0001549084 pnmd:CustomerConcentrationRiskTwoMember us-gaap:SalesRevenueNetMember 2016-01-01 2016-03-31 0001549084 pnmd:CustomerConcentrationRiskThreeMember us-gaap:SalesRevenueNetMember 2016-01-01 2016-03-31 0001549084 pnmd:CustomerFourMember us-gaap:SalesRevenueNetMember 2016-01-01 2016-03-31 0001549084 us-gaap:SalesRevenueNetMember pnmd:CustomerConcentrationRiskOneMember 2015-01-01 2015-03-31 0001549084 us-gaap:SalesRevenueNetMember pnmd:CustomerConcentrationRiskTwoMember 2015-01-01 2015-03-31 0001549084 pnmd:MedicalDeviceMember 2016-03-31 0001549084 us-gaap:SalesRevenueNetMember 2016-01-01 2016-03-31 0001549084 us-gaap:DevelopedTechnologyRightsMember 2016-03-31 0001549084 us-gaap:CustomerRelationshipsMember 2016-03-31 0001549084 us-gaap:CustomerListsMember 2016-03-31 0001549084 pnmd:EquipoisLlcMember 2015-11-20 2015-12-01 0001549084 pnmd:EquipoisLlcMember 2015-12-01 0001549084 pnmd:EquipoisLlcMember 2016-03-31 0001549084 pnmd:EquipoisLlcMember 2016-01-01 2016-03-31 0001549084 pnmd:AllOtherMember 2016-01-01 2016-03-31 0001549084 pnmd:AllOtherMember 2015-01-01 2015-03-31 0001549084 pnmd:MaintenanceMember 2015-12-31 0001549084 pnmd:WarrantyMember 2015-12-31 0001549084 pnmd:MaintenanceMember 2016-01-01 2016-03-31 0001549084 pnmd:WarrantyMember 2016-01-01 2016-03-31 0001549084 pnmd:MaintenanceMember 2016-03-31 0001549084 pnmd:WarrantyMember 2016-03-31 0001549084 pnmd:MaintenanceMember 2014-12-31 0001549084 pnmd:WarrantyMember 2014-12-31 0001549084 pnmd:MaintenanceMember 2015-01-01 2015-03-31 0001549084 pnmd:WarrantyMember 2015-01-01 2015-03-31 0001549084 pnmd:MaintenanceMember 2015-03-31 0001549084 pnmd:WarrantyMember 2015-03-31 0001549084 us-gaap:SeriesAPreferredStockMember 2015-11-30 2015-12-31 0001549084 us-gaap:SeriesAPreferredStockMember 2015-12-31 0001549084 us-gaap:SeriesAPreferredStockMember 2016-03-31 0001549084 us-gaap:WarrantMember 2015-12-31 0001549084 us-gaap:WarrantMember 2015-11-30 2015-12-31 0001549084 us-gaap:MinimumMember 2016-01-01 2016-03-31 0001549084 us-gaap:MaximumMember 2016-01-01 2016-03-31 0001549084 us-gaap:MinimumMember 2015-01-01 2015-03-31 0001549084 us-gaap:MaximumMember 2015-01-01 2015-03-31 0001549084 pnmd:EquityIncentivePlan2014Member 2016-03-31 0001549084 us-gaap:EmployeeStockOptionMember 2016-03-31 0001549084 pnmd:MedicalDevicesMember 2016-01-01 2016-03-31 0001549084 pnmd:EngineeringServicesMember 2016-01-01 2016-03-31 0001549084 pnmd:MedicalDevicesMember 2015-01-01 2015-03-31 0001549084 pnmd:EngineeringServicesMember 2015-01-01 2015-03-31 0001549084 us-gaap:SubsequentEventMember 2016-04-21 2016-05-04 0001549084 pnmd:TwentySixteenWarrantMemberMember 2016-01-01 2016-03-31 0001549084 pnmd:BinomialLatticeOptionPricingModelMember us-gaap:WarrantMember 2016-03-31 0001549084 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2015-12-31 0001549084 pnmd:ContingentConsiderationMember 2015-12-31 0001549084 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2016-01-01 2016-03-31 0001549084 pnmd:ContingentConsiderationMember 2016-01-01 2016-03-31 0001549084 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2016-03-31 0001549084 pnmd:ContingentConsiderationMember 2016-03-31 0001549084 pnmd:MedicalDeviceMember 2015-11-30 2015-12-31 0001549084 pnmd:MedicalDeviceMember us-gaap:MinimumMember 2015-11-30 2015-12-31 0001549084 pnmd:MedicalDeviceMember us-gaap:MaximumMember 2015-11-30 2015-12-31 0001549084 pnmd:MedicalDeviceMember us-gaap:MinimumMember 2016-01-01 2016-03-31 0001549084 pnmd:MedicalDeviceMember us-gaap:MaximumMember 2016-01-01 2016-03-31 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure 10-Q false 2016-03-31 2016 Q1 EKSO BIONICS HOLDINGS, INC. 0001549084 --12-31 Accelerated Filer PNMD 16182889

12314000

19552000

2383000

2069000

2531000

1056000

738000

436000

255000

2088000

18221000

25201000

2617000

2625000

2502000

93000

97000

22551000

32198000

3618000

2694000

2928000

1885000

1222000

3960000

81000

80000

7849000

8619000

766000

4613000

205000

195000

15798000

23390000

101686000

100094000

-95042000

-91391000

6753000

8808000

22551000

32198000

1431000

1584000

189000

6210000

9195000

768000

8057000

985000

429000

704000

8486000

1689000

6669000

798000

319000

488000

6988000

1286000

1498000

403000

2503000

1851000

2149000

983000

3488000

1662000

8140000

4496000

-6642000

-4093000

2991000

-22000

-3651000

-4115000

-3124000

-6775000

-4115000

2985000 0

440000

200000

45000

-9000

-10000

1574000

349000

314000

-94000

1475000

261000

298000

59000

-4335000

354000

924000

681000

1255000

-721000

-6585000

323000

-6789000

-3828000

285000

281000

-285000

-281000

28000

31000

-7238000

-4057000

25190000

21133000

19000

11000

-164000

52000

1800000

9195000

768000

9195000

6210000

768000

6210000

47000

551000

1326000

48000

7388000

1066000

255000

4590000

1563000

1464000

158000

257000

216000

80000

164000

200000

0.07

2017-05-31

166000

0.047

2020-07-01

4000 3000

96000

86000

224000

56000

168000

18000

2000

16000

206000

54000

152000

45000

36000

125000

9000

116000

869000

8.75

P5Y

2122000

9.66

P5Y P3Y P5Y

426000

371000

1078000

88000

426000

371000

1078000

88000

8.75

P4Y8M23D

0.0116

0.0055

0.75

1963000

145000

10000

110000

1979000

7.09

5.55

2.73

8.41

6.91

P7Y

P6Y10M6D

P5Y2M23D

1518000

1464000

232000

231000

1111000

132000

54000

163000

0.01 0.21 0.01

50000

157000

50000

7373000

3462000

1979000

4085000

1496000

1966000

1309000

4521000

1271000

0.001

10000000

9000

13000

9000

13000

0.001

71429000

6000

-22000

-0.44

-0.28

15388000

14542000

173000

32000

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="center"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>1. Organization</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>Description of Business</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">On January 15, 2014, a wholly-owned subsidiary of Ekso Bionics Holdings, Inc. named Ekso Acquisition Corp. merged with and into Ekso Bionics, Inc. (the “Merger”). Ekso Bionics, Inc. was the surviving corporation and became a wholly-owned subsidiary of Ekso Bionics Holdings, Inc. As a result of this transaction, Ekso Bionics Holdings, Inc. discontinued its pre-merger operations, acquired the business of Ekso Bionics, Inc. and continues the operations of Ekso Bionics, Inc. as a publicly traded company. Ekso Bionics, Inc. was incorporated in January 2005 in the State of Delaware.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">As used in these notes to the consolidated financial statements, the term “the Company” refers to Ekso Bionics Holdings, Inc. formerly known as PN Med Group, Inc., and its wholly-owned subsidiaries, including Ekso Bionics, Inc. after giving effect to the Merger; the term “Holdings” refers to the business of Ekso Bionics Holdings, Inc. prior to the Merger, and the term “Ekso Bionics” refers to Ekso Bionics, Inc. prior to the Merger. Unless otherwise indicated, all dollar and share amounts included in these notes to the financial statements are in thousands. All common stock share and per share amounts have been retroactively adjusted to reflect the one-for-seven reverse stock split completed on May 4, 2016. See <i> Note 15, Subsequent Event</i>.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company designs, develops, and sells exoskeletons that augment human strength, endurance and mobility. The Company’s exoskeletons have applications in health care, industrial, military, and consumer markets.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b>Liquidity</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Largely as a result of significant research and development activities related to the development of the Company’s advanced technology and commercialization of this technology into its medical device business, the Company has incurred significant operating losses and negative cash flows from operations since inception. The Company has also recognized significant non-cash losses associated with the revaluation of certain securities, which have also contributed significantly to its accumulated deficit. As of March 31, 2016, the Company had an accumulated deficit of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">95,042</font>.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Cash on hand at March 31, 2016 was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">12,314</font>, compared to $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">19,552</font> at December 31, 2015. For the three months ended March 31, 2016, the Company used $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">6,789</font> of cash in operations which included non-routine investments of working capital, the majority of which the Company expects will be reversed during the year, compared to $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3,828</font> for the three months ended March 31, 2015.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Based upon the Company’s current twelve-month average net use of cash of approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,800</font> per month and assuming increases in current revenue, offset by an incremental increase in expenses related to increased sales and marketing and research and development, and a potential increase in rental activity from its medical device business, the Company believes it has sufficient resources to meet its financial obligations into the first quarter of 2017.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company’s actual capital requirements may vary significantly and will depend on many factors. For example, the Company plans to continue to increase its investments (i) in its clinical, sales and marketing initiatives to accelerate adoption of the Ekso robotic exoskeleton in the rehabilitation market, (ii) in its research, development and commercialization activities with respect to an Ekso robotic exoskeleton for home use, and/or (iii) in the development and commercialization of able-bodied exoskeletons for industrial use. Consequently, the Company will require significant additional financing in the future, which the Company intends to raise by the end of the year through corporate collaborations, public or private equity offerings, debt financings or warrant solicitations. Sales of additional equity securities by us could result in the dilution of the interests of existing stockholders. There can be no assurance that financing will be available when required in sufficient amounts, on acceptable terms or at all. In the event that the necessary additional financing is not obtained, the Company may be required to reduce its discretionary overhead costs substantially, including research and development, general and administrative, and sales and marketing expenses or otherwise curtail operations.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><b><font style="FONT-SIZE: 10pt">Concentration of Credit Risk and Other Risks and Uncertainties</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash and accounts receivable. We maintain our cash accounts in excess of federally insured limits. However, we believe we are not exposed to significant credit risk due to the financial position of the depository institutions in which these deposits are held.  We extend credit to customers in the normal course of business and perform ongoing credit evaluations of our customers. Concentrations of credit risk with respect to accounts receivable exist to the full extent of amounts presented in the consolidated financial statements. We do not require collateral from our customers to secure accounts receivable.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Accounts receivable are derived from the sale of products shipped and services performed for customers located in the U.S. and throughout the world. Invoices are aged based on contractual terms with the customer. We review accounts receivable for collectability and provide an allowance for credit losses, as needed. We have not experienced any material losses related to accounts receivable as of March 31, 2016 and December 31, 2015. Many of the sales contracts with customers outside of the U.S. are settled in a foreign currency other than the U.S. dollar.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"></font> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">We do not enter into any foreign currency hedging agreements and are susceptible to gains and losses from foreign currency fluctuations. To date, we have not experienced significant gains or losses upon settling foreign currency denominated accounts receivable.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"></font><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">As of March 31, 2016, we had one customer with accounts receivable balances totaling <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10</font>% or more of our total accounts receivable (<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">16</font>%), compared with one customer as of December 31, 2015 (<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">10</font>%).</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">In the three months ended March 31, 2016, we had four customers with billed revenue of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10</font>% or more of total billed revenue (<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">27</font>%, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 20</font>%, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 11</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10</font>%), compared with two customers in the three months ended March 31, 2015 (<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">17</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 16</font>%).</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

2358000

0.16

0.1

0.27

0.2

0.11

0.1

0.17

0.16

6517000

4159000

212000

911000

0.1

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Deferred revenues and deferred cost of revenues consist of the following:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 95%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="70%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>March 31<br/> 2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>December 31,<br/> 2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>Customer deposits and advances</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>47</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>48</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>Deferred medical device revenues</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>551</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>7,388</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>Deferred rental income</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>64</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>71</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>Deferred extended maintenance and support</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,326</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,066</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>Total deferred revenues</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,988</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>8,573</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>Less current portion</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(1,222)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(3,960)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>Deferred revenues, non-current</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>766</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>4,613</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>Deferred medical device unit costs</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>255</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4,590</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>Less current portion</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(255)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(2,088)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="70%"> <div>Deferred cost of revenue, non-current</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2,502</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

64000

71000

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The following table reflects the amortization of the purchased intangible assets as of March 31, 2016:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in 0in 0in 0.75in; WIDTH: 75%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="38%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Cost</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Accumulated<br/> Amortization</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Net</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="38%"> <div>Developed technology</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,160</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(129)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,031</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="38%"> <div>Customer relationships</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>70</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(8)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>62</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="38%"> <div>Customer trade name</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>380</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(42)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>338</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="38%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,610</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(179)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,431</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

1610000

1160000

70000

380000

179000

129000

8000

42000

1431000

1031000

62000

338000

404000

537000

490000

1071000

768000

1610000

P3Y

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Accrued liabilities consist of the following:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>March 31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>December 31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Salaries, benefits and related expenses</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,563</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,464</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Maintenance</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>911</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Warranty expense</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>216</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Professional fees</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>158</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>257</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Other</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>80</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>164</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2,928</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,885</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

0 911000

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company estimates future minimum payments as of March 31, 2016 to be the following:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 95%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="38%"> <div>Period</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="13%" colspan="2"> <div>Operating<br/> Lease</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="13%" colspan="2"> <div>Note<br/> Payable</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="13%" colspan="2"> <div>Capital<br/> Lease</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="13%" colspan="2"> <div>Total<br/> Minimum<br/> Payments</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="38%"> <div>2016 - remainder</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>350</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>36</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>32</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>68</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="38%"> <div>2017</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>248</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>20</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>40</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>60</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="38%"> <div>2018</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>91</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>37</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>37</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="38%"> <div>2019</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>91</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>37</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>37</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="38%"> <div>2020</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>89</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>22</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>22</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="38%"> <div>Total minimum payments</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>869</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>56</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>168</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>224</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="38%"> <div>Less interest</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(2)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(16)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(18)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="38%"> <div>Present value minimum payments</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>54</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>152</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>206</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="38%"> <div>less current portion</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(45)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(36)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(81)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="38%"> <div>Long-term portion</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>9</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>116</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>125</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

68000

350000

36000

32000

60000

248000

20000

40000

37000

91000

37000

91000

37000

22000

89000

22000

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">14.</font></strong> <font style="FONT-SIZE: 10pt"><strong>Segment Disclosures</strong></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="center"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company has two reportable segments, Engineering Services and Medical Devices. Engineering Services generates revenue principally from collaborative research and development service arrangements, technology license agreements, and government grants where the Company uses its robotics domain knowledge in bionic exoskeletons to bid on and procure contracts and grants from entities such as such as the National Science Foundation and the Defense Advanced Research Projects Agency. The Medical Devices segment designs, engineers, and manufactures exoskeletons for applications in the medical and military markets.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt"> </font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company evaluates performance and allocates resources based on segment gross profit margin. The reportable segments are each managed separately because they serve distinct markets, and one segment provides a service and the other manufactures and distributes a unique product. The Company does not consider net assets as a segment measure and, accordingly, assets are not allocated.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="center"><strong><font style="FONT-SIZE: 10pt">  </font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Segment reporting information is as follows:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both" align="center"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 84%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="47%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Medical</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Engineering</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="47%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Devices</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Services</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Total</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Three months ended March 31, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Revenue</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,057</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>429</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,486</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Cost of revenue</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>6,669</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>319</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>6,988</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Gross profit</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,388</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>110</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,498</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Three months ended March 31, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Revenue</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>985</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>704</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,689</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Cost of revenue</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>798</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>488</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,286</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Gross profit</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>187</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>216</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>403</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Geographic information for revenue based on location of customer is as follows:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both" align="center"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 50%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="25%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Three Months Ended March 31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="25%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="25%"> <div>North America</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>4,521</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,271</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="25%"> <div>All Other</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>3,965</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>418</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="25%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>8,486</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,689</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="center"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Segment reporting information is as follows:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both" align="center"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 84%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="47%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Medical</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Engineering</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="47%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Devices</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Services</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Total</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Three months ended March 31, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Revenue</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,057</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>429</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,486</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Cost of revenue</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>6,669</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>319</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>6,988</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Gross profit</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,388</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>110</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,498</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Three months ended March 31, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Revenue</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>985</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>704</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,689</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Cost of revenue</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>798</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>488</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,286</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Gross profit</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>187</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>216</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>403</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

3965000

418000

2358000 0.15 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong>7. Maintenance and Warranty</strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Sales of devices generally include an initial warranty for parts and services for one year in the U.S. and two years in Europe, the Middle East and Africa. During the quarter ended March 31, 2016, the Company determined it had sufficient historical experience of warranty costs to estimate future costs for devices sold. As a result, and beginning during the quarter ended March 31, 2016, a liability for the estimated cost of product warranty is established at the time revenue is recognized based on the historical experience of known product failure rates and expected material and labor costs to provide warranty services. From time to time, specific additional warranty accruals may be made if unforeseen technical problems arise. Alternatively, if estimates are determined to be greater than the actual amounts necessary, a portion of the liability may be reversed in future periods. Warranty costs are reflected in the condensed consolidated statement of operations as a component of costs of revenue.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In addition, for the quarter ended March 31, 2016, the Company recorded a one-time charge of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">911</font> for a preventative maintenance and improvement program for devices sold prior to 2016 to bring the devices to second generation GT-level of functionality.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>A reconciliation of the changes in the maintenance and warranty liabilities for the periods ended March 31, 2016 and 2015 are as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 90%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="47%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="41%" colspan="8"> <div>2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="47%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="13%" colspan="2"> <div>Maintenance</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="13%" colspan="2"> <div>Warranty</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="13%" colspan="2"> <div>Total</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Balance at December 31, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Additions for estimated future expense</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>911</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>255</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,166</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Incurred costs</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Other</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Balance at March 31, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>911</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>255</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>1,166</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Current portion</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>911</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>216</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,127</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Long-term portion</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>39</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>39</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>911</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>255</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>1,166</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 90%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="47%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="41%" colspan="8"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="47%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="13%" colspan="2"> <div>Maintenance</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="13%" colspan="2"> <div>Warranty</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="13%" colspan="2"> <div>Total</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Balance at December 31, 2014</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>126</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>126</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Additions for estimated future expense</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Incurred costs</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(17)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(17)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Other</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Balance at March 31, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>109</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>109</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Current portion</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>109</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>109</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Long-term portion</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>109</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>109</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The long-term portion of warranty accrual is included as a component of Other long-term liabilities in the condensed consolidated balance sheets.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">A reconciliation of the changes in the maintenance and warranty liabilities for the periods ended March 31, 2016 and 2015 are as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 90%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="47%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="41%" colspan="8"> <div>2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="47%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="13%" colspan="2"> <div>Maintenance</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="13%" colspan="2"> <div>Warranty</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="13%" colspan="2"> <div>Total</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Balance at December 31, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Additions for estimated future expense</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>911</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>255</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,166</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Incurred costs</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Other</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Balance at March 31, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>911</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>255</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>1,166</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Current portion</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>911</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>216</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,127</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Long-term portion</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>39</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>39</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>911</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>255</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>1,166</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 90%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="47%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="41%" colspan="8"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="47%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="13%" colspan="2"> <div>Maintenance</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="13%" colspan="2"> <div>Warranty</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="13%" colspan="2"> <div>Total</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Balance at December 31, 2014</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>126</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>126</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Additions for estimated future expense</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Incurred costs</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(17)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(17)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Other</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Balance at March 31, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>109</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>109</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Current portion</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>109</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>109</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Long-term portion</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>109</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>109</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 0 0 0 1166000 911000 255000 0 0 0 0 0 0 1127000 911000 216000 39000 0 39000 1166000 911000 255000 126000 0 126000 0 0 0 -17000 0 -17000 0 0 0 109000 0 109000 109000 0 109000 0 0 0

911000

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong>9. Capitalization and Equity Structure</strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt">Refer to <i>Note 15, Subsequent Event</i>, for a discussion of the Company’s May 4, 2016 reverse stock split.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><strong><i>Summary:</i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company’s authorized capital stock at March 31, 2016 consisted of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 71,429</font> shares of common stock and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10,000</font> shares of preferred stock. At March 31, 2016, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 15,604</font></font> shares of common stock were issued and outstanding and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 9</font></font> shares of preferred stock were issued and outstanding.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><strong><i>Convertible Preferred Stock:</i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In December 2015, the Company issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">15</font> shares of Series A Convertible Preferred Stock (the “Preferred Shares”) and warrants to purchase <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2,122</font> shares of the Company’s common stock for which the Company received gross proceeds of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">15,000</font>. Each Preferred Share is convertible into Common Stock at any time at the election of the investor. At December 31, 2015, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">13</font> Preferred Shares remained outstanding. During the three-months ended March 31, 2016, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4</font> Preferred Shares were converted to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 566</font> shares of common stock at the Series A Conversion Price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">7.07</font> per share. The conversion resulted in the amortization of the discount related to the issuance of warrants in the December 2015 transaction of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3,124</font>, which has been accounted for as a preferred deemed dividend in the condensed consolidated statement of operations. As of March 31, 2016, $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">7,221</font> of non-cash warrant discounts remain unamortized, and will be recognized as preferred deemed dividend on the conversion of outstanding shares of convertible preferred stock.</div> </div>  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong><i>Warrants</i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Warrant share activity for the three-month period ended March 31, 2016 is as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="43%"> <div>Source</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="13%" colspan="2"> <div>Exercise<br/> Price</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="13%" colspan="2"> <div>Term<br/> (Years)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="13%" colspan="2"> <div>At December 31,<br/> 2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="13%" colspan="2"> <div>At March 31,<br/> 2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="43%"> <div>2015 Series A Preferred warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>8.75</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>5</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>2,122</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>2,122</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>2014 PPO and Merger</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Placement agent warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>7.00</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>5</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>426</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>426</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Bridge warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>7.00</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>3</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>371</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>371</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>PPO warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>14.00</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>5</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,078</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,078</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Pre 2014 warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>9.66</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>various</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>88</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>88</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>4,085</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>4,085</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In connection with the December 2015 issuance of convertible preferred stock mentioned above, the Company issued warrants to purchase up to an aggregate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2,122</font> shares of common stock. The warrants have a <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 5</font> year term and an exercise price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">8.75</font> per share. The Company estimates the fair value of the warrant liability by using a Binomial Lattice Option Pricing Model. The warrant liability is measured at fair value using certain estimated inputs, which are classified within Level 3 of the valuation hierarchy. <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following assumptions were used in the Binomial Lattice Option Pricing Model to measure the fair value of the embedded anti-dilution feature in the warrants as of March 31, 2016:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 40%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="27%"> <div>Current share price</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5.25</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="27%"> <div>Conversion price</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8.75</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="27%"> <div>Risk-free interest rate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.16</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="27%"> <div>Periodic rate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.55</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="27%"> <div>Term (years)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4.73</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="27%"> <div>Volatility of stock</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>75</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The warrants were valued at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">9,195</font> at December 31, 2015. Due to a decrease in the Company’s common stock price from December 31, 2015 to March 31, 2016, the fair value of the warrants decreased by $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,985</font>, which was recorded as a gain in the Company’s consolidated statements of operations for the three month period ended March 31, 2016.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Warrant share activity for the three-month period ended March 31, 2016 is as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="43%"> <div>Source</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="13%" colspan="2"> <div>Exercise<br/> Price</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="13%" colspan="2"> <div>Term<br/> (Years)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="13%" colspan="2"> <div>At December 31,<br/> 2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="13%" colspan="2"> <div>At March 31,<br/> 2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="43%"> <div>2015 Series A Preferred warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>8.75</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>5</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>2,122</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>2,122</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>2014 PPO and Merger</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Placement agent warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>7.00</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>5</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>426</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>426</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Bridge warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>7.00</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>3</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>371</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>371</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>PPO warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>14.00</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>5</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,078</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,078</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div>Pre 2014 warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>9.66</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>various</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>88</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>88</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="43%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>4,085</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>4,085</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

4085000

4000

566000

3124000

15000

2122000

15000000 7221000 7.07

9195000

2985000

2122000

P5Y

8.75

15604000

10.11

9000

0.0124

0.0141

0.0178

0.0192

P5Y

P10Y

P6Y

P10Y

0.77

0.73

349000

1574000

3714000

1480000

59000

774000

4640000

P2Y9M18D

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> The Company’s fair value hierarchies for its financial assets and liabilities which require fair value measurement are as follows: <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Quoted Prices in</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Significant</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Active Markets</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Other</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Significant</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>For Identical</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Observable</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Unobservable</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Items</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Inputs</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Inputs</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Total</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>(Level 1)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>(Level 2)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>(Level 3)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>March 31, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="51%"> <div>Liabilities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Warrant liability</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(6,210)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(6,210)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Contingent consideration liability</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(768)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(768)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>December 31, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="51%"> <div>Liabilities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Warrant liability</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(9,195)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(9,195)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Contingent consideration liability</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(768)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(768)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><strong>8. Lease and Note Obligations</strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">On November 29, 2011, the Company entered into an operating lease agreement for its headquarters and manufacturing facility in Richmond, California. The lease term commenced in March 2012 and expires in May 2017. The lease provides the Company with one option to renew for five additional years. The Company also leases nominal office space in Germany.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In 2012, the Company entered into a note agreement in connection with the lease for its Richmond, California facility. The note, for an aggregate principal of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">200</font>, with an interest rate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 7</font>%, minimum monthly payments of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4</font>, and a <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">May 31, 2017</font> maturity, was used to fund leasehold improvements. This note is classified as a component of capital lease obligation-current and other non-current liabilities in the condensed consolidated balance sheet.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Commencing in August 2015, the Company entered into a long-term capital lease obligation for equipment. The aggregate principal of the lease is $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">166</font>, with an interest rate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 4.7</font>%, minimum monthly payments of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3</font> and matures on <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">July 1, 2020</font>. This capital lease is classified as a component of capital lease obligation-current and other non-current liabilities in the condensed consolidated balance sheet.</div>  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The Company estimates future minimum payments as of March 31, 2016 to be the following:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 95%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="38%"> <div>Period</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="13%" colspan="2"> <div>Operating<br/> Lease</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="13%" colspan="2"> <div>Note<br/> Payable</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="13%" colspan="2"> <div>Capital<br/> Lease</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="13%" colspan="2"> <div>Total<br/> Minimum<br/> Payments</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="38%"> <div>2016 - remainder</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>350</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>36</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>32</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>68</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="38%"> <div>2017</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>248</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>20</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>40</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>60</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="38%"> <div>2018</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>91</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>37</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>37</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="38%"> <div>2019</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>91</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>37</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>37</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="38%"> <div>2020</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>89</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>22</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>22</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="38%"> <div>Total minimum payments</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>869</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>56</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>168</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>224</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="38%"> <div>Less interest</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(2)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(16)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(18)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="38%"> <div>Present value minimum payments</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>54</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>152</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>206</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="38%"> <div>less current portion</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(45)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(36)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(81)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="38%"> <div>Long-term portion</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>9</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>116</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>125</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Rent expense under the Company’s operating leases was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">96</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">86</font> for the three month periods ended March 31, 2016 and 2015, respectively.</div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

2017-05-31

1851000

1062000

1522000

8057000

429000

985000

704000

6669000

319000

798000

488000

1388000

110000

187000

216000

1-for-7 reverse split

15027000

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> The following assumptions were used in the Binomial Lattice Option Pricing Model to measure the fair value of the embedded anti-dilution feature in the warrants as of March 31, 2016: <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 40%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="27%"> <div>Current share price</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5.25</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="27%"> <div>Conversion price</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8.75</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="27%"> <div>Risk-free interest rate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.16</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="27%"> <div>Periodic rate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.55</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="27%"> <div>Term (years)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4.73</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="27%"> <div>Volatility of stock</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>75</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

5.25

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The following table summarizes information about the Company’s stock options outstanding at March 31, 2016, and activity during the three-month period then ended:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="FONT-SIZE: 10pt"> </font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 98%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="49%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Weighted-</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="49%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Average</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="49%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Weighted-</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Remaining</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="49%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Average</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Contractual</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Aggregate</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="49%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Stock</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Exercise</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Life</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Intrinsic</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="49%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Awards</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Price</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>(Years)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Value</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="49%"> <div>Balance as of December 31, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,963</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>7.09</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="49%"> <div>Options granted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>145</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5.55</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="49%"> <div>Options exercised</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(10)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.73</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="49%"> <div>Options forfeited</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(110)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8.41</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="49%"> <div>Options cancelled</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(9)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>10.11</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="49%"> <div>Balance as of March 31, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,979</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>6.91</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>7.00</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,522</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="49%"> <div>Vested and expected to vest at March 31, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>1,851</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>6.85</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,518</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="49%"> <div>Exercisable as of  March 31, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>1,062</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5.23</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,464</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The per-share fair value of each stock option was determined on the date of grant using the Black-Scholes option pricing model using the following assumptions:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both; size: 8.5in 11.0in" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 59%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="33%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="24%" colspan="6"> <div>Three months ended March 31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="33%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="33%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>Dividend yield</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>Risk-free interest rate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.24% - 1.78</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.41% - 1.92</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>Expected term (in years)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5-10</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>6-10</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>Volatility</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>77</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>73</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> </table> </div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

1988000

8573000

9195000

768000

2985000

6210000

768000

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial liabilities for the three month period ended March 31, 2016, which were measured at fair value on a recurring basis:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="75%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Warrant<br/> Liability</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Contingent<br/> Consideration<br/> Liability</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="75%"> <div>Balance at December 31, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(9,195)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(768)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Gain on decrease in fair value of warrants issued with 2015 financing</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2,985</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="75%"> <div>Balance at March 31, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(6,210)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(768)</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

6517000

4159000

P1Y P3Y

109000

105000

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">3. Fair Value Measurements</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt"> </font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Three levels of inputs, of which the first two are considered observable and the last unobservable, may be used to measure fair value which are the following:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px; font-size-adjust: none; font-stretch: normal" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in"></td> <td style="TEXT-ALIGN: left; WIDTH: 0.75in"> <div><font style="FONT-SIZE: 10pt">•</font></div> </td> <td style="TEXT-ALIGN: justify"> <div align="justify"><font style="FONT-SIZE: 10pt"><strong>Level 1</strong>Quoted prices in active markets for identical assets or liabilities. The Company considers a market to be active when transactions for the asset occur with sufficient frequency and volume to provide pricing information on an ongoing basis.</font></div> </td> </tr> </table> <table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px; font-size-adjust: none; font-stretch: normal" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in"> <div> </div> </td> <td style="WIDTH: 0.75in; FONT-SIZE: 10pt"> <div><font style="FONT-SIZE: 10pt">•</font></div> </td> <td style="TEXT-ALIGN: justify; FONT-SIZE: 10pt"> <div align="justify"><font style="FONT-SIZE: 10pt"><strong>Level 2</strong>Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</font></div> </td> </tr> </table> <table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px; font-size-adjust: none; font-stretch: normal" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0.25in"> <div> </div> </td> <td style="WIDTH: 0.75in; FONT-SIZE: 10pt"> <div><font style="FONT-SIZE: 10pt">•</font></div> </td> <td style="TEXT-ALIGN: justify; FONT-SIZE: 10pt"> <div align="justify"><font style="FONT-SIZE: 10pt"><strong>Level 3</strong>Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The valuation of Level 3 investments requires the use of significant management judgments or estimation.</font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>The Company’s fair value hierarchies for its financial assets and liabilities which require fair value measurement are as follows:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Quoted Prices in</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Significant</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Active Markets</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Other</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Significant</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>For Identical</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Observable</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Unobservable</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Items</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Inputs</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Inputs</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Total</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>(Level 1)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>(Level 2)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>(Level 3)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>March 31, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="51%"> <div>Liabilities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Warrant liability</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(6,210)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(6,210)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Contingent consideration liability</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(768)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(768)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>December 31, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="51%"> <div>Liabilities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Warrant liability</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(9,195)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(9,195)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Contingent consideration liability</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(768)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(768)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial liabilities for the three month period ended March 31, 2016, which were measured at fair value on a recurring basis:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="75%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Warrant<br/> Liability</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Contingent<br/> Consideration<br/> Liability</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="75%"> <div>Balance at December 31, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(9,195)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(768)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Gain on decrease in fair value of warrants issued with 2015 financing</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2,985</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="75%"> <div>Balance at March 31, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(6,210)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(768)<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">Refer to <i>Note 9. Capitalization and Equity Structure  Warrants</i> for additional information regarding the valuation of warrants.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><strong><font style="FONT-SIZE: 10pt">10. Stock-based Compensation</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> Refer to <i>Note 15, Subsequent Event</i>, for a discussion of the Company’s May 4, 2016 reverse stock split.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt">The Company’s Amended and Restated 2014 Equity Incentive Plan (the “2014 Plan”) allows for the issuance of an aggregate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3,714</font> shares of common stock, of which <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,480</font> are available for future grant as of March 31, 2016.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="FONT-SIZE: 10pt">The following table summarizes information about the Company’s stock options outstanding at March 31, 2016, and activity during the three-month period then ended:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="FONT-SIZE: 10pt"> </font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 98%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="49%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Weighted-</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="49%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Average</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="49%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Weighted-</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Remaining</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="49%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Average</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Contractual</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Aggregate</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="49%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Stock</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Exercise</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Life</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Intrinsic</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="49%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Awards</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Price</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>(Years)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Value</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="49%"> <div>Balance as of December 31, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,963</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>7.09</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="49%"> <div>Options granted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>145</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5.55</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="49%"> <div>Options exercised</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(10)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.73</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="49%"> <div>Options forfeited</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(110)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8.41</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="49%"> <div>Options cancelled</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(9)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>10.11</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="49%"> <div>Balance as of March 31, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,979</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>6.91</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>7.00</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,522</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="49%"> <div>Vested and expected to vest at March 31, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>1,851</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>6.85</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,518</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="49%"> <div>Exercisable as of  March 31, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>1,062</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5.23</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,464</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt">As of March 31, 2016, total unrecognized compensation cost related to unvested stock options was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4,640</font>. This amount is expected to be recognized as stock-based compensation expense in the Company’s Condensed Consolidated Statements of Operations over the remaining weighted average vesting period of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2.8</font> years.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in"> <font style="FONT-SIZE: 10pt">  </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt">The per-share fair value of each stock option was determined on the date of grant using the Black-Scholes option pricing model using the following assumptions:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both; size: 8.5in 11.0in" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 59%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="33%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="24%" colspan="6"> <div>Three months ended March 31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="33%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="33%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>Dividend yield</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>Risk-free interest rate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.24% - 1.78</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.41% - 1.92</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>Expected term (in years)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5-10</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>6-10</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%"> <div>Volatility</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>77</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>73</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> </table> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt">Total stock-based compensation expense related to options granted to employees and non-employees was included in the Condensed Consolidated Statements of Operations as follows:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both; size: 8.5in 11.0in" align="center"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 60%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="35%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Three months ended March 31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="35%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>Sales and marketing</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>232</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>132</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>Research and development</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>231</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>54</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div>General and administrative</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,111</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>163</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="35%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,574</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>349</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt">In conjunction with the resignation of the Company’s then Chief Executive Officer in February 2016, the Company accelerated the vesting of options that would have vested in the subsequent twelve months and extended the exercise period of the resulting shares from three months to six years. In addition, the Company extended the exercise period for an employee that was terminated in March 2016 from three months to one year. These modifications resulted in incremental stock compensation expense of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">59</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">774</font> included in research and development and general administration, respectively.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

P1Y P4Y

EX-101.SCH 7 pnmd-20160331.xsd XBRL TAXONOMY EXTENSION SCHEMA 101 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink 102 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 103 - Statement - Condensed Consolidated Balance Sheets [Parenthetical] link:presentationLink link:definitionLink link:calculationLink 104 - Statement - Condensed Consolidated Statement of Operations link:presentationLink link:definitionLink link:calculationLink 105 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 106 - Disclosure - Organization link:presentationLink link:definitionLink link:calculationLink 107 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies and Estimates link:presentationLink link:definitionLink link:calculationLink 108 - Disclosure - Fair Value Measurements link:presentationLink link:definitionLink link:calculationLink 109 - Disclosure - Deferred Revenues link:presentationLink link:definitionLink link:calculationLink 110 - Disclosure - Intangible Assets link:presentationLink link:definitionLink link:calculationLink 111 - Disclosure - Accrued Liabilities link:presentationLink link:definitionLink link:calculationLink 112 - Disclosure - Maintenance and Warranty link:presentationLink link:definitionLink link:calculationLink 113 - Disclosure - Lease and Note Obligations link:presentationLink link:definitionLink link:calculationLink 114 - Disclosure - Capitalization and Equity Structure link:presentationLink link:definitionLink link:calculationLink 115 - Disclosure - Stock-based Compensation link:presentationLink link:definitionLink link:calculationLink 116 - Disclosure - Income Taxes link:presentationLink link:definitionLink link:calculationLink 117 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 118 - Disclosure - Net Loss Per Share link:presentationLink link:definitionLink link:calculationLink 119 - Disclosure - Segment Disclosures link:presentationLink link:definitionLink link:calculationLink 120 - Disclosure - Subsequent Event - Reverse Stock Split link:presentationLink link:definitionLink link:calculationLink 121 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies and Estimates (Policies) link:presentationLink link:definitionLink link:calculationLink 122 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:definitionLink link:calculationLink 123 - Disclosure - Deferred Revenues (Tables) link:presentationLink link:definitionLink link:calculationLink 124 - Disclosure - Intangible Assets (Tables) link:presentationLink link:definitionLink link:calculationLink 125 - Disclosure - Accrued Liabilities (Tables) link:presentationLink link:definitionLink link:calculationLink 126 - Disclosure - Maintenance and Warranty (Tables) link:presentationLink link:definitionLink link:calculationLink 127 - Disclosure - Lease and Note Obligations (Tables) link:presentationLink link:definitionLink link:calculationLink 128 - Disclosure - Capitalization and Equity Structure (Tables) link:presentationLink link:definitionLink link:calculationLink 129 - Disclosure - Stock-based Compensation (Tables) link:presentationLink link:definitionLink link:calculationLink 130 - Disclosure - Net Loss Per Share (Tables) link:presentationLink link:definitionLink link:calculationLink 131 - Disclosure - Segment Disclosures (Tables) link:presentationLink link:definitionLink link:calculationLink 132 - Disclosure - Organization (Details Textual) link:presentationLink link:definitionLink link:calculationLink 133 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies and Estimates (Details Textual) link:presentationLink link:definitionLink link:calculationLink 134 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:definitionLink link:calculationLink 135 - Disclosure - Fair Value Measurements (Details 1) link:presentationLink link:definitionLink link:calculationLink 136 - Disclosure - Deferred Revenues (Details) link:presentationLink link:definitionLink link:calculationLink 137 - Disclosure - Deferred Revenues (Details Textual) link:presentationLink link:definitionLink link:calculationLink 138 - Disclosure - Intangible Assets (Details) link:presentationLink link:definitionLink link:calculationLink 139 - Disclosure - Intangible Assets (Details Textual) link:presentationLink link:definitionLink link:calculationLink 140 - Disclosure - Accrued Liabilities (Details) link:presentationLink link:definitionLink link:calculationLink 141 - Disclosure - Maintenance and Warranty (Details) link:presentationLink link:definitionLink link:calculationLink 142 - Disclosure - Maintenance and Warranty (Details Textual) link:presentationLink link:definitionLink link:calculationLink 143 - Disclosure - Lease and Note Obligations (Details) link:presentationLink link:definitionLink link:calculationLink 144 - Disclosure - Lease and Note Obligations (Details Textual) link:presentationLink link:definitionLink link:calculationLink 145 - Disclosure - Capitalization and Equity Structure (Details) link:presentationLink link:definitionLink link:calculationLink 146 - Disclosure - Capitalization and Equity Structure (Details 1) link:presentationLink link:definitionLink link:calculationLink 147 - Disclosure - Capitalization and Equity Structure (Details Textual) link:presentationLink link:definitionLink link:calculationLink 148 - Disclosure - Stock-based Compensation (Details) link:presentationLink link:definitionLink link:calculationLink 149 - Disclosure - Stock-based Compensation (Details 1) link:presentationLink link:definitionLink link:calculationLink 150 - Disclosure - Stock-based Compensation (Details 2) link:presentationLink link:definitionLink link:calculationLink 151 - Disclosure - Stock-based Compensation (Details Textual) link:presentationLink link:definitionLink link:calculationLink 152 - Disclosure - Commitments and Contingencies (Details Textual) link:presentationLink link:definitionLink link:calculationLink 153 - Disclosure - Net Loss Per Share (Details) link:presentationLink link:definitionLink link:calculationLink 154 - Disclosure - Net Loss Per Share (Details 1) link:presentationLink link:definitionLink link:calculationLink 155 - Disclosure - Net Loss Per Share (Details Textual) link:presentationLink link:definitionLink link:calculationLink 156 - Disclosure - Segment Disclosures (Details) link:presentationLink link:definitionLink link:calculationLink 157 - Disclosure - Segment Disclosures (Details 1) link:presentationLink link:definitionLink link:calculationLink 158 - Disclosure - Subsequent Event - Reverse Stock Split (Details Textual) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 pnmd-20160331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 pnmd-20160331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 pnmd-20160331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document And Entity Information [Abstract] Document Information [Table] Class of Stock [Axis] Document Type Amendment Flag Document Period End Date Document Fiscal Year Focus Document Fiscal Period Focus Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Entity Filer Category Trading Symbol Entity Common Stock, Shares Outstanding Statement of Financial Position [Abstract] Statement [Table] Class of Stock [Domain] Statement [Line Items] Statement [Line Items] Assets [Abstract] Assets Assets, Current [Abstract] Current assets: Cash and Cash Equivalents, at Carrying Value, Total Cash Cash at beginning of period Cash at end of period Accounts Receivable, Net, Current, Total Accounts receivable Inventory, Net, Total Inventories, net Inventories, net Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Deferred Costs, Current, Total Deferred cost of revenue, current Less current portion Assets, Current, Total Total current assets Property, Plant and Equipment, Net, Total Property and equipment, net Property and equipment, net Deferred Costs, Noncurrent, Total Deferred cost of revenue Deferred cost of revenue, non-current Other Intangible Assets, Net Intangible assets, net Goodwill Goodwill Goodwill Liabilities and Equity [Abstract] Liabilities and Stockholders' Equity Liabilities, Current [Abstract] Current liabilities: Accounts Payable, Current Accounts payable Accrued Liabilities, Current Accrued liabilities Total Deferred Revenue, Current Deferred revenues, current Less current portion Capital Lease Obligations, Current Capital lease obligation, current less current portion Liabilities, Current, Total Total current liabilities Deferred Revenue, Noncurrent Deferred revenues Deferred revenues, non-current Derivative Liability Warrant liability Warrant liability Business Combination, Contingent Consideration, Liability Contingent consideration liability Estimated contingent consideration Other Liabilities, Noncurrent Other non-current liabilities Liabilities, Total Total liabilities Preferred Stock, Value, Issued Convertible preferred stock, $0.001 par value; 10,000 shares authorized at March 31, 2016 and December 31, 2015; 9 and 13 outstanding at March 31, 2016 and December 31, 2015, respectively Common Stock, Value, Issued Common stock, $0.001 par value; 71,429 shares authorized at March 31, 2016 and December 31, 2015; 15,604 and 15,027 outstanding at March 31, 2016 and December 31, 2015, respectively Additional Paid in Capital, Total Additional paid-in capital Retained Earnings (Accumulated Deficit), Total Accumulated deficit Stockholders' Equity Attributable to Parent, Total Total stockholders' equity Balance Balance Commitments and Contingencies Commitments and contingencies (Note 12) Preferred Stock, Par or Stated Value Per Share Convertible Preferred stock, par value per share Preferred Stock, Shares Authorized Convertible Preferred stock, shares authorized Preferred Stock, Shares Issued Convertible Preferred stock, shares issued Preferred Stock, Shares Outstanding Convertible Preferred stock, shares outstanding Common Stock, Par or Stated Value Per Share Common Stock, Shares Authorized Income Statement [Abstract] Revenues [Abstract] Revenue: Sales Revenue, Goods, Net, Total Medical devices (see Note 2) Sales Revenue, Services, Net, Total Engineering services Revenue, Net, Total Total revenue Revenue Cost of Goods and Services Sold [Abstract] Cost of revenue: Cost of Goods Sold, Total Medical devices Cost of Services, Total Engineering services Cost of Goods and Services Sold, Total Total cost of revenue Cost of revenue Gross Profit, Total Gross profit Gross profit Operating Expenses [Abstract] Operating expenses: Selling and Marketing Expense, Total Sales and marketing Research and Development Expense, Total Research and development General and Administrative Expense, Total General and administrative Operating Expenses, Total Total operating expenses Operating Income (Loss), Total Loss from operations Other Income and Expenses [Abstract] Other income (expense) net: Gain loss on warrant liability Gain on warrant liability (Gain) on change in fair value of warrant liability Amount of expense (income) related to adjustment to fair value of warrant liability. Net Income (Loss) Attributable to Parent, Total Net loss Net loss Net income (loss) Net loss Preferred Stock, Amount of Preferred Dividends in Arrears Less: Preferred deemed dividend Net Income (Loss) Available to Common Stockholders, Basic, Total Net loss applicable to common shareholders Basic Net loss attributable to common shareholders Net loss applicable to common stockholders, basic and diluted Statement of Cash Flows [Abstract] Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities Depreciation, Total Depreciation and amortization Inventory Write-down Inventory allowance expense Amortization of Deferred Charges, Total Amortization of deferred rent Increase (Decrease) in Accounts Receivable Accounts receivable Increase (Decrease) in Inventories, Total Inventories Increase (Decrease) in Prepaid Expense and Other Assets, Total Prepaid expense and other assets Increase (Decrease) in Deferred Charges Deferred costs of revenue Increase (Decrease) in Accounts Payable, Total Accounts payable Increase (Decrease) in Accrued Liabilities, Total Accrued liabilities Increase (Decrease) in Deferred Revenue Deferred revenues Net Cash Provided by (Used in) Operating Activities, Continuing Operations, Total Net cash used in operating activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Investing activities: Payments to Acquire Property, Plant, and Equipment, Total Acquisition of property and equipment Net Cash Provided by (Used in) Investing Activities, Continuing Operations, Total Net cash used in investing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Financing activities: Repayments of Notes Payable Principal payments on note payable Payments of Stock Issuance Costs Fees paid related to 2015 issuance of convertible preferred stock Cash and Cash Equivalents, Period Increase (Decrease), Total Net decrease in cash Organization, Consolidation and Presentation of Financial Statements [Abstract] Business Description and Basis of Presentation [Text Block] Organization Organization [Table] Organization [Line Items] Average Monthly Cash Burn Average Monthly Cash Burn. Accounting Policies [Abstract] Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies and Estimates Basis of Accounting, Policy [Policy Text Block] Basis of Presentation Use of Estimates, Policy [Policy Text Block] Use of Estimates Schedule Of Significant Accounting Policies [Table] Concentration Risk Type [Axis] Concentration Risk, Percentage Customer [Axis] Concentration Risk Type [Domain] Concentration Risk Benchmark [Axis] Customer [Domain] Customer Concentration Risk One [Member] Customer One [Member] Customer Concentration Risk Two [Member] Customer Two [Member] Customer Concentration Risk Three [Member] Customer Three [Member] Property, Plant and Equipment, Type [Axis] Concentration Risk Benchmark [Domain] Accounts Receivable [Member] Sales Revenue, Net [Member] Segment Reporting [Abstract] Segment Reporting Disclosure [Text Block] Segment Disclosures Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of Segment Reporting Information Revenue from External Customers by Geographic Areas [Table Text Block] Schedule of Geographic Information Schedule of Segment Reporting Information, by Segment [Table] Segments [Axis] Segment Reporting Information [Line Items] Segments [Domain] Medical Devices [Member] Engineering Services [Member] Geographical [Axis] Geographical [Domain] North America [Member] Earnings Per Share [Abstract] Earnings Per Share [Text Block] Net Loss Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of basic and diluted net income (loss) per share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of Antidilutive Securities Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Equity Components [Axis] Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Antidilutive securities Option Indexed to Issuer's Equity, Type [Axis] Option Indexed to Issuer's Equity, Type [Domain] Employee Stock Option [Member] Options to purchase common stock [Member] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Equity Component [Domain] Warrant [Member] Warrants for common stock [Member] Deferred Revenue Disclosure [Abstract] Deferred Revenue Disclosure [Text Block] Deferred Revenues Deferred Revenue, by Arrangement, Disclosure [Table Text Block] Schedule of Deferred Revenue Deferred Revenue Arrangement, by Type [Table] Deferred Revenue Arrangement Type [Axis] Deferred Revenue [Domain] Deferred Revenue Arrangement [Line Items] Deferred Rent Credit Deferred rental income Software License Arrangement [Member] Customer deposits and advances [Member] Nonsoftware Service, Support and Maintenance Arrangement [Member] Deferred Ekso medical device revenues [Member] Software Service, Support and Maintenance Arrangement [Member] Deferred extended maintenance and support [Member] Deferred Revenue Deferred Revenue Deferred Costs, Total Deferred medical device unit costs Accrued Liabilities and Other Liabilities [Abstract] Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Schedule of Accrued Liabilities Accrued Liabilities [Table] Accrued Liabilities [Line Items] Employee-related Liabilities, Current Salaries, benefits and related expenses Accrued Maintenance Current Maintenance Carrying value as of the balance sheet date of obligations incurred through that date and payable for maintenance costs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Product Warranty Accrual, Current Warranty expense Accrued Professional Fees, Current Professional fees Other Liabilities, Current Other Debt Disclosure [Abstract] Schedule of Long-term Debt Instruments [Table] Debt Instrument [Axis] Debt Instrument, Name [Domain] Lease hold Improvement Note [Member] Capital Lease Obligations [Member] Capital lease [Member] Debt Instrument [Line Items] Short-term Debt, Type [Axis] Long-term Debt, Maturities, Repayments of Principal, Remainder of Fiscal Year 2016 - remainder Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Two 2017 Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Three 2018 Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Four 2019 Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Five 2020 Long-term Debt and Capital Lease Obligations, Total Total minimum payments Capital Leases, Future Minimum Payments, Interest Included in Payments Less interest Capital Lease Obligations, Total Present value minimum payments Debt Disclosure [Text Block] Lease and Note Obligations Schedule of Maturities of Long-term Debt [Table Text Block] Schedule of Maturities of Future Obligations Long-term Debt, Gross Debt Instrument, Interest Rate, Stated Percentage Annual interest rate of note receivable Debt Instrument, Maturity Date Long-term Debt, Type [Axis] Short-term Debt, Type [Domain] EX-101.PRE 11 pnmd-20160331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 R1.htm IDEA: XBRL DOCUMENT

Document And Entity Information - shares	3 Months Ended
Document And Entity Information - shares	Mar. 31, 2016	May. 05, 2016
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2016
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	Q1
Entity Registrant Name	EKSO BIONICS HOLDINGS, INC.
Entity Central Index Key	0001549084
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Trading Symbol	PNMD
Entity Common Stock, Shares Outstanding		16,182,889

XML 13 R2.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Current assets:
Cash	$ 12,314	$ 19,552
Accounts receivable	2,383	2,069
Inventories, net	2,531	1,056
Prepaid expenses and other current assets	738	436
Deferred cost of revenue, current	255	2,088
Total current assets	18,221	25,201
Property and equipment, net	2,617	2,625
Deferred cost of revenue	0	2,502
Intangible assets, net	1,431	1,584
Goodwill	189	189
Other assets	93	97
Total assets	22,551	32,198
Current liabilities:
Accounts payable	3,618	2,694
Accrued liabilities	2,928	1,885
Deferred revenues, current	1,222	3,960
Capital lease obligation, current	81	80
Total current liabilities	7,849	8,619
Deferred revenues	766	4,613
Warrant liability	6,210	9,195
Contingent consideration liability	768	768
Other non-current liabilities	205	195
Total liabilities	$ 15,798	$ 23,390
Commitments and contingencies (Note 12)
Stockholders' equity:
Convertible preferred stock, $0.001 par value; 10,000 shares authorized at March 31, 2016 and December 31, 2015; 9 and 13 outstanding at March 31, 2016 and December 31, 2015, respectively	$ 0	$ 0
Common stock, $0.001 par value; 71,429 shares authorized at March 31, 2016 and December 31, 2015; 15,604 and 15,027 outstanding at March 31, 2016 and December 31, 2015, respectively	109	105
Additional paid-in capital	101,686	100,094
Accumulated deficit	(95,042)	(91,391)
Total stockholders' equity	6,753	8,808
Total liabilities and stockholders' equity	$ 22,551	$ 32,198

XML 14 R3.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets [Parenthetical] - $ / shares shares in Thousands	Mar. 31, 2016	Dec. 31, 2015
Convertible Preferred stock, par value per share	$ 0.001	$ 0.001
Convertible Preferred stock, shares authorized	10,000	10,000
Convertible Preferred stock, shares issued	9	13
Convertible Preferred stock, shares outstanding	9	13
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	71,429	71,429
Common Stock, Shares, Issued	15,604	15,027
Common Stock, Shares, Outstanding	15,604	15,027

XML 15 R4.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statement of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Revenue:
Medical devices (see Note 2)	$ 8,057	$ 985
Engineering services	429	704
Total revenue	8,486	1,689
Cost of revenue:
Medical devices	6,669	798
Engineering services	319	488
Total cost of revenue	6,988	1,286
Gross profit	1,498	403
Operating expenses:
Sales and marketing	2,503	1,851
Research and development	2,149	983
General and administrative	3,488	1,662
Total operating expenses	8,140	4,496
Loss from operations	(6,642)	(4,093)
Other income (expense) net:
Gain on warrant liability	2,985	0
Interest and other, net	6	(22)
Total other income (expense), net	2,991	(22)
Net loss	(3,651)	(4,115)
Less: Preferred deemed dividend	(3,124)	0
Net loss applicable to common shareholders	$ (6,775)	$ (4,115)
Basic and diluted net loss per share (In dollars per share)	$ (0.44)	$ (0.28)
Weighted average number of shares of common stock outstanding, basic and diluted	15,388	14,542

XML 16 R5.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Operating activities:
Net loss	$ (3,651)	$ (4,115)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization	440	200
Inventory allowance expense	0	45
Amortization of deferred rent	(9)	(10)
Stock-based compensation expense	1,574	349
(Gain) on change in fair value of warrant liability	(2,985)	0
Changes in operating assets and liabilities:
Accounts receivable	(314)	94
Inventories	(1,475)	(261)
Prepaid expense and other assets	(298)	(59)
Deferred costs of revenue	4,335	(354)
Accounts payable	924	681
Accrued liabilities	1,255	(721)
Deferred revenues	(6,585)	323
Net cash used in operating activities	(6,789)	(3,828)
Investing activities:
Acquisition of property and equipment	(285)	(281)
Net cash used in investing activities	(285)	(281)
Financing activities:
Principal payments on note payable	(19)	(11)
Fees paid related to 2015 issuance of convertible preferred stock	(173)	0
Proceeds from exercise of stock options	28	31
Proceeds from exercise of warrants	0	32
Net cash (used in) provided by financing activities	(164)	52
Net decrease in cash	(7,238)	(4,057)
Cash at beginning of period	19,552	25,190
Cash at end of period	$ 12,314	$ 21,133

XML 17 R6.htm IDEA: XBRL DOCUMENT

Organization

3 Months Ended

Mar. 31, 2016

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Organization

1. Organization

Description of Business

Liquidity

XML 18 R7.htm IDEA: XBRL DOCUMENT

Basis of Presentation and Summary of Significant Accounting Policies and Estimates

3 Months Ended

Mar. 31, 2016

Accounting Policies [Abstract]

Summary of Significant Accounting Policies and Estimates

2. Basis of Presentation and Summary of Significant Accounting Policies and Estimates

Basis of Presentation

Use of Estimates

Concentration of Credit Risk and Other Risks and Uncertainties

As of March 31, 2016, we had one customer with accounts receivable balances totaling 10% or more of our total accounts receivable (16%), compared with one customer as of December 31, 2015 (10%).

Medical Device Revenue and Cost of Revenue Recognition

Recent Accounting Pronouncements

XML 19 R8.htm IDEA: XBRL DOCUMENT

Fair Value Measurements

3 Months Ended

Mar. 31, 2016

Fair Value Disclosures [Abstract]

Fair Value Measurements

3. Fair Value Measurements

•

The Company’s fair value hierarchies for its financial assets and liabilities which require fair value measurement are as follows:

			Quoted Prices in		Significant
			Active Markets		Other		Significant
			For Identical		Observable		Unobservable
			Items		Inputs		Inputs
	Total		(Level 1)		(Level 2)		(Level 3)
March 31, 2016
Liabilities
Warrant liability	$	(6,210)	$	-	$	-	$	(6,210)
Contingent consideration liability	$	(768)	$	-	$	-	$	(768)

December 31, 2015
Liabilities
Warrant liability	$	(9,195)	$	-	$	-	$	(9,195)
Contingent consideration liability	$	(768)	$	-	$	-	$	(768)

	Warrant Liability		Contingent Consideration Liability
Balance at December 31, 2015	$	(9,195)	$	(768)
Gain on decrease in fair value of warrants issued with 2015 financing		2,985		-
Balance at March 31, 2016	$	(6,210)		(768)

Refer to Note 9. Capitalization and Equity Structure – Warrants for additional information regarding the valuation of warrants.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

XML 20 R9.htm IDEA: XBRL DOCUMENT

Deferred Revenues

3 Months Ended

Mar. 31, 2016

Deferred Revenue Disclosure [Abstract]

Deferred Revenues

4. Deferred Revenues

Deferred revenues and deferred cost of revenues consist of the following:

	March 31 2016		December 31, 2015
Customer deposits and advances	$	47	$	48
Deferred medical device revenues		551		7,388
Deferred rental income		64		71
Deferred extended maintenance and support		1,326		1,066
Total deferred revenues		1,988		8,573
Less current portion		(1,222)		(3,960)
Deferred revenues, non-current		766		4,613

Deferred medical device unit costs	$	255	$	4,590
Less current portion		(255)		(2,088)
Deferred cost of revenue, non-current	$	-	$	2,502

XML 21 R10.htm IDEA: XBRL DOCUMENT

Intangible Assets

3 Months Ended

Mar. 31, 2016

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets

5. Intangible Assets

	Cost		Accumulated Amortization		Net
Developed technology	$	1,160	$	(129)	$	1,031
Customer relationships		70		(8)		62
Customer trade name		380		(42)		338
	$	1,610	$	(179)	$	1,431

Estimated future amortization for the remainder of 2016 is $404, and $537 and $490 for the years 2017 and 2018, respectively.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details

XML 22 R11.htm IDEA: XBRL DOCUMENT

Accrued Liabilities

3 Months Ended

Mar. 31, 2016

Accrued Liabilities and Other Liabilities [Abstract]

Accrued Liabilities

6. Accrued Liabilities

Accrued liabilities consist of the following:

	March 31,		December 31,
	2016		2015
Salaries, benefits and related expenses	$	1,563	$	1,464
Maintenance		911		-
Warranty expense		216		-
Professional fees		158		257
Other		80		164
Total	$	2,928	$	1,885

XML 23 R12.htm IDEA: XBRL DOCUMENT

Maintenance and Warranty

3 Months Ended

Mar. 31, 2016

Maintenance And Warranty [Abstract]

Maintenance and Warranty

7. Maintenance and Warranty

A reconciliation of the changes in the maintenance and warranty liabilities for the periods ended March 31, 2016 and 2015 are as follows:

	2016
	Maintenance		Warranty		Total
Balance at December 31, 2015	$	-	$	-	$	-
Additions for estimated future expense		911		255		1,166
Incurred costs		-		-		-
Other		-		-		-
Balance at March 31, 2016	$	911	$	255	$	1,166

Current portion		911		216		1,127
Long-term portion		-		39		39
Total	$	911	$	255	$	1,166

	2015
	Maintenance		Warranty		Total
Balance at December 31, 2014	$	-	$	126	$	126
Additions for estimated future expense		-		-		-
Incurred costs		-		(17)		(17)
Other		-		-		-
Balance at March 31, 2015	$	-	$	109	$	109

Current portion		-		109		109
Long-term portion		-		-		-
Total	$	-	$	109	$	109

The long-term portion of warranty accrual is included as a component of Other long-term liabilities in the condensed consolidated balance sheets.

XML 24 R13.htm IDEA: XBRL DOCUMENT

Lease and Note Obligations

3 Months Ended

Mar. 31, 2016

Debt Disclosure [Abstract]

Lease and Note Obligations

8. Lease and Note Obligations

The Company estimates future minimum payments as of March 31, 2016 to be the following:

Period	Operating Lease		Note Payable		Capital Lease		Total Minimum Payments
2016 - remainder	$	350	$	36	$	32	$	68
2017		248		20		40		60
2018		91		-		37		37
2019		91		-		37		37
2020		89		-		22		22
Total minimum payments	$	869		56		168		224
Less interest				(2)		(16)		(18)
Present value minimum payments				54		152		206
less current portion				(45)		(36)		(81)
Long-term portion			$	9	$	116	$	125

Rent expense under the Company’s operating leases was $96 and $86 for the three month periods ended March 31, 2016 and 2015, respectively.

XML 25 R14.htm IDEA: XBRL DOCUMENT

Capitalization and Equity Structure

3 Months Ended

Mar. 31, 2016

Stockholders' Equity Note [Abstract]

Capitalization and Equity Structure

9. Capitalization and Equity Structure

Refer to Note 15, Subsequent Event, for a discussion of the Company’s May 4, 2016 reverse stock split.

Summary:

Convertible Preferred Stock:

Warrants

Warrant share activity for the three-month period ended March 31, 2016 is as follows:

Source	Exercise Price		Term (Years)		At December 31, 2015		At March 31, 2016
2015 Series A Preferred warrants	$	8.75		5		2,122		2,122

2014 PPO and Merger
Placement agent warrants	$	7.00		5		426		426
Bridge warrants	$	7.00		3		371		371
PPO warrants	$	14.00		5		1,078		1,078

Pre 2014 warrants	$	9.66		various		88		88
						4,085		4,085

Current share price	$	5.25
Conversion price	$	8.75
Risk-free interest rate		1.16	%
Periodic rate		0.55	%
Term (years)		4.73
Volatility of stock		75	%

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(d),(e))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB TOPIC 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section E

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section C

+ Details

XML 26 R15.htm IDEA: XBRL DOCUMENT

Stock-based Compensation

3 Months Ended

Mar. 31, 2016

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock-based Compensation

10. Stock-based Compensation

Refer to Note 15, Subsequent Event, for a discussion of the Company’s May 4, 2016 reverse stock split.

The following table summarizes information about the Company’s stock options outstanding at March 31, 2016, and activity during the three-month period then ended:

					Weighted-
					Average
			Weighted-		Remaining
			Average		Contractual		Aggregate
	Stock		Exercise		Life		Intrinsic
	Awards		Price		(Years)		Value
Balance as of December 31, 2015		1,963	$	7.09
Options granted		145	$	5.55
Options exercised		(10)	$	2.73
Options forfeited		(110)	$	8.41
Options cancelled		(9)	$	10.11
Balance as of March 31, 2016		1,979		6.91		7.00		1,522
Vested and expected to vest at March 31, 2016		1,851				6.85		1,518
Exercisable as of March 31, 2016		1,062				5.23		1,464

The per-share fair value of each stock option was determined on the date of grant using the Black-Scholes option pricing model using the following assumptions:

	Three months ended March 31,
	2016			2015

Dividend yield		—			—
Risk-free interest rate		1.24% - 1.78	%		1.41% - 1.92	%
Expected term (in years)		5-10			6-10
Volatility		77	%		73	%

Total stock-based compensation expense related to options granted to employees and non-employees was included in the Condensed Consolidated Statements of Operations as follows:

	Three months ended March 31,
	2016		2015
Sales and marketing	$	232	$	132
Research and development		231		54
General and administrative		1,111		163
	$	1,574	$	349

XML 27 R16.htm IDEA: XBRL DOCUMENT

Income Taxes

3 Months Ended

Mar. 31, 2016

Income Tax Disclosure [Abstract]

Income Taxes

11. Income Taxes

XML 28 R17.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies

3 Months Ended

Mar. 31, 2016

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

12. Commitments and Contingencies

Contingencies

Material Contracts

U.S. Food and Drug Administration Clearance

XML 29 R18.htm IDEA: XBRL DOCUMENT

Net Loss Per Share

3 Months Ended

Mar. 31, 2016

Earnings Per Share [Abstract]

Net Loss Per Share

13. Net Loss Per Share

Refer to Note 15, Subsequent Event, for a discussion of the Company’s May 4, 2016 reverse stock split.

The following table sets forth the computation of basic and diluted net loss per share:

	Three months ended March 31,
	2016		2015
Numerator:
Net loss applicable to common stockholders, basic and diluted	$	(6,775)	$	(4,115)

Denominator
Weighted-average number of shares, basic and diluted		15,388		14,542

Net loss per share, basic and diluted	$	(0.44)	$	(0.28)

	March 31,
	2016		2015
Options to purchase common stock		1,979		1,496
Warrants for common stock		4,085		1,966
Common stock issuable upon conversion of preferred shares		1,309		-
Total common stock equivalents		7,373		3,462

XML 30 R19.htm IDEA: XBRL DOCUMENT

Segment Disclosures

3 Months Ended

Mar. 31, 2016

Segment Reporting [Abstract]

Segment Disclosures

14. Segment Disclosures

Segment reporting information is as follows:

	Medical		Engineering
	Devices		Services		Total
Three months ended March 31, 2016
Revenue	$	8,057	$	429	$	8,486
Cost of revenue		6,669		319		6,988
Gross profit	$	1,388	$	110	$	1,498

Three months ended March 31, 2015
Revenue	$	985	$	704	$	1,689
Cost of revenue		798		488		1,286
Gross profit	$	187	$	216	$	403

Geographic information for revenue based on location of customer is as follows:

	Three Months Ended March 31,
	2016		2015
North America	$	4,521	$	1,271
All Other		3,965		418
	$	8,486	$	1,689

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8906-108599

+ Details

XML 31 R20.htm IDEA: XBRL DOCUMENT

Subsequent Event - Reverse Stock Split

3 Months Ended

Mar. 31, 2016

Subsequent Events [Abstract]

Subsequent Events [Text Block]

15. Subsequent Event – Reverse Stock Split

XML 32 R21.htm IDEA: XBRL DOCUMENT

Basis of Presentation and Summary of Significant Accounting Policies and Estimates (Policies)

3 Months Ended

Mar. 31, 2016

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

Use of Estimates

Use of Estimates

Concentration of Credit Risk and Other Risks and Uncertainties

Concentration of Credit Risk and Other Risks and Uncertainties

As of March 31, 2016, we had one customer with accounts receivable balances totaling 10% or more of our total accounts receivable (16%), compared with one customer as of December 31, 2015 (10%).

Revenue and Cost of Revenue Recognition

Medical Device Revenue and Cost of Revenue Recognition

Recent Accounting Pronouncements

Recent Accounting Pronouncements

- Definition

Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.

+ References + Details

XML 33 R22.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Tables)

3 Months Ended

Mar. 31, 2016

Fair Value Disclosures [Abstract]

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis

The Company’s fair value hierarchies for its financial assets and liabilities which require fair value measurement are as follows:

			Quoted Prices in		Significant
			Active Markets		Other		Significant
			For Identical		Observable		Unobservable
			Items		Inputs		Inputs
	Total		(Level 1)		(Level 2)		(Level 3)
March 31, 2016
Liabilities
Warrant liability	$	(6,210)	$	-	$	-	$	(6,210)
Contingent consideration liability	$	(768)	$	-	$	-	$	(768)

December 31, 2015
Liabilities
Warrant liability	$	(9,195)	$	-	$	-	$	(9,195)
Contingent consideration liability	$	(768)	$	-	$	-	$	(768)

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation

	Warrant Liability		Contingent Consideration Liability
Balance at December 31, 2015	$	(9,195)	$	(768)
Gain on decrease in fair value of warrants issued with 2015 financing		2,985		-
Balance at March 31, 2016	$	(6,210)		(768)

XML 34 R23.htm IDEA: XBRL DOCUMENT

Deferred Revenues (Tables)

3 Months Ended

Mar. 31, 2016

Deferred Revenue Disclosure [Abstract]

Schedule of Deferred Revenue

Deferred revenues and deferred cost of revenues consist of the following:

	March 31 2016		December 31, 2015
Customer deposits and advances	$	47	$	48
Deferred medical device revenues		551		7,388
Deferred rental income		64		71
Deferred extended maintenance and support		1,326		1,066
Total deferred revenues		1,988		8,573
Less current portion		(1,222)		(3,960)
Deferred revenues, non-current		766		4,613

Deferred medical device unit costs	$	255	$	4,590
Less current portion		(255)		(2,088)
Deferred cost of revenue, non-current	$	-	$	2,502

XML 35 R24.htm IDEA: XBRL DOCUMENT

Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2016

Goodwill and Intangible Assets Disclosure [Abstract]

Amortization of Purchased Intangible Assets

The following table reflects the amortization of the purchased intangible assets as of March 31, 2016:

	Cost		Accumulated Amortization		Net
Developed technology	$	1,160	$	(129)	$	1,031
Customer relationships		70		(8)		62
Customer trade name		380		(42)		338
	$	1,610	$	(179)	$	1,431

XML 36 R25.htm IDEA: XBRL DOCUMENT

Accrued Liabilities (Tables)

3 Months Ended

Mar. 31, 2016

Accrued Liabilities and Other Liabilities [Abstract]

Schedule of Accrued Liabilities

Accrued liabilities consist of the following:

	March 31,		December 31,
	2016		2015
Salaries, benefits and related expenses	$	1,563	$	1,464
Maintenance		911		-
Warranty expense		216		-
Professional fees		158		257
Other		80		164
Total	$	2,928	$	1,885

XML 37 R26.htm IDEA: XBRL DOCUMENT

Maintenance and Warranty (Tables)

3 Months Ended

Mar. 31, 2016

Maintenance And Warranty [Abstract]

Reconciliation of Changes in Maintenance and Warranty Liabilities

A reconciliation of the changes in the maintenance and warranty liabilities for the periods ended March 31, 2016 and 2015 are as follows:

	2016
	Maintenance		Warranty		Total
Balance at December 31, 2015	$	-	$	-	$	-
Additions for estimated future expense		911		255		1,166
Incurred costs		-		-		-
Other		-		-		-
Balance at March 31, 2016	$	911	$	255	$	1,166

Current portion		911		216		1,127
Long-term portion		-		39		39
Total	$	911	$	255	$	1,166

	2015
	Maintenance		Warranty		Total
Balance at December 31, 2014	$	-	$	126	$	126
Additions for estimated future expense		-		-		-
Incurred costs		-		(17)		(17)
Other		-		-		-
Balance at March 31, 2015	$	-	$	109	$	109

Current portion		-		109		109
Long-term portion		-		-		-
Total	$	-	$	109	$	109

XML 38 R27.htm IDEA: XBRL DOCUMENT

Lease and Note Obligations (Tables)

3 Months Ended

Mar. 31, 2016

Debt Disclosure [Abstract]

Schedule of Maturities of Future Obligations

The Company estimates future minimum payments as of March 31, 2016 to be the following:

Period	Operating Lease		Note Payable		Capital Lease		Total Minimum Payments
2016 - remainder	$	350	$	36	$	32	$	68
2017		248		20		40		60
2018		91		-		37		37
2019		91		-		37		37
2020		89		-		22		22
Total minimum payments	$	869		56		168		224
Less interest				(2)		(16)		(18)
Present value minimum payments				54		152		206
less current portion				(45)		(36)		(81)
Long-term portion			$	9	$	116	$	125

XML 39 R28.htm IDEA: XBRL DOCUMENT

Capitalization and Equity Structure (Tables)

3 Months Ended

Mar. 31, 2016

Schedule of Warrant share activity

Warrant share activity for the three-month period ended March 31, 2016 is as follows:

Source	Exercise Price		Term (Years)		At December 31, 2015		At March 31, 2016
2015 Series A Preferred warrants	$	8.75		5		2,122		2,122

2014 PPO and Merger
Placement agent warrants	$	7.00		5		426		426
Bridge warrants	$	7.00		3		371		371
PPO warrants	$	14.00		5		1,078		1,078

Pre 2014 warrants	$	9.66		various		88		88
						4,085		4,085

2016 Warrants [Member]

Schedule of assumption used in valuation

The following assumptions were used in the Binomial Lattice Option Pricing Model to measure the fair value of the embedded anti-dilution feature in the warrants as of March 31, 2016:

Current share price	$	5.25
Conversion price	$	8.75
Risk-free interest rate		1.16	%
Periodic rate		0.55	%
Term (years)		4.73
Volatility of stock		75	%

XML 40 R29.htm IDEA: XBRL DOCUMENT

Stock-based Compensation (Tables)

3 Months Ended

Mar. 31, 2016

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Summary of Stock Option Activity

The following table summarizes information about the Company’s stock options outstanding at March 31, 2016, and activity during the three-month period then ended:

					Weighted-
					Average
			Weighted-		Remaining
			Average		Contractual		Aggregate
	Stock		Exercise		Life		Intrinsic
	Awards		Price		(Years)		Value
Balance as of December 31, 2015		1,963	$	7.09
Options granted		145	$	5.55
Options exercised		(10)	$	2.73
Options forfeited		(110)	$	8.41
Options cancelled		(9)	$	10.11
Balance as of March 31, 2016		1,979		6.91		7.00		1,522
Vested and expected to vest at March 31, 2016		1,851				6.85		1,518
Exercisable as of March 31, 2016		1,062				5.23		1,464

Schedule of Fair Value Calculation Assumptions

The per-share fair value of each stock option was determined on the date of grant using the Black-Scholes option pricing model using the following assumptions:

	Three months ended March 31,
	2016			2015

Dividend yield		—			—
Risk-free interest rate		1.24% - 1.78	%		1.41% - 1.92	%
Expected term (in years)		5-10			6-10
Volatility		77	%		73	%

Allocation of Stock Option Compensation Expense

Total stock-based compensation expense related to options granted to employees and non-employees was included in the Condensed Consolidated Statements of Operations as follows:

	Three months ended March 31,
	2016		2015
Sales and marketing	$	232	$	132
Research and development		231		54
General and administrative		1,111		163
	$	1,574	$	349

XML 41 R30.htm IDEA: XBRL DOCUMENT

Net Loss Per Share (Tables)

3 Months Ended

Mar. 31, 2016

Earnings Per Share [Abstract]

Schedule of basic and diluted net income (loss) per share

The following table sets forth the computation of basic and diluted net loss per share:

	Three months ended March 31,
	2016		2015
Numerator:
Net loss applicable to common stockholders, basic and diluted	$	(6,775)	$	(4,115)

Denominator
Weighted-average number of shares, basic and diluted		107,718		101,791


Net loss per share, basic and diluted	$	(0.06)	$	(0.04)

Schedule of Antidilutive Securities

	March 31,
	2016		2015
Options to purchase common stock		1,979		1,496
Warrants for common stock		4,085		1,966
Common stock issuable upon conversion of preferred shares		1,309		-
Total common stock equivalents		7,373		3,462

XML 42 R31.htm IDEA: XBRL DOCUMENT

Segment Disclosures (Tables)

3 Months Ended

Mar. 31, 2016

Segment Reporting [Abstract]

Schedule of Segment Reporting Information

Segment reporting information is as follows:

	Medical		Engineering
	Devices		Services		Total
Three months ended March 31, 2016
Revenue	$	8,057	$	429	$	8,486
Cost of revenue		6,669		319		6,988
Gross profit	$	1,388	$	110	$	1,498

Three months ended March 31, 2015
Revenue	$	985	$	704	$	1,689
Cost of revenue		798		488		1,286
Gross profit	$	187	$	216	$	403

Schedule of Geographic Information

Geographic information for revenue based on location of customer is as follows:

	Three Months Ended March 31,
	2016		2015
North America	$	4,521	$	1,271
All Other		3,965		418
	$	8,486	$	1,689

XML 43 R32.htm IDEA: XBRL DOCUMENT

Organization (Details Textual) - USD ($) $ in Thousands	3 Months Ended
Organization (Details Textual) - USD ($) $ in Thousands	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015	Dec. 31, 2014
Organization [Line Items]
Retained Earnings (Accumulated Deficit), Total	$ (95,042)		$ (91,391)
Cash and Cash Equivalents, at Carrying Value, Total	12,314	$ 21,133	$ 19,552	$ 25,190
Net Cash Provided by (Used in) Operating Activities, Continuing Operations, Total	(6,789)	$ (3,828)
Average Monthly Cash Burn	$ 1,800

XML 44 R33.htm IDEA: XBRL DOCUMENT

Basis of Presentation and Summary of Significant Accounting Policies and Estimates (Details Textual) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended		12 Months Ended
	Dec. 31, 2015	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015
Significant Accounting Policies [Line Items]
Reduction In Net Loss Attributable To Common Stock Holders		$ 2,358
Medical Device [Member]
Significant Accounting Policies [Line Items]
Reduction In Net Loss Attributable To Common Stock Holders				$ 2,358
Deferred Revenue, Revenue Recognized	$ 6,517			6,517
Cost of Revenue	$ 4,159			$ 4,159
Product Liability Accrual, Component Amount		212
Customer Advances and Deposits, Current, Total		$ 911
Minimum [Member] \| Medical Device [Member]
Significant Accounting Policies [Line Items]
Revenue Maintenance Contractual Agreement Term	1 year	1 year
Maximum [Member] \| Medical Device [Member]
Significant Accounting Policies [Line Items]
Revenue Maintenance Contractual Agreement Term	3 years	4 years
Sales Revenue, Net [Member]
Significant Accounting Policies [Line Items]
Concentration Risk, Percentage		10.00%
Customer One [Member] \| Accounts Receivable [Member]
Significant Accounting Policies [Line Items]
Concentration Risk, Percentage		16.00%		10.00%
Customer One [Member] \| Sales Revenue, Net [Member]
Significant Accounting Policies [Line Items]
Concentration Risk, Percentage		27.00%	17.00%
Customer Two [Member] \| Sales Revenue, Net [Member]
Significant Accounting Policies [Line Items]
Concentration Risk, Percentage		20.00%	16.00%
Customer Three [Member] \| Sales Revenue, Net [Member]
Significant Accounting Policies [Line Items]
Concentration Risk, Percentage		11.00%
Customer Four [Member] \| Sales Revenue, Net [Member]
Significant Accounting Policies [Line Items]
Concentration Risk, Percentage		10.00%

XML 45 R34.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Details) - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Liabilities:
Warrant liability	$ (6,210)	$ (9,195)
Fair Value, Measurements, Recurring [Member]
Liabilities:
Warrant liability	(6,210)	(9,195)
Contingent consideration liability	(768)	(768)
Quoted Prices in Active Markets for Identical Items Level 1 [Member] \| Fair Value, Measurements, Recurring [Member]
Liabilities:
Warrant liability	0	0
Contingent consideration liability	0	0
Significant Other Observable Inputs Level 2 [Member] \| Fair Value, Measurements, Recurring [Member]
Liabilities:
Warrant liability	0	0
Contingent consideration liability	0	0
Significant Unobservable Inputs Level 3 [Member] \| Fair Value, Measurements, Recurring [Member]
Liabilities:
Warrant liability	(6,210)	(9,195)
Contingent consideration liability	$ (768)	$ (768)

XML 46 R35.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Details 1) $ in Thousands	3 Months Ended
Fair Value Measurements (Details 1) $ in Thousands	Mar. 31, 2016 USD ($)
Derivative Financial Instruments, Liabilities [Member]
Balance at December 31, 2015	$ (9,195)
Gain on decrease in fair value of warrants issued with 2015 financing	2,985
Balance at March 31, 2016	(6,210)
Contingent Consideration [Member]
Balance at December 31, 2015	(768)
Gain on decrease in fair value of warrants issued with 2015 financing	0
Balance at March 31, 2016	$ (768)

XML 47 R36.htm IDEA: XBRL DOCUMENT

Deferred Revenues (Details) - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Deferred Revenue Arrangement [Line Items]
Deferred rental income	$ 64	$ 71
Deferred Revenue	1,988	8,573
Less current portion	1,222	3,960
Deferred revenues, non-current	766	4,613
Deferred medical device unit costs	255	4,590
Less current portion	(255)	(2,088)
Deferred cost of revenue, non-current	0	2,502
Customer deposits and advances [Member]
Deferred Revenue Arrangement [Line Items]
Deferred Revenue	47	48
Deferred Ekso medical device revenues [Member]
Deferred Revenue Arrangement [Line Items]
Deferred Revenue	551	7,388
Deferred extended maintenance and support [Member]
Deferred Revenue Arrangement [Line Items]
Deferred Revenue	$ 1,326	$ 1,066

XML 48 R37.htm IDEA: XBRL DOCUMENT

Deferred Revenues (Details Textual) - Medical Device [Member] - USD ($) $ in Thousands	1 Months Ended	3 Months Ended	12 Months Ended
	Dec. 31, 2015	Mar. 31, 2016	Dec. 31, 2015
Deferred Revenue Arrangement [Line Items]
Deferred Revenue, Revenue Recognized	$ 6,517		$ 6,517
Cost of Revenue	$ 4,159		$ 4,159
Maximum [Member]
Deferred Revenue Arrangement [Line Items]
Revenue Maintenance Contractual Agreement Term	3 years	4 years
Minimum [Member]
Deferred Revenue Arrangement [Line Items]
Revenue Maintenance Contractual Agreement Term	1 year	1 year

XML 49 R38.htm IDEA: XBRL DOCUMENT

Intangible Assets (Details) $ in Thousands	Mar. 31, 2016 USD ($)
Indefinite-lived Intangible Assets [Line Items]
Cost	$ 1,610
Accumulated Amortization	(179)
Net	1,431
Developed Technology Rights [Member]
Indefinite-lived Intangible Assets [Line Items]
Cost	1,160
Accumulated Amortization	(129)
Net	1,031
Customer Relationships [Member]
Indefinite-lived Intangible Assets [Line Items]
Cost	70
Accumulated Amortization	(8)
Net	62
Customer Trade Name [Member]
Indefinite-lived Intangible Assets [Line Items]
Cost	380
Accumulated Amortization	(42)
Net	$ 338

XML 50 R39.htm IDEA: XBRL DOCUMENT

Intangible Assets (Details Textual) - USD ($) $ in Thousands		3 Months Ended
	Dec. 01, 2015	Mar. 31, 2016	Dec. 31, 2015
Indefinite-lived Intangible Assets [Line Items]
Business Combination, Contingent Consideration, Liability		$ 768	$ 768
Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year		404
Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months		537
Finite-Lived Intangible Assets, Amortization Expense, Year Two		490
Equipois, LLC [Member]
Indefinite-lived Intangible Assets [Line Items]
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable	$ 1,071
Business Combination, Contingent Consideration, Liability	$ 768
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill, Total		$ 1,610
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life		3 years

XML 51 R40.htm IDEA: XBRL DOCUMENT

Accrued Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Accrued Liabilities [Line Items]
Salaries, benefits and related expenses	$ 1,563	$ 1,464
Maintenance	911	0
Warranty expense	216	0
Professional fees	158	257
Other	80	164
Total	$ 2,928	$ 1,885

XML 52 R41.htm IDEA: XBRL DOCUMENT

Maintenance and Warranty (Details) - USD ($) $ in Thousands	3 Months Ended
Maintenance and Warranty (Details) - USD ($) $ in Thousands	Mar. 31, 2016	Mar. 31, 2015	Mar. 31, 2016	Mar. 31, 2015
Beginning Balance	$ 0	$ 126
Additions for estimated future expense	1,166	0
Incurred costs	0	(17)
Other	0	0
Closing Balance	1,166	109
Current portion			$ 1,127	$ 109
Long-term portion			39	0
Total	0	126	1,166	109
Maintenance [Member]
Beginning Balance	0	0
Additions for estimated future expense	911	0
Incurred costs	0	0
Other	0	0
Closing Balance	911	0
Current portion			911	0
Long-term portion			0	0
Total	0	0	911	0
Warranty [Member]
Beginning Balance	0	126
Additions for estimated future expense	255	0
Incurred costs	0	(17)
Other	0	0
Closing Balance	255	109
Current portion			216	109
Long-term portion			39	0
Total	$ 0	$ 126	$ 255	$ 109

XML 53 R42.htm IDEA: XBRL DOCUMENT

Maintenance and Warranty (Details Textual) $ in Thousands	3 Months Ended
Maintenance and Warranty (Details Textual) $ in Thousands	Mar. 31, 2016 USD ($)
Cost of Property Repairs and Maintenance	$ 911

XML 54 R43.htm IDEA: XBRL DOCUMENT

Lease and Note Obligations (Details) - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Debt Instrument [Line Items]
2016 - remainder	$ 68
2017	60
2018	37
2019	37
2020	22
Total minimum payments	224
Less interest	(18)
Present value minimum payments	206
less current portion	(81)	$ (80)
Long-term portion	125
Lease hold Improvement Note [Member]
Debt Instrument [Line Items]
2016 - remainder	36
2017	20
2018	0
2019	0
2020	0
Total minimum payments	56
Less interest	(2)
Present value minimum payments	54
less current portion	(45)
Long-term portion	9
Capital Lease Obligations [Member]
Debt Instrument [Line Items]
2016 - remainder	32
2017	40
2018	37
2019	37
2020	22
Total minimum payments	168
Less interest	(16)
Present value minimum payments	152
less current portion	(36)
Long-term portion	116
Operating Lease [Member]
Debt Instrument [Line Items]
2016 - remainder	350
2017	248
2018	91
2019	91
2020	89
Total minimum payments	$ 869

XML 55 R44.htm IDEA: XBRL DOCUMENT

Lease and Note Obligations (Details Textual) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Debt Instrument [Line Items]
Operating Leases, Rent Expense, Net, Total	$ 96	$ 86
Lease Expiration Date	May 31, 2017
Capital Lease Obligations [Member]
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 166
Debt Instrument, Interest Rate, Stated Percentage	4.70%
Debt Instrument, Maturity Date	Jul. 01, 2020
Debt Instrument Minimum Monthly Payments	$ 3
Notes Payable, Other Payables [Member]
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 200
Debt Instrument, Interest Rate, Stated Percentage	7.00%
Debt Instrument, Maturity Date	May 31, 2017
Debt Instrument Minimum Monthly Payments	$ 4

XML 56 R45.htm IDEA: XBRL DOCUMENT

Capitalization and Equity Structure (Details) - $ / shares shares in Thousands	3 Months Ended
	Mar. 31, 2016	Dec. 31, 2015
Schedule of Capitalization, Equity [Line Items]
Merger/PPO Warrant Shares Outstanding	4,085	4,085
2015 Series A Preferred Warrants [Member]
Schedule of Capitalization, Equity [Line Items]
Exercise price	$ 8.75
Warrant term	5 years
Merger/PPO Warrant Shares Outstanding	2,122	2,122
Pre 2014 Warrants [Member]
Schedule of Capitalization, Equity [Line Items]
Exercise price	$ 9.66
Merger/PPO Warrant Shares Outstanding	88	88
2014 PPO and Merger [Member] \| Placement agent warrants [Member]
Schedule of Capitalization, Equity [Line Items]
Exercise price	$ 7
Warrant term	5 years
Merger/PPO Warrant Shares Outstanding	426	426
2014 PPO and Merger [Member] \| Bridge warrants [Member]
Schedule of Capitalization, Equity [Line Items]
Exercise price	$ 7
Warrant term	3 years
Merger/PPO Warrant Shares Outstanding	371	371
2014 PPO and Merger [Member] \| PPO warrants [Member]
Schedule of Capitalization, Equity [Line Items]
Exercise price	$ 14
Warrant term	5 years
Merger/PPO Warrant Shares Outstanding	1,078	1,078

XML 57 R46.htm IDEA: XBRL DOCUMENT

Capitalization and Equity Structure (Details 1) - Binomial Lattice Option Pricing Model [Member] - Warrant [Member]	3 Months Ended
	Mar. 31, 2016 $ / shares
Schedule of Capitalization, Equity [Line Items]
Current Share Price	$ 5.25
Conversion Price	$ 8.75
Risk-free interest rate	1.16%
Periodic rate	0.55%
Term (years)	4 years 8 months 23 days
Volatility of stock	75.00%

XML 58 R47.htm IDEA: XBRL DOCUMENT

Capitalization and Equity Structure (Details Textual) $ / shares in Units, shares in Thousands, $ in Thousands	1 Months Ended	3 Months Ended
	Dec. 31, 2015 USD ($) $ / shares shares	Mar. 31, 2016 USD ($) shares
Class of Stock [Line Items]
Common Stock, Shares Authorized	71,429	71,429
Preferred Stock, Shares Authorized	10,000	10,000
Common Stock, Shares, Issued	15,027	15,604
Common Stock, Shares, Outstanding	15,027	15,604
Preferred Stock, Shares Issued	13	9
Preferred Stock, Shares Outstanding	13	9
Fair Value Adjustment of Warrants \| $		$ 2,985
Warrants Not Settleable in Cash, Fair Value Disclosure \| $	$ 9,195
Conversion of Stock, Shares Converted		4
Conversion of Stock, Shares Issued		566
Preferred Stock Dividends, Income Statement Impact \| $		$ 3,124
Unamortized Warrant Discount \| $		$ 7,221
Warrant [Member]
Class of Stock [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	2,122
Class of Warrant or Right, Exercise Price of Warrants or Rights \| $ / shares	$ 8.75
Warrants Term	5 years
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues	15
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	2,122
Gross Proceeds from Preferred Stock and Warrants \| $	$ 15,000
Preferred Stock Convertible Conversion Price		7.07

XML 59 R48.htm IDEA: XBRL DOCUMENT

Stock-based Compensation (Details) - 2014 Plan [Member] $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2016 USD ($) $ / shares shares
Options Outstanding
Stock Awards, Balance \| shares	1,963
Stock Awards, Options granted \| shares	145
Stock Awards, Options exercised \| shares	(10)
Stock Awards, Options forfeited \| shares	(110)
Stock Awards, Options cancelled \| shares	(9)
Stock Awards, Balance \| shares	1,979
Stock Awards, Vested and expected to vest \| shares	1,851
Stock Awards, Exercisable \| shares	1,062
Weighted-Average Exercise Price, Balance \| $ / shares	$ 7.09
Weighted-Average Exercise Price, Options granted \| $ / shares	5.55
Weighted-Average Exercise Price, Options exercised \| $ / shares	2.73
Weighted-Average Exercise Price, Options forfeited \| $ / shares	8.41
Weighted-Average Exercise Price, Options cancelled \| $ / shares	10.11
Weighted-Average Exercise Price, Balance \| $ / shares	6.91
Weighted-Average Exercise Price, Vested and expected to vest \| $ / shares	0
Weighted-Average Exercise Price, Exercisable \| $ / shares	$ 0
Weighted-Average Remaining Contractual Life (Years), Balance	7 years
Weighted-Average Remaining Contractual Life (Years), Vested and expected to vest	6 years 10 months 6 days
Weighted-Average Remaining Contractual Life (Years), Exercisable	5 years 2 months 23 days
Aggregate Intrinsic Value, Balance \| $	$ 1,522
Aggregate Intrinsic Value, Vested and expected to vest \| $	1,518
Aggregate Intrinsic Value, Exercisable \| $	$ 1,464

XML 60 R49.htm IDEA: XBRL DOCUMENT

Stock-based Compensation (Details 1)	3 Months Ended
Stock-based Compensation (Details 1)	Mar. 31, 2016	Mar. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend yield	0.00%	0.00%
Risk-free interest rate, minimum	1.24%	1.41%
Risk-free interest rate, maximum	1.78%	1.92%
Volatility	77.00%	73.00%
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	5 years	6 years
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	10 years	10 years

XML 61 R50.htm IDEA: XBRL DOCUMENT

Stock-based Compensation (Details 2) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Allocated Share-based Compensation Expense	$ 1,574	$ 349
Sales and marketing [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Allocated Share-based Compensation Expense	232	132
Research and development [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Allocated Share-based Compensation Expense	231	54
General and administrative [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Allocated Share-based Compensation Expense	$ 1,111	$ 163

XML 62 R51.htm IDEA: XBRL DOCUMENT

Stock-based Compensation (Details Textual) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation, Total	$ 1,574	$ 349
Research and Development Expense [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation, Total	59
General and Administrative Expense [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation, Total	774
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options	$ 4,640
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	2 years 9 months 18 days
Equity Incentive Plan 2014 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	3,714
Common Stock, Capital Shares Reserved for Future Issuance	1,480

XML 63 R52.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies (Details Textual) $ in Thousands	3 Months Ended
	Mar. 31, 2016 USD ($)
Future minimum annual royalties:
Supply Agreement ,Minimum Annual Price	$ 157
Contractual Obligation, Due in Next Fiscal Year	50
Royalty Agreement Terms [Member]
Future minimum annual royalties:
Contractual Obligation, Due in Next Fiscal Year	$ 50
Royalty Agreement Terms [Member] \| Net sales [Member]
Future minimum annual royalties:
Royalty Percentage	1.00%
Royalty Agreement Terms [Member] \| License fees [Member]
Future minimum annual royalties:
Royalty Percentage	21.00%
Royalty Agreement Terms [Member] \| Sub-licensee net sales [Member]
Future minimum annual royalties:
Royalty Percentage	1.00%

XML 64 R53.htm IDEA: XBRL DOCUMENT

Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Numerator:
Net loss applicable to common stockholders, basic and diluted	$ (6,775)	$ (4,115)
Denominator
Weighted-average number of shares, basic and diluted	15,388	14,542
Net loss per share, basic and diluted	$ (0.44)	$ (0.28)

XML 65 R54.htm IDEA: XBRL DOCUMENT

Net Loss Per Share (Details 1) - shares shares in Thousands	3 Months Ended
Net Loss Per Share (Details 1) - shares shares in Thousands	Mar. 31, 2016	Mar. 31, 2015
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities	7,373	3,462
Options to purchase common stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities	1,979	1,496
Warrants for common stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities	4,085	1,966
Common stock issuable upon conversion of preferred shares [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities	1,309	0

XML 66 R55.htm IDEA: XBRL DOCUMENT

Net Loss Per Share (Details Textual) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2016 USD ($) $ / shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Reduction In Net Loss Attributable To Common Stock Holders \| $	$ 2,358
Reduction In Net Loss Per Share Attributable To Common Stock Holders \| $ / shares	$ 0.15

XML 67 R56.htm IDEA: XBRL DOCUMENT

Segment Disclosures (Details) - USD ($) $ in Thousands	3 Months Ended
Segment Disclosures (Details) - USD ($) $ in Thousands	Mar. 31, 2016	Mar. 31, 2015
Segment Reporting Information [Line Items]
Revenue	$ 8,486	$ 1,689
Cost of revenue	6,988	1,286
Gross profit	1,498	403
Medical Devices [Member]
Segment Reporting Information [Line Items]
Revenue	8,057	985
Cost of revenue	6,669	798
Gross profit	1,388	187
Engineering Services [Member]
Segment Reporting Information [Line Items]
Revenue	429	704
Cost of revenue	319	488
Gross profit	$ 110	$ 216

XML 68 R57.htm IDEA: XBRL DOCUMENT

Segment Disclosures (Details 1) - USD ($) $ in Thousands	3 Months Ended
Segment Disclosures (Details 1) - USD ($) $ in Thousands	Mar. 31, 2016	Mar. 31, 2015
Segment Reporting Information [Line Items]
Revenue	$ 8,486	$ 1,689
North America [Member]
Segment Reporting Information [Line Items]
Revenue	4,521	1,271
All Other [Member]
Segment Reporting Information [Line Items]
Revenue	$ 3,965	$ 418

XML 69 R58.htm IDEA: XBRL DOCUMENT

Subsequent Event - Reverse Stock Split (Details Textual)	May. 04, 2016
Subsequent Event [Member]
Subsequent Event [Line Items]
Stockholders' Equity, Reverse Stock Split	1-for-7 reverse split

EXCEL 70 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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
K;A*8$;"V1-S#L]ST\B(IV6V 'IL$G3J% M/" 0%(Z"!+!&."'=X5ZN]+&T5J;&M+Z(6O+F[4A=K^ >UO45J![I/:Y^H01* MG-UW@A7U(P8E)V H+8$XVU">@809 %;/1+!H>-FS__($!Q M%Z!XUVM^*&+D@Q,)HP4Y1@$":4WN@Q!,E[!(<_"G<8=H!MBW2/VQ.FLOJNGO %-%@A<9K#/ MJLACY;H2I%$4L$PU#RCF%1%%*O%56,#[ M^%Z,V5W4$Y?:ZD0.>0EX CH FL=O;BD,91$5Q$Z97"-5*\NKY&,J99J6(/[R M\HN$*9!:JQL0*7%]37;V3;V*<=.@"%Y7-Q&*FKH@*4VV7L[Z6L^=ZF]_^=^M M$0DBRLA@C@#@O9%Q"NQV#J!#I%X ; HXB$BL<$B@Z4@SE;(&RE%V)1S&60)L M:8$1DK,8L ,AV^2&N-%D"7/!^HL.H],1TJXB@N?A/D6\M;FS>'&+^X?'Y?PF MR]/\^EXM=+5")2).'46:&;-]D 0+$OBJ8;(;:$ M,KPS>4U6,BLI2[)K6D8O#()'AS](WC;.C::+TY(M%ICLSZU9R8>-8^M)RS)' M8T1+3EPZH"]H]6;_R"H!T!;TO@/!@G<#84&T5R16:D,QW*!(95 M[/LMB:/#^$WW:1MZ8!]EH;?QS6?B>!+UQT.V F&U-V1/>1Y9%#K/Q& 8C09C M,3B.)I.A.(RF1\=B%!T-C\0KLH/J=9YYF*+]_=6=3&]!PF*0VIJYH K6K' 2 M3.%?H) B_YJL8*FP>9@T.NKW/R@"CRJ[P",]]A M*EK6%_*&33]&.9XB@I78I6@6$#7I/TBR#E<@E%:.=UIDUKT88-_B!OTV<*+$ MMI[#![ &7D2;J71R"[27#J[R12(730:*XUL6B;/T2%MG;I_>-P^-CEKA18. M8QLJL-:*6N"RKFKDQ$R=[G# LP!IV)41H^P%8P>_5U8'_GJ/T?7J!C29ZQNC MZZ)>!5+Y*C<*)2M[Z)$&(7^+3W"$ (99DGN4Q--595=7XL/:/8 ZVER=-" M MNQP1;'9;:CS+;G"Q-:!C7J<++2+TD:##R$&U1'GK:$SY-6$#V8UH$+LLD,%F M(."!'R(+5.*0I*:%*IT!/!/?QDE*GK6[&Y+N2J5&GE@OD1L11K#J$ E"063. M[(P#_8D@@ (Y37N@(#'D2;K3C/AG)N<@.I#LPP=+'.-* MVG61;K*HYTS<:"F $H,CHDT"K NDMG9_H%I:P;D 1B(&6KVT2^9&XKK3M:NT MD0"O,-%^@(/5_^!\83NI(]N\3!%T4M)9-JQ8'/RR7JV4D77ID(<*:M<.J'O;$]]\PXCL N\YB.-F*S#,=E]EJ,SEZ M\!K]; KK ;WS8D$DP^:V7<.:G4F( @I14'81.1@%'BR!Q'AR0>* =?&Y=]D3 M[V:S<[3'62>O"W0E&=.GJ#5:%?(:50%ME9*U:'D%[?VK\E)2I+TL$80XR^6; M$QP_(EZ,[ZU;OA%B'\G*@45BT\9Z!.L"R0-I1:M%SA,T^3+/*W*>(>&!EE6C M_SO#1Q 4KBT3A/@F.!LH.>=B3C,BXEHE%1E4+OC*&N@X"#_6'3L0XDH%:4H M(08%$*9&=-I(V$'P:UHC(,%B *2R+BTQIE\?38]_)" M3ZK=#^S(7K12]LRR^0L,G//N'&\$Z:>1,FFT^7"O/\8L=+!HC!,+;5Q$QF2% MX1P^3M9PVPZ.EM.FSE!'!DQ:6*%946(MM>Q6Q,AXSFQ*(B@?Y"S0'8$MHD:#% MI25N[IY3SXGR)!GHLK6*9"/^KH'/*XT?B?>/B,RU=A#,*2?;*%=@.8!(%$52 M?N%:YGL:A+\QB+PQN9+FB7\BM:V'I2!";(H'R%/G*E]2HY!5LOV&=D M_//*!XVL"C2$ZYRB33R0=<656J,P Y/_8,.!>=X/_X#81C:@0?%!&R'U1?,2 M*Z343K;R7H+((J?3T4X,45- M2@@]RR?/?MT(U=!, D4Q=I*L5;0"()/D_&;? 2HDF 7*_F#'CQY:5!SPV(83 M7GOP5':O28N= AHJ"AH6[I@.A)M23S/0!/ M[I^GKDISL*JGJ&IB8$M(,+,(Z M;\!E6N/!:P,K)_E-O"MX"B[+XAG@,-4$Y)(F(. *O9E N+" ."5R>R[?8C.F8<=FD>9H34#MU M- -8+HP\G,*+8C"@N:8XG1OCN*J3=.&%7P(^75;'B26PFD[N]N3/I,B0S::S MJS09H/,2F-6\4BD$Z@_R@++ZJ_UGK%UFTC$A096LT1U?J[ BROW55:J)H%3: M!B GNA%=Q?J*V$M%_KIE4@!'Q@ B.<.;FR05%;UJ.#_ =MCT!+)B@!@&MH%V M4,1.C!PU(F 2=_0^+PFP45A:JT5&7"3#TDK!#2@$V", MRX9FWYZ?MAD[&U7V!GG*,2X=8_HH:'N9I%Q0AEO*?A^-B"Y,)3'^O"!,G^/P MG+[5/JF\2("U ]IH\R&R*.-8%$HHD0,MDPGG^ ;VJ,.X/?&&3$"TRX-(;>/U M*/L3,DPJXH"@H0-73K!+WM%"XJN_).HPKV(?BIOXZ MVD377!='T&(^6!Z!K122N>1642C?'%&O7QE\*+V1[!KPA0^ODF5=S F"J.P1 M<32\#,3HJ[O<@II-O@;UOQ![@WV'HCJXD,$GA],7S67K Q/)TK@I%2"&^UL9 MEA_+)_!4: M2-I7D;(C#)-=5* !L&,%K"!?:#Z+&#(G/X7> _):W)S>K1U0V\J+YHBE\$G[%X@!=P/?VM6A8=NW1.D/9@ $[.;-*7(Q6![A T6T)9_!JNM M*AU81Q?7U^)0>M:3<0_I<4V(^WZ-NP:UH^#DI=8)Q$7H/"^RN$?"F2]G5V^HD@9UY^%'_^\)L :?Q8>\1]_"FB*+8GB&)TU3\<08#;L] MI59_V#_M[R,5GIC(X&'CRA.%^A 6Y)P/&=7 M' 1U/FS&;B&>!-5@;* MJ-YBZ027\KT'-;E6N3\;'GOMA+\>FJP] FX3GI _YQH.YKNDK*C49ZG#J,QK MR7EX9P-I:"+JR$/&3DY*"\&Z &3P*'N6I/F9FA"Q%Z/'+ZEX2)-98UR*., * MN1MEZ*&- 92F31X3[=-3V7'1S &-M5A0>JXC]F"IU1TR-C4&\N4$IU)E#CC> MRD*$;/4>08K)@/+^L->)2CY& XP?=^M?5H F,,/79(4BF40;N_CR*SP$,J23 M;%TKWP(F3;2?K#/O6=0&4&5.,?VBY/@T?AY1A8/)\6&#$56-G](:?K;7_Z?.,/%B8'S^]#Y?21^4^GEK>O M?QN:WT;[;3_6F1-Z\9H( "_?.XR&@SZ6EQVH__0GVSL*X,/3PZ/&R_2W+S>V M+N,X&AQ/&B.I3[YA&7HB9PA=S!T4;NXR> 1=4>G6Q@1+Q'35-'-8<F.@VC MXZ,)K,N9O'5*%NH\[P5R=\1;_K*!$R M!6(7'?TEV@\XO/G!K'G<$]Y\*#;;KB5495KZB,VSDH':9/*Y@>%"^6K$J3GT M8DJ\KMBJP(%!1!:#]3Y:G2>F"JFQV:SC;FW'C,NK>UHHB2H M"Z3&OX-C:Y=\RTX@C=0=0F5IFP#*/&96&=JOFH;$5F [8 -@U(B<]N(JIYQU MQ31I"C=2\?/A&%1'^^56DV$0C8:'\+-_>*A8=QO2)7Q[#!,>19/I2&"9 MM$G.IC VZJR#:#A$#C^*C@_[^R+0KL;MX3*%N<;1X6#4N5_R$[+7])D83I#M MC:/)<;]C>G@")A]&_:,C9W*O89&[!N;!PVC2'WJM7)Q60K-@+:ON(D20])[^ M%KXTZ07&^YA9=#(98(W\$%ULUD@K)3>>#?!+=KX@2U[GZ.L[.SO!FL /\D[\ M%*_6P!U@P3JGP$JNNG%[IF#UYFM. M9VV6?^"[@\,^BI?!\'B?QP(",C3#'@@0J\"]2C'MBSTXY,.A?8"JWZA&48R. MX.LQ8.)H=$0CX5IPY*D:>0PCOS$>")7DX!:"&V47]%(@F057TY, 3(A2^V,Q M&0&Y'_>[^CB==7<@"CQ".,0*F/OI0Q'GD'S8WN!6AK=5B4/6 "Y!WG-MW)7, MP RI=*XB'YM)7T'@30Y'#$1@,N\=?H)6]8&6Z_>F(GP(@Q1Y/.2C.P)]Q&\WTN1B>LY-S\V8?/VD11'>U2I0B1YT\1 MF*8O_@(WJ"&%>3^-0MQ(5?9JC]QBU_6[1JXF7>MBU") 9278M0(MNR$!-S83 M=L.:# -\KA,67)^J9P,M/,7]%R:GS:0-FO _1;4IRFG IS,-S&(UCO3$6XI& MX2I1AX-_(V&\HD[]@O6,(TN(TU(;FRODE D:O:B$EFB?LZ$]I_A'#D)GA6D5 M"1;)S%*,/L1<@4EN22=!CR);!ETP("#%-=@?E9L9H%R).GQE4D+QV+3P5@+* MGJ*IJJ!:3D[89CQ2N9T]2X(JU8PB1I3%VLB5">5@EFX7)#>=U-,XVWTJ2(75 M0+:I[+N3E]5NJ6R5CG%^@V68JJ8.V"@Q9I?CF*TR@]QB&QZ8_W1GLT;HQXH\ MS:-I3M"O4 8?8@UQ[?3H.*#_,9OFWS=9ASB45M9XN).6GD:380I#-!A.Q1FF M\Y&767]_($;'^'\M"_P1:9N/ \]8@68P/%0_=P01[]P##>@4^_QC%P#IPQGT MC]7/-G .Z%/\+P08_)\&2W,<#%REWALN7U9, !F:FRS?0G?>A1W)S8?=3%*- MU%B_E.B,G!+(Y\A"00Y QH>;TXK#%0XFL8_QKU#\>]C0QVV.\+T-P)?(HNIU2J M)$TUYZR^1I>R;V*U]F'I9-[1<)69BNXJQ,OL6)G=,ID8R.C&O:D8B5_5J0I* M#ONZ=[3MHD48KON],G,@5GS@V"[/Q&B"%M (F=YHB(&Q(][W<(R_@#TCP/B" M3XZ W2('GN+_X>_CYM_PZ-$Q_#T5@B3$\PWPH56;0 W3]N6*E8#/1A_T>:)@_9^38(R&XC_QW)'Z;H^=) MEY;P1J?TZ(US7)2P1DR,[$B .\9G.*"RJ?V?&_7W-*%&P5(C/^!">69..#^+ M,P&NW$R 1W05Z_=$U])V82)MWD%7,ZC<_PM9<@==0D_%HDZI? +U#R"3S+0& M8SJ"3[@:.365??B]BXIM?!E%4^PP$HV/N.>'B94*;@90$I=3"YYW2D"G"H\<6]Z[6@I$O5MD1E75:8!T2 >2%TYTXPU%1/$_O)!4EO M'$A_=^+DY\-^.NCWGA@OI[C4B@5?8]]M/T>F'W-);;D#:QO>BP.>Z"@$*<<1!/@%K^5 M)((:;A; VEOJ(>O)K$%T-!G &$>XW0EH/PJ.W=46&",9(ML9*1=H1Q<=4HWJ MS/$=-1I]DDO*21JLJ0>,8:0:[5CS&$>'H* ->T=WNUM'H?,&:$.7^ MGTS1ES(:'RL5HEG/S[$3+*YIE V[#)88X MAXXH]%0W$J!FIXJ?]R)56]LYIV(913](%F1(3XZ!GL9^V)0BT)_BKZ'^O/J[ M;W'P# 8(3CN+:BE$&EB66Z?Z7+4\-NG.#C/&PF 3ZDIVKJ32B5PF5J)[9;"L M:1; VNF[I]8=G^CP;3>H)5^YQ&?V2LYCE:;6IB$.07 R. QKJ@]5'X)2^0#0 MI"6W#]5#8YL-SS_7OA7EQ"V!?M##WW2TPY[8/'CSK],MM;UM"\147*-*H&RB M%/0HK"G *HO2-(A2C30HN=OT*-!%0<"Z3=\K*LU1;W.^->(#]^9S CP+[DFI M&HJ&6MWMWBT"HY%J7)LPZSKLR$VEBB_,-BD;5D:VMU2CMYC?W=')(J<,1!V0 MXLCE?:/80$^,WUUC(GE&8URKFGH,^$9:YTE65WA,ZGV30LXED"2UL)FKDQM@ M4UFI00-M0PU)0>K\/DY!MKOMLRD[*U#.<9>; 9S]45F?JI*GKBTEBJ("-7$V M4^.*P?ZIB4RJTZ/M^P5+$!C<@!^3?LBTCIN]QVT61D.ZH4:E!():!)48.5YL MYUWEQ(K]C?&4[\!"E54E7A7YG1(]ZI@YJ<$V4JHDE3MS$91JBN[H/RN)'(UB MA-K7WZ@Z /7+')K3I9)Q %L$8CP;;W04Q:3@4B=>UTP [0%;WM>@[@X/=;][JGQY/4-,SFMN M.XQ13#QTW3148#!,YVLTFUP1LMBUV/V:XFN8\>.\RLE9.FA/2OTZ*;F$S0Y. M2M7.+)PV-'9K"2R:V9CBK!RJ%T/B5K [C4SUH&JL1'LT)$6;5/#-\.ADQ[JQ M!XURM!ID(@*#T^?>HPU[KMT2C%HG=@/+PD4Y@QMB+T/GWV>\N1/]0&<252KL M==Z^1 M>SDVO545ZG%INS2J2FJ$$O5/T,FC]Q M3^7S:U^G/N>/K<8=%691@!<5*=?P9BH-H78LO5:$X0/' %&9<93:=XY4CWD1!5P7S7$7#UXH1 MNU=A7NJT<>].Z>P6[ MDG"; ^[7-N?D<^TGHQ4H5*1[RU#A1)KA'COV7US.AUB)W\LY9W>_!5)S;O?B M5(DE;7.F;S4Q(9;S(D=/0"EFI)2R!&X=DSY9>[N,KJ]3T'*:G;3NA*'@0.M* M&%R0KJ+B6F>^"<;>_=)P1G![0]N2SWAUW%X>)>7/E#;Y72_YVKGP%"> =?/X M <2E]&P*4;([=6$ZEZ#/0GFX8?6N&JSDYD1;:ICW&B71%O"04=9]8GI)7H0NV8U088[=_E'Y: MM$Q_C8\.1>O>6W$8'1X> MP\O'\!N6\[EWUE)8#P4DYLOUN<;G^&CK$B;.$K!Z^)F8]L=<=G5T["U@"B.. M40A'0UA>>_HC7/^0DO7&_9&:^CU/_:9;ZR#=9@:J!X"5BP2' UK!<#J@GLB< MUHQUB1,Q'AP9\.A5^A<-M/2J ]HDZKR<;W&)MTIM>VOS50;>LY_DUTJ\ BSY MLJLLF?1\#?"O_Q%:JI@M*]W>)KFWXQ[NV MH2T?/[/(?^"-2.VWGFZ#>+H-XNDVB(?>!N%G3SG7!E!F/_>.QP18IP\$_LG+ M^6PZ(ONY6!V4^VUS/-U?\71_Q=/]%4_W5SS=7_%T?\4_P_T5;0F\8P!L-U'[ MR.!:(QOKZ4J-IRLU&J4G3U=J/%VI\72EQM.5&D]7:CQ=J?%TI<;3E1K_ %=J M^$HV.A<:4=TBYQ3\T'4+'=KUME&>+O)XNLC#NU=C[Q,Q.2]+X'(.:DK-^KE] M-](=EGDNIVTNCTD$?F$"990OL!OR?FHKVK9APTT"G+C ONBE:7%F?6$=,8A& MC4?C!@SG#@UR)SF- YZN@/B'N *B&[>C79$R:AT*G@/Y'#*L;GA 2LR6+/+8 M%#+I^)\J=5>.SV9?DK8-HZ\FL=CNHKA65ARWD#:N.IQ#UB!=:=#$56,-&348 MUJ BT?SB'_?*C:TW9NS$_MIO[8887DM_E14<[K5?FJ"/;FM@+Z]YNB+AG_&* MA$[4F[G-]3'73A4,!"Y.>#R+4LDPG+H=MV:DS#4S:V)GM5F]GK/[Q=_U#0:[ M7"NP"RO8?F-!QQGH%UW^O9WB_\DO(>@$>5,04TS>BLW.T1Y^*&3Q-2<*R.@V MFS,^GY PUGE9X7*E;,'GUU8\G[J8/W4Q?U@7\]V;AN_$V-['E4YP1H./0='= M>7R[$>@V+@R%NOABAQ0^?.CE_6R?G1[1BW@EKM&&@4G]55\_=<"7\ M;M.H.=AJU%!O(8>1/C4PWM# N'V4!$!3;?J']P0AO_S&.7";5,K7<(*$-&E3 MCU%&W215LDOUJ(@"KQ),N@!B.XLK:A'!5;3DGL&7WU.C3>==&R=UT[%06T:@*NK,'47'0_?'4._BI M=_#W[AV\FW\:^Y#,5?$1VLB:N>R.S$\M@[]#RV#/W.;8K#*Q&NRFP:O>L.Z] MXVD]M27^7FV)MW=NV4D=#/='44[$/58M_%O5[]SV[2TI]&4^"F@_X@ MF@)_?D";%HPI\B]C/Y[2\'B!TL0ZTZU;!OM=3L_41^C.)%1=Y+0CX;HE57S0 M)L6YP^JQ=*7SM&W/A!Q3E25TY)R#WF=IEC#U0),HF$2DI+_#8TL/A;7<:9=(GNO914GV(E4?D5+8!^H MZ?/E:['W#/EF@CGIJD;9CS'.>\;YN'&./YQA^A/E WA&]X54[>9,B[0]-[3R M6F(:9[4?,6K[_AU5*4:_O+$D'Z%R?@+C3'30PT_MV MN/'K;8O,_( -#J>A@0?!3\UTG^[RQTZW&4(LXQXW]&"P<>BWF/CZN)$[ M4P05M]R=2SJ1V!>;DK7<:2(G1:MKA5Y^7BLG;]G(P.-,.Y54Y\+D6Y;@\G#6 M,#ZVTLCTE,/_C"G]K#6;)?:=IMN&!IB@N/GXWV-=J%;7%,;XXJ5(;MDK87.0 M3VT%?3.3KVNMF^+B[6>_2P[:A@4TM=0 A]6Y-=,==Y>]CZ+ ]AIC9!I0; MM8UP(MBVX?V8M!^\W#!3(*VK\^G.W*[.-S9E;G5RTW!NW=8CH_;@7>EV6]_> MFE_W<)1Q%=T.76-GI&JK+]N4K1TRX0QB;Y[Y%*"RQ&I0J?J8^$-M0FK43@.) M8,:HSA8'VG# M]COXZ"O=3 -T]BO50ST27?S-\O%V1/'E6S[*L_!11HWST*&!2 7L%NP;?ZW1V=E)MYCK KDC1SZIJY^H MO,O<&LNAGE*$S/AFIB@$HH^V MG<2[/%]@F5B7DT /_W8CV4?&?VZBN)^Y#1+&:7=*_GRP; V-LHG[[)BRN2%W MLOU5.W4S8&XW0_O#L '=F<'Y8+B],A6/2G?R +M3?I[/_MQ$/8^1 MIGFY8F'-],]D%UX!SKE(W/FU* M(7R$ZGE5.?K\1M)HI^X%4=)+DPMJFSJX[=/"IHR[]M.AK+LPM##DYQ8K,N@Z MY;G*6.1W70!WO6']K/Q.UW,[G-W#U8#6Y&0]8O-D*RR['&Z\''@P4=()RQY] MA+]'<^E??O8SS,KL)CI$I8C#&UNP+#(23UQ0*Z!+ODF]VY4U[DU]9XHWJLJ. MO0]NXU=UVA-J&\/^-CK0VK%V>Y]WH. ':I8*WZ*TU2)3_=F-+F%_UB[9G@Z! M/Q//=2!1_;,)2=PX4G,FHX9LHGW.G7R."8\Z(_22)_UH<\$"#".8L[DUE]'D M;U&F7@>+IF27]G>3L(_59&%NG3J4,>IX;#J31Q\Y7CO%]+'+FXG"P"=PEZSFDY#R&!D\X9_+XCDC32#FM7535Z$XF!=;[ 5 MMNO3&QB@XZ.=F6;43D9^":3[K(.]E:@B /?$AG]DRL$A8/ UWTYBC'\P+=OM$F"ZFDK:<"P-.8DJXO;JWAZ/?Z,9*?VPCNL[U_;+^<+B= M3MYG'@]%*@/"5!%&5U""OE5NA=>'>VO*,'L6@$@]$*HN_%VT)\:AMOTQEF&]@" X*3 MT2.3UOWO'0C1?+J=>OZPMVQ6^L/>L_GJ#WO/)K+O]MZF?/7=1G!3UKO>,%F< MV@O5)%KW2#;0Z;9!_)/Z#H.Y!_@=AG//]3L,YQ[W-PRW&0N^8> FMPX%CAP$FAENT M75NR8\MS5"331 M6-"A,AV%/NVJE>D@(&]E_8XLKJU8,=S=H_?-Z!(U7R-7\R8,FNFK_$3GU.&B MGY>A,ICN++V.DIBN%S;4R&Q4>#>>0\"_^@C5L M.'9[6QM9?.UM78-T)!+,F M"+:]:IOQN95WK'>J9OC5O,XTCTXI!O7_!U0$,%M5,@L+.H=@;7J%7V>L 3"+!/ DFL&RF MGK?-7A/JWK8BOX_38#;B9;U>I_=.&F^D'?3J7K4N'Z%18&RH)0([F+PIE$2P M(37A@I9SWTH>[O:O;GL>E G,Z^2.LML&V9#6&Y3GV^<^4Y<74YN@3C_S8T>_ MK*\.U/7(DHJ[-F\S5+H8#%Y^'T/>%@B&%O+H>D'?%VI*!3OU[ =4#G:N=5/A MX ,@S4[^W6-('46&>,\FE_RI1JF-0D]3&6/GWZB)N'.4786,+[?6\6V)[P=J M^KJ3[A];W_<(Y-_BG_\6=Y6ODCRV5"5D%85'LQO<==S.Y08K'1^<[["Q[G%+ M94\P>;95[.<=2>MN]$[M*W2S?:% Y=&6T?>EZ6U7!E&UL4$L! A0#% @ Z(JJ2$AU!>[% *P( L M ( !,@( %]R96QS+RYR96QS4$L! A0#% @ Z(JJ2 R( MN@0) @ 2R, !H ( !( , 'AL+U]R96QS+W=O&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0 ( .B*JDC..)7U1@( 'H* M - " 8 0 !X;"]S='EL97,N>&UL4$L! A0#% @ MZ(JJ2(^#D@2G! NQ( \ ( !\1( 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ Z(JJ2 0=;;T5 @ -@< !@ M ( !AAX 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0# M% @ Z(JJ2%5CX%2> 0 L0, !@ ( !HR@ 'AL+W=O M&PO=V]R:W-H965T&UL4$L! A0#% @ Z(JJ2'D.-ANA M 0 L0, !@ ( !(BX 'AL+W=O&UL4$L! A0#% @ Z(JJ M2,%<>/B@ 0 L0, !D ( !SS$ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ Z(JJ2+&40O"@ 0 L0, M !D ( !4C< 'AL+W=OC * ! "Q P &0 @ $I.0 M>&PO=V]R:W-H965T&UL4$L! A0#% @ Z(JJ2"&JWJ&? 0 L0, !D M ( !USP 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0# M% @ Z(JJ2/%!B0VB 0 L0, !D ( !6T( 'AL+W=O M&PO=V]R:W-H965T&UL4$L! A0#% @ Z(JJ2,\/ M5U"C 0 L0, !D ( !)$@ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ Z(JJ2*Z\P@.C 0 L0, !D M ( !LDT 'AL+W=O&PO M=V]R:W-H965T&UL4$L! A0#% @ Z(JJ2'\U^Q6] 0 >P0 !D ( ! M25, 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ Z(JJ2)GTXK4W @ O 8 !D ( !"ED 'AL+W=OQ> !X M;"]W;W)K&UL4$L! A0#% @ Z(JJ2)2GQE[\ M 0 ]@4 !D ( !@6$ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ Z(JJ2'ON1=5- @ -PD !D M ( !WV@ 'AL+W=O&PO=V]R M:W-H965T&UL M4$L! A0#% @ Z(JJ2&5*=S>$ P :1( !D ( !_6\ M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ MZ(JJ2%D>TV=F @ XP@ !D ( !1GD 'AL+W=OP >&PO=V]R:W-H965T&UL4$L! A0#% @ Z(JJ2-43P<@F P M80T !D ( !(($ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ Z(JJ2!3<%%$X @ < < !D M ( !&XH 'AL+W=O&PO=V]R:W-H M965T&UL4$L! M A0#% @ Z(JJ2%[4814% @ H 4 !D ( !C)$ 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ Z(JJ M2,CT7UB4 @ JPD !D ( !)I@ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ Z(JJ2"PKLMZ9-P ' $! M !0 ( !_IX 'AL+W-H87)E9%-T&UL4$L%!@ 0 !# $, 1Q( ,G6 $! end XML 71 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 72 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 74 FilingSummary.xml IDEA: XBRL DOCUMENT 3.4.0.3 html 125 230 1 false 55 0 false 4 false false R1.htm 101 - Document - Document And Entity Information Sheet http://www.eksobionics.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 102 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.eksobionics.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 103 - Statement - Condensed Consolidated Balance Sheets [Parenthetical] Sheet http://www.eksobionics.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets [Parenthetical] Statements 3 false false R4.htm 104 - Statement - Condensed Consolidated Statement of Operations Sheet http://www.eksobionics.com/role/CondensedConsolidatedStatementOfOperations Condensed Consolidated Statement of Operations Statements 4 false false R5.htm 105 - Statement - Consolidated Statements of Cash Flows Sheet http://www.eksobionics.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 5 false false R6.htm 106 - Disclosure - Organization Sheet http://www.eksobionics.com/role/Organization Organization Notes 6 false false R7.htm 107 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies and Estimates Sheet http://www.eksobionics.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAndEstimates Basis of Presentation and Summary of Significant Accounting Policies and Estimates Notes 7 false false R8.htm 108 - Disclosure - Fair Value Measurements Sheet http://www.eksobionics.com/role/FairValueMeasurements Fair Value Measurements Notes 8 false false R9.htm 109 - Disclosure - Deferred Revenues Sheet http://www.eksobionics.com/role/DeferredRevenues Deferred Revenues Notes 9 false false R10.htm 110 - Disclosure - Intangible Assets Sheet http://www.eksobionics.com/role/IntangibleAssets Intangible Assets Notes 10 false false R11.htm 111 - Disclosure - Accrued Liabilities Sheet http://www.eksobionics.com/role/AccruedLiabilities Accrued Liabilities Notes 11 false false R12.htm 112 - Disclosure - Maintenance and Warranty Sheet http://www.eksobionics.com/role/MaintenanceAndWarranty Maintenance and Warranty Notes 12 false false R13.htm 113 - Disclosure - Lease and Note Obligations Sheet http://www.eksobionics.com/role/LeaseAndNoteObligations Lease and Note Obligations Notes 13 false false R14.htm 114 - Disclosure - Capitalization and Equity Structure Sheet http://www.eksobionics.com/role/CapitalizationAndEquityStructure Capitalization and Equity Structure Notes 14 false false R15.htm 115 - Disclosure - Stock-based Compensation Sheet http://www.eksobionics.com/role/StockbasedCompensation Stock-based Compensation Notes 15 false false R16.htm 116 - Disclosure - Income Taxes Sheet http://www.eksobionics.com/role/IncomeTaxes Income Taxes Notes 16 false false R17.htm 117 - Disclosure - Commitments and Contingencies Sheet http://www.eksobionics.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 17 false false R18.htm 118 - Disclosure - Net Loss Per Share Sheet http://www.eksobionics.com/role/NetLossPerShare Net Loss Per Share Notes 18 false false R19.htm 119 - Disclosure - Segment Disclosures Sheet http://www.eksobionics.com/role/SegmentDisclosures Segment Disclosures Notes 19 false false R20.htm 120 - Disclosure - Subsequent Event - Reverse Stock Split Sheet http://www.eksobionics.com/role/SubsequentEventReverseStockSplit Subsequent Event - Reverse Stock Split Notes 20 false false R21.htm 121 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies and Estimates (Policies) Sheet http://www.eksobionics.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAndEstimatesPolicies Basis of Presentation and Summary of Significant Accounting Policies and Estimates (Policies) Policies http://www.eksobionics.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAndEstimates 21 false false R22.htm 122 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.eksobionics.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.eksobionics.com/role/FairValueMeasurements 22 false false R23.htm 123 - Disclosure - Deferred Revenues (Tables) Sheet http://www.eksobionics.com/role/DeferredRevenuesTables Deferred Revenues (Tables) Tables http://www.eksobionics.com/role/DeferredRevenues 23 false false R24.htm 124 - Disclosure - Intangible Assets (Tables) Sheet http://www.eksobionics.com/role/IntangibleAssetsTables Intangible Assets (Tables) Tables http://www.eksobionics.com/role/IntangibleAssets 24 false false R25.htm 125 - Disclosure - Accrued Liabilities (Tables) Sheet http://www.eksobionics.com/role/AccruedLiabilitiesTables Accrued Liabilities (Tables) Tables http://www.eksobionics.com/role/AccruedLiabilities 25 false false R26.htm 126 - Disclosure - Maintenance and Warranty (Tables) Sheet http://www.eksobionics.com/role/MaintenanceAndWarrantyTables Maintenance and Warranty (Tables) Tables http://www.eksobionics.com/role/MaintenanceAndWarranty 26 false false R27.htm 127 - Disclosure - Lease and Note Obligations (Tables) Sheet http://www.eksobionics.com/role/LeaseAndNoteObligationsTables Lease and Note Obligations (Tables) Tables http://www.eksobionics.com/role/LeaseAndNoteObligations 27 false false R28.htm 128 - Disclosure - Capitalization and Equity Structure (Tables) Sheet http://www.eksobionics.com/role/CapitalizationAndEquityStructureTables Capitalization and Equity Structure (Tables) Tables http://www.eksobionics.com/role/CapitalizationAndEquityStructure 28 false false R29.htm 129 - Disclosure - Stock-based Compensation (Tables) Sheet http://www.eksobionics.com/role/StockbasedCompensationTables Stock-based Compensation (Tables) Tables http://www.eksobionics.com/role/StockbasedCompensation 29 false false R30.htm 130 - Disclosure - Net Loss Per Share (Tables) Sheet http://www.eksobionics.com/role/NetLossPerShareTables Net Loss Per Share (Tables) Tables http://www.eksobionics.com/role/NetLossPerShare 30 false false R31.htm 131 - Disclosure - Segment Disclosures (Tables) Sheet http://www.eksobionics.com/role/SegmentDisclosuresTables Segment Disclosures (Tables) Tables http://www.eksobionics.com/role/SegmentDisclosures 31 false false R32.htm 132 - Disclosure - Organization (Details Textual) Sheet http://www.eksobionics.com/role/OrganizationDetailsTextual Organization (Details Textual) Details http://www.eksobionics.com/role/Organization 32 false false R33.htm 133 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies and Estimates (Details Textual) Sheet http://www.eksobionics.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAndEstimatesDetailsTextual Basis of Presentation and Summary of Significant Accounting Policies and Estimates (Details Textual) Details http://www.eksobionics.com/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAndEstimatesPolicies 33 false false R34.htm 134 - Disclosure - Fair Value Measurements (Details) Sheet http://www.eksobionics.com/role/FairValueMeasurementsDetails Fair Value Measurements (Details) Details http://www.eksobionics.com/role/FairValueMeasurementsTables 34 false false R35.htm 135 - Disclosure - Fair Value Measurements (Details 1) Sheet http://www.eksobionics.com/role/FairValueMeasurementsDetails1 Fair Value Measurements (Details 1) Details http://www.eksobionics.com/role/FairValueMeasurementsTables 35 false false R36.htm 136 - Disclosure - Deferred Revenues (Details) Sheet http://www.eksobionics.com/role/DeferredRevenuesDetails Deferred Revenues (Details) Details http://www.eksobionics.com/role/DeferredRevenuesTables 36 false false R37.htm 137 - Disclosure - Deferred Revenues (Details Textual) Sheet http://www.eksobionics.com/role/DeferredRevenuesDetailsTextual Deferred Revenues (Details Textual) Details http://www.eksobionics.com/role/DeferredRevenuesTables 37 false false R38.htm 138 - Disclosure - Intangible Assets (Details) Sheet http://www.eksobionics.com/role/IntangibleAssetsDetails Intangible Assets (Details) Details http://www.eksobionics.com/role/IntangibleAssetsTables 38 false false R39.htm 139 - Disclosure - Intangible Assets (Details Textual) Sheet http://www.eksobionics.com/role/IntangibleAssetsDetailsTextual Intangible Assets (Details Textual) Details http://www.eksobionics.com/role/IntangibleAssetsTables 39 false false R40.htm 140 - Disclosure - Accrued Liabilities (Details) Sheet http://www.eksobionics.com/role/AccruedLiabilitiesDetails Accrued Liabilities (Details) Details http://www.eksobionics.com/role/AccruedLiabilitiesTables 40 false false R41.htm 141 - Disclosure - Maintenance and Warranty (Details) Sheet http://www.eksobionics.com/role/MaintenanceAndWarrantyDetails Maintenance and Warranty (Details) Details http://www.eksobionics.com/role/MaintenanceAndWarrantyTables 41 false false R42.htm 142 - Disclosure - Maintenance and Warranty (Details Textual) Sheet http://www.eksobionics.com/role/MaintenanceAndWarrantyDetailsTextual Maintenance and Warranty (Details Textual) Details http://www.eksobionics.com/role/MaintenanceAndWarrantyTables 42 false false R43.htm 143 - Disclosure - Lease and Note Obligations (Details) Sheet http://www.eksobionics.com/role/LeaseAndNoteObligationsDetails Lease and Note Obligations (Details) Details http://www.eksobionics.com/role/LeaseAndNoteObligationsTables 43 false false R44.htm 144 - Disclosure - Lease and Note Obligations (Details Textual) Sheet http://www.eksobionics.com/role/LeaseAndNoteObligationsDetailsTextual Lease and Note Obligations (Details Textual) Details http://www.eksobionics.com/role/LeaseAndNoteObligationsTables 44 false false R45.htm 145 - Disclosure - Capitalization and Equity Structure (Details) Sheet http://www.eksobionics.com/role/CapitalizationAndEquityStructureDetails Capitalization and Equity Structure (Details) Details http://www.eksobionics.com/role/CapitalizationAndEquityStructureTables 45 false false R46.htm 146 - Disclosure - Capitalization and Equity Structure (Details 1) Sheet http://www.eksobionics.com/role/CapitalizationAndEquityStructureDetails1 Capitalization and Equity Structure (Details 1) Details http://www.eksobionics.com/role/CapitalizationAndEquityStructureTables 46 false false R47.htm 147 - Disclosure - Capitalization and Equity Structure (Details Textual) Sheet http://www.eksobionics.com/role/CapitalizationAndEquityStructureDetailsTextual Capitalization and Equity Structure (Details Textual) Details http://www.eksobionics.com/role/CapitalizationAndEquityStructureTables 47 false false R48.htm 148 - Disclosure - Stock-based Compensation (Details) Sheet http://www.eksobionics.com/role/StockbasedCompensationDetails Stock-based Compensation (Details) Details http://www.eksobionics.com/role/StockbasedCompensationTables 48 false false R49.htm 149 - Disclosure - Stock-based Compensation (Details 1) Sheet http://www.eksobionics.com/role/StockbasedCompensationDetails1 Stock-based Compensation (Details 1) Details http://www.eksobionics.com/role/StockbasedCompensationTables 49 false false R50.htm 150 - Disclosure - Stock-based Compensation (Details 2) Sheet http://www.eksobionics.com/role/StockbasedCompensationDetails2 Stock-based Compensation (Details 2) Details http://www.eksobionics.com/role/StockbasedCompensationTables 50 false false R51.htm 151 - Disclosure - Stock-based Compensation (Details Textual) Sheet http://www.eksobionics.com/role/StockbasedCompensationDetailsTextual Stock-based Compensation (Details Textual) Details http://www.eksobionics.com/role/StockbasedCompensationTables 51 false false R52.htm 152 - Disclosure - Commitments and Contingencies (Details Textual) Sheet http://www.eksobionics.com/role/CommitmentsAndContingenciesDetailsTextual Commitments and Contingencies (Details Textual) Details http://www.eksobionics.com/role/CommitmentsAndContingencies 52 false false R53.htm 153 - Disclosure - Net Loss Per Share (Details) Sheet http://www.eksobionics.com/role/NetLossPerShareDetails Net Loss Per Share (Details) Details http://www.eksobionics.com/role/NetLossPerShareTables 53 false false R54.htm 154 - Disclosure - Net Loss Per Share (Details 1) Sheet http://www.eksobionics.com/role/NetLossPerShareDetails1 Net Loss Per Share (Details 1) Details http://www.eksobionics.com/role/NetLossPerShareTables 54 false false R55.htm 155 - Disclosure - Net Loss Per Share (Details Textual) Sheet http://www.eksobionics.com/role/NetLossPerShareDetailsTextual Net Loss Per Share (Details Textual) Details http://www.eksobionics.com/role/NetLossPerShareTables 55 false false R56.htm 156 - Disclosure - Segment Disclosures (Details) Sheet http://www.eksobionics.com/role/SegmentDisclosuresDetails Segment Disclosures (Details) Details http://www.eksobionics.com/role/SegmentDisclosuresTables 56 false false R57.htm 157 - Disclosure - Segment Disclosures (Details 1) Sheet http://www.eksobionics.com/role/SegmentDisclosuresDetails1 Segment Disclosures (Details 1) Details http://www.eksobionics.com/role/SegmentDisclosuresTables 57 false false R58.htm 158 - Disclosure - Subsequent Event - Reverse Stock Split (Details Textual) Sheet http://www.eksobionics.com/role/SubsequentEventReverseStockSplitDetailsTextual Subsequent Event - Reverse Stock Split (Details Textual) Details http://www.eksobionics.com/role/SubsequentEventReverseStockSplit 58 false false All Reports Book All Reports pnmd-20160331.xml pnmd-20160331.xsd pnmd-20160331_cal.xml pnmd-20160331_def.xml pnmd-20160331_lab.xml pnmd-20160331_pre.xml true true ZIP 76 0001144204-16-100556-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-16-100556-xbrl.zip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end